nlmpubs.nlm.nih.gov/2014.05.nlmpubs.nlm.nih.gov.tar/nlmpubs.nlm.nih.gov/bibs/aids/oct95pt2.txt

Text File | 1995-09-28 | 641KB | 9,287 lines

 IGA

   ANALYSIS

 HIV-specific IgA in infants born to  HIV  seropositive  women.
  American  Pediatric  Society 104th annual meeting and Society
  for Pediatric Research 63rd annual  meeting;  1994  May  2-5;
  Seattle.  Livingston  RA, et al. Pediatr AIDS HIV Infect 1994
  Oct;5(5):321 (unnumbered abstract)

   BLOOD

 IgA antiphospholipid antibodies in HTLV-1-associated  tropical
  spastic  paraparesis.  Wilson  WA,  et  al.  Lupus  1995 Apr;
  4(2):138-41

 IGD

   GENETICS

 Selective variations in  vivo  of  VH3  and  VH1  gene  family
  expression  in  peripheral B cell IgM, IgD and IgG during HIV
  infection. David D, et al. Eur J Immunol 1995 Jun;25(6):1524-8

 IGE

   ANALYSIS

 Immunoglobulin E levels in relationship to HIV-1 disease, route
  of infection, and vitamin E status. Miguez-Burbano MJ, et al.
  Allergy 1995 Feb;50(2):157-61

   BIOSYNTHESIS

 Staphylococcal enterotoxin B affects in vitro  IgE  synthesis,
  interferon-gamma,  interleukin-4 and interleukin-5 production
  in atopic eczema. Neuber K, et al. Int Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):179-82
 Humoral  immune responses to recombinant tree pollen allergens
  (Bet v I and Bet v II) in mice: construction of a  live  oral
  allergy  vaccine.  Vrtala  S, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):290-4 (15 ref.)

   IMMUNOLOGY

 Genetic basis of IgE responsiveness: relevance to  the  atopic
  diseases.  Marsh  DG,  et  al.  Int Arch Allergy Immunol 1995
  May-Jun;107(1-3):25-8 (19 ref.)

 IGG

   BIOSYNTHESIS

 Immunologic  aspects  of  vigabatrin  treatment  in  epileptic
  children. Pacifici R, et al. Epilepsia 1995 Apr;36(4):423-6
 Humoral immune responses to recombinant tree pollen  allergens
  (Bet  v  I and Bet v II) in mice: construction of a live oral
  allergy vaccine. Vrtala S, et al. Int  Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):290-4 (15 ref.)

   BLOOD

 Further  simplification  of  ultrasensitive enzyme immunoassay
  (immune complex transfer enzyme immunoassay) for  anti-HTLV-I
  IgG  using microplates and fluororeader. Ishikawa S, et al. J
  Clin Lab Anal 1995;9(3):204-11

   GENETICS

 Selective variations in  vivo  of  VH3  and  VH1  gene  family
  expression  in  peripheral B cell IgM, IgD and IgG during HIV
  infection. David D, et al. Eur J Immunol 1995 Jun;25(6):1524-8

 IGM

   GENETICS

 Selective variations in vivo of VH3 and VH1 gene family
  expression in peripheral B cell IgM, IgD and IgG  during  HIV
  infection. David D, et al. Eur J Immunol 1995 Jun;25(6):1524-8

 IMAGE PROCESSING, COMPUTER-ASSISTED

   INSTRUMENTATION

 [Measuring  retinal nerve fiber density with laser polarimetry
  in patients with AIDS in comparison with health probands with
  reference to computer perimetry findings. A pilot study using
  the nerve fiber analyzer] Thierfelder S, et al. Klin Monatsbl
  Augenheilkd 1995 Mar;206(3):165-9 (Eng. Abstr.)         (Ger)

 IMMEDIATE-EARLY PROTEINS

   IMMUNOLOGY

 Vaccination with recombinant vaccinia viruses expressing ICP27
  induces protective  immunity  against  herpes  simplex  virus
  through  CD4+  Th1+  T cells. Manickan E, et al. J Virol 1995
  Aug;69(8):4711-6

 IMMUNE SYSTEM

 Immune  restoration--conference  outlines  future  directions.
  James JS. AIDS Treat News 1995 Mar 3;(no 218):3-4

 IMMUNE TOLERANCE

 Autoimmunity following neonatal tolerance to alloantigens: role
  of donor I-A and I-E molecules. Kramar G, et al. J  Autoimmun
  1995 Apr;8(2):177-92

   DRUG EFFECTS

 Reversal of ferritin-mediated immunosuppression by levamisole:
  a rationale for its application to management of the acquired
  immune deficiency syndrome (AIDS). Wigginton JM. Med
  Hypotheses 1995 Feb;44(2):85-8 (45 ref.)

   IMMUNOLOGY

 In  the  absence  of  a  CD40 signal, B cells are tolerogenic.
  Buhlmann JE, et al. Immunity 1995 Jun;2(6):645-53
 CD4+ but not CD8+ T cells are required for  the  induction  of
  oral  tolerance.  Garside  P,  et  al.  Int Immunol 1995 Mar;
  7(3):501-4

 IMMUNITY, CELLULAR

   DRUG EFFECTS

 Effects of inhalative exposure to dioxins in wood preservatives
  on cell-mediated immunity in day-care center teachers. Wolf N,
  et al. Environ Res 1995 Feb;68(2):96-105
 Immunologic  aspects  of  vigabatrin  treatment  in  epileptic
  children. Pacifici R, et al. Epilepsia 1995 Apr;36(4):423-6

   IMMUNOLOGY

 Interleukin-4 is required for the induction of lung Th2 mucosal
  immunity. Coyle AJ, et al. Am J Respir Cell Mol Biol 1995 Jul;
  13(1):54-9

 IMMUNIZATION

 The need for physician education regarding pediatric
  immunization  practices.  American  Pediatric  Society  104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Matson CC, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):314 (unnumbered abstract)

 IMMUNIZATION, SECONDARY

 Antibody response to booster doses of hepatitis B  vaccine  in
  HIV-infected children. American Pediatric Society 104th annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting;  1994 May 2-5; Seattle. Choudhury SA, et al. Pediatr
  AIDS HIV Infect 1994 Oct;5(5):321 (unnumbered abstract)

 IMMUNOCOMPROMISED HOST

 Cytomegalovirus retinitis. Br J Theatre Nurs 1995 May;5(2):29
 Histologic patterns of basal cell carcinoma based upon patient
  immunostatus.  Oram  Y,  et  al.  Dermatol  Surg  1995   Jul;
  21(7):611-4
 A  case of protracted coxsackie virus meningoencephalitis in a
  marginally immunodeficient child  treated  successfully  with
  intravenous  immunoglobulin.  Geller  TJ, et al. J Neurol Sci
  1995 Apr;129(2):131-3
 Pulmonary infection in the immunocompromised patient. White DA.
  Semin Thorac Cardiovasc Surg 1995 Apr;7(2):78-87 (99 ref.)

   IMMUNOLOGY

 Genetic modification of T cell clones to improve the safety and
  efficacy of adoptive T cell therapy. Greenberg PD, et al. Ciba
  Found Symp 1994;187:212-23; discussion 224-8
 Nosocomial transmission of hepatitis A in a pediatric hospital
  traced to an anti-hepatitis  A  virus-negative  patient  with
  immunodeficiency.  Burkholder BT, et al. Pediatr Infect Dis J
  1995 Apr;14(4):261-6

 IMMUNODEFICIENCY VIRUS, BOVINE

   IMMUNOLOGY

 Seroprevalence of bovine immunodeficiency-virus (BIV)
  antibodies in the cattle population in  Germany.  Muluneh  A.
  Zentralbl Veterinarmed [B] 1994 Dec;41(10):679-84

   PHYSIOLOGY

 Monocyte function in cattle experimentally infected with bovine
  immunodeficiency-like  virus.  Rovid  AH,  et al. Vet Immunol
  Immunopathol 1995 Mar;45(1-2):31-43

 IMMUNODEFICIENCY VIRUS, FELINE

 Feline Retroviruses. Proceedings of an international symposium.
  Research Triangle Park, North Carolina, 6-9 October 1993. Vet
  Immunol Immunopathol 1995 May;46(1-2):1-194
 Quantification of lymphadenopathy  in  experimentally  induced
  feline immunodeficiency virus infection in domestic cats. del
  Fierro   GM,  et  al.  Vet  Immunol  Immunopathol  1995  May;
  46(1-2):3-12

   GENETICS

 Two different mutations in  the  envelope  protein  of  feline
  immunodeficiency   virus  allow  the  virus  to  escape  from
  neutralization by feline serum antibodies. Siebelink  KH,  et
  al. Vet Immunol Immunopathol 1995 May;46(1-2):51-9

   IMMUNOLOGY

 Analysis  of  leucocytes  and  lymphocyte subsets in cats with
  naturally-occurring cryptococcosis but differing feline
  immunodeficiency virus status. Walker C, et al.  Aust  Vet  J
  1995 Mar;72(3):93-7
 Neutralization  of feline immunodeficiency virus by polyclonal
  feline antibody: simultaneous  involvement  of  hypervariable
  regions 4 and 5 of the surface glycoprotein. Siebelink KH, et
  al. J Virol 1995 Aug;69(8):5124-7
 Is  it possible to catch leukemia from a cat? [letter] Nowotny
  N, et al. Lancet 1995 Jul 22;346(8969):252-3
 Serological diagnosis of feline immunodeficiency virus
  infection using recombinant transmembrane glycoprotein.
  Calzolari M,  et  al.  Vet  Immunol  Immunopathol  1995  May;
  46(1-2):83-92
 Evaluation of an autologous red cell agglutination test, VetRED
  FIV, for the presence of FIV antibody in cats. del Fierro GM,
  et al. Vet Immunol Immunopathol 1995 May;46(1-2):93-101
 FIV  vaccine  studies.  II.  Clinical  findings, hematological
  changes and kinetics of blood lymphocyte subsets.
  Hofmann-Lehmann R, et al. Vet Immunol Immunopathol 1995  May;
  46(1-2):115-25
 Recombinant  FeLV  vaccine: long-term protection and effect on
  course and outcome of FIV infection. Hofmann-Lehmann R, et al.
  Vet Immunol Immunopathol 1995 May;46(1-2):127-37
 FIV vaccine studies. I. Immune response to recombinant FIV env
  gene products and outcome after challenge infection. Lutz  H,
  et al. Vet Immunol Immunopathol 1995 May;46(1-2):103-13
 Tumor   necrosis  factor-alpha  responses  are  depressed  and
  interleukin-6 responses unaltered in feline  immunodeficiency
  virus  infected  cats.  Ma J, et al. Vet Immunol Immunopathol
  1995 May;46(1-2):35-50
 Vaccination against feline immunodeficiency virus using  fixed
  infected cells. Verschoor EJ, et al. Vet Immunol Immunopathol
  1995 May;46(1-2):139-49

   ISOLATION & PURIFICATION

 Competitive reverse transcription-polymerase chain reaction for
  quantitation of feline immunodeficiency virus. Vahlenkamp TW,
  et al. J Virol Methods 1995 Apr;52(3):335-46
 The  feline  lymphoid  cell  line  MBM  and its use for feline
  immunodeficiency virus isolation and quantitation.  Matteucci
  D, et al. Vet Immunol Immunopathol 1995 May;46(1-2):71-82
 Renal  involvement in feline immunodeficiency virus infection:
  p24 antigen detection, virus isolation and PCR analysis. Poli
  A, et al. Vet Immunol Immunopathol 1995 May;46(1-2):13-20

   PHYSIOLOGY

 A single mutation within the V3 envelope neutralization domain
  of feline immunodeficiency virus determines its  tropism  for
  CRFK cells. Verschoor EJ, et al. J Virol 1995 Aug;69(8):4752-7
 Dehydroepiandrosterone inhibits replication of feline
  immunodeficiency virus in chronically infected cells. Bradley
  WG, et al. Vet Immunol Immunopathol 1995 May;46(1-2):159-68
 Reduced provirus burden and enhanced humoral immune function in
  AZT-treated SCID-feline mice inoculated with feline
  immunodeficiency  virus.  Johnson  CM,  et  al.  Vet  Immunol
  Immunopathol 1995 May;46(1-2):169-80
 FIV  infection of macrophages: in vitro and in vivo inhibition
  by dideoxycytidine 5'-triphosphate. Magnani  M,  et  al.  Vet
  Immunol Immunopathol 1995 May;46(1-2):151-8
 A  determinant  of  feline  immunodeficiency virus involved in
  Crandell feline kidney cell tropism. Siebelink KH, et al. Vet
  Immunol Immunopathol 1995 May;46(1-2):61-9

 IMMUNOENZYME TECHNIQUES

   INSTRUMENTATION

 Further simplification of  ultrasensitive  enzyme  immunoassay
  (immune  complex transfer enzyme immunoassay) for anti-HTLV-I
  IgG using microplates and fluororeader. Ishikawa S, et al.  J
  Clin Lab Anal 1995;9(3):204-11

 IMMUNOGLOBULIN ISOTYPES

   BIOSYNTHESIS

 Cytokine  and  immunoglobulin  subclass  responses  of rats to
  infection  with  Eimeria  nieschulzi.  Smith   NC,   et   al.
  Parasitology 1995 Jul;111 ( Pt 1):51-7

 IMMUNOGLOBULINS, FAB

   BIOSYNTHESIS

 Engineering human monoclonal antibody fragments: a recombinant
  enzyme-linked Fab. Burioni R, et al. Microbiologica 1995 Apr;
  18(2):127-33

 IMMUNOGLOBULINS, HEAVY-CHAIN

   GENETICS

 Persistence of immunoglobulin heavy chain/c-myc
  recombination-positive lymphocyte clones in the blood of human
  immunodeficiency virus-infected homosexual men. Muller JR, et
  al. Proc Natl Acad Sci U S A 1995 Jul 3;92(14):6577-81

 IMMUNOGLOBULINS, INTRAVENOUS

   THERAPEUTIC USE

 A  case of protracted coxsackie virus meningoencephalitis in a
  marginally immunodeficient child  treated  successfully  with
  intravenous  immunoglobulin.  Geller  TJ, et al. J Neurol Sci
  1995 Apr;129(2):131-3

 IMMUNOLOGIC DEFICIENCY SYNDROMES

   EPIDEMIOLOGY

 [Cellular immunodeficiency  (including  AIDS):  incidence  and
  length  of  stay  of  hospitalized  cases in Austria in 1990]
  Haidinger G, et al. Soz Praventivmed 1995;40(3):157-60  (Eng.
  Abstr.)                                                 (Ger)

 IMMUNOLOGIC MEMORY

 Depletion of CD4+ and CD8+ cells eliminates immunologic memory
  of   thyroiditogenicity  in  murine  experimental  autoimmune
  thyroiditis. Fuller BE, et al. Autoimmunity 1994;19(3):161-8
 Human/mouse radiation chimera are capable of mounting a  human
  primary  humoral response. Marcus H, et al. Blood 1995 Jul 1;
  86(1):398-406
 Generation and in vivo persistence of polarized  Th1  and  Th2
  memory cells. Swain SL. Immunity 1994 Oct;1(7):543-52

   PHYSIOLOGY

 On the cellular basis of immunological T cell memory. Bruno L,
  et al. Immunity 1995 Jan;2(1):37-43

 IMMUNOPHENOTYPING

   VETERINARY

 Functional  and  phenotypic  analysis  of  in vitro stimulated
  canine peripheral blood mononuclear cells. Rivas AL,  et  al.
  Vet Immunol Immunopathol 1995 Mar;45(1-2):55-71

 IMMUNOTHERAPY

 Can virostatic chemotherapy and/or adoptive allogeneic
  immunotherapy  eradicate  in  vivo  Friend's virus infection?
  [letter] Mathe G, et al. Biomed Pharmacother 1990;44(1):57-9

 IMMUNOTHERAPY, ACTIVE

   METHODS

 [Tumor vaccination in renal cell carcinoma  with  and  without
  interleukin-2  (IL-2) as adjuvant. A clinical contribution to
  the development of effective  active  specific  immunization]
  Pomer S, et al. Urologe A 1995 May;34(3):215-20 (Eng. Abstr.)
                                                          (Ger)

 IMMUNOTHERAPY, ADOPTIVE

 Principles for adoptive T cell therapy of human viral diseases.
  Riddell SR, et al. Annu Rev Immunol 1995;13:545-86 (249 ref.)
 Human/mouse  radiation chimera are capable of mounting a human
  primary humoral response. Marcus H, et al. Blood 1995 Jul  1;
  86(1):398-406

   ADVERSE EFFECTS

 Genetic modification of T cell clones to improve the safety and
  efficacy of adoptive T cell therapy. Greenberg PD, et al. Ciba
  Found Symp 1994;187:212-23; discussion 224-8

   METHODS

 [Repeated passive immunotherapy delays AIDS progression (news)]
  Paris KA. Fortschr Med 1995 May 20;113(14):13           (Ger)

 IMMUNOTOXINS

   THERAPEUTIC USE

 Prospects  for  immunotoxin therapy of non-Hodgkin's lymphoma.
  Grossbard ML, et al.  Clin  Immunol  Immunopathol  1995  Aug;
  76(2):107-14 (51 ref.)

 INAPPROPRIATE ADH SYNDROME

   COMPLICATIONS

 [Granulomatous angiitis of the central nervous system
  complicated  by  the  syndrome  of inappropriate antidiuretic
  hormone] Shiozi Y, et al. No To Shinkei 1995  Jun;47(6):595-9
  (Eng. Abstr.)                                           (Jpn)

 INDANS

   PHARMACOKINETICS

 Time- and dose-dependent pharmacokinetics of L-754,394, an HIV
  protease inhibitor, in rats, dogs and monkeys. Lin JH, et al.
  J Pharmacol Exp Ther 1995 Jul;274(1):264-9

 INFECTION

   METABOLISM

 [Oxidative stress and infectious pathology] Romero Alvira D, et
  al.  An  Med  Interna  1995 Mar;12(3):139-49 (172 ref.) (Eng.
  Abstr.)                                                 (Spa)

 INFECTION CONTROL

 Survey to assess dental practitioner's knowledge of infectious
  disease. Epstein JB, et  al.  J  Can  Dent  Assoc  1995  Jun;
  61(6):519-25
 The  cost-effectiveness of voluntary counseling and testing of
  hospital patients for HIV [letter] Mundy LM, et al. JAMA 1995
  Jul 12;274(2):129; discussion 130
 The cost-effectiveness of voluntary counseling and testing  of
  hospital patients for HIV [letter] Weber JT, et al. JAMA 1995
  Jul 12;274(2):129-30

   LEGISLATION & JURISPRUDENCE

 Infection  control for our patients and ourselves. Stern A, et
  al. J Emerg Med Serv JEMS 1995 Jun;20(6):92-3, 95

   METHODS

 Infection control for peritoneal dialysis patients  with  HIV.
  Baldasseroni A. ANNA J 1995 Feb;22(1):56, 62

   STANDARDS

 Infection  control  guidelines  from  Ohio State Dental Board.
  Tomasi NJ. Cincinnati Dent Soc Bull 1986 Sep;55(7):21, 23-4
 Evaluation of infection control  measures  in  preventing  the
  nosocomial  transmission of multidrug-resistant Mycobacterium
  tuberculosis in a New York City hospital. Stroud LA,  et  al.
  Infect Control Hosp Epidemiol 1995 Mar;16(3):141-7

   STATISTICS & NUMERICAL DATA

 Compliance to recommended infection control procedures: changes
  over six years among British Columbia dentists. Gibson GB, et
  al. J Can Dent Assoc 1995 Jun;61(6):526-32

 INFECTIOUS MONONUCLEOSIS

   IMMUNOLOGY

 Peripheral  T  cell  receptor  repertoire  among CD4+ and CD8+
  subsets during acute infectious mononucleosis. Slobod KS,  et
  al. Viral Immunol 1994;7(3):151-3

 INFERTILITY, MALE

   THERAPY

 [What role is left to sperm banks in 1995?] Demoulin A, et al.
  Rev Med Liege 1995 Jun;50(6):254-8 (15 ref.)            (Fre)

 INFLAMMATORY BOWEL DISEASES

   PREVENTION & CONTROL

 Inhibition of Th1 responses prevents inflammatory bowel disease
  in scid mice reconstituted with CD45RBhi CD4+ T cells. Powrie
  F, et al. Immunity 1994 Oct;1(7):553-62

 INFLUENZA

   DRUG THERAPY

 Prolonged  influenza  A  infection  responsive  to rimantadine
  therapy in a  human  immunodeficiency  virus-infected  child.
  Evans KD, et al. Pediatr Infect Dis J 1995 Apr;14(4):332-4

   IMMUNOLOGY

 Prolonged  influenza  A  infection  responsive  to rimantadine
  therapy in a  human  immunodeficiency  virus-infected  child.
  Evans KD, et al. Pediatr Infect Dis J 1995 Apr;14(4):332-4

 INFLUENZA VACCINE

   IMMUNOLOGY

 Routine  immunizations  of  HIV-infected  individuals  and HIV
  replication. American Pediatric Society 104th annual  meeting
  and  Society for Pediatric Research 63rd annual meeting; 1994
  May 2-5; Seattle. Ramilo O, et al. Pediatr  AIDS  HIV  Infect
  1994 Oct;5(5):321 (unnumbered abstract)
 Response to trivalent influenza vaccine in children vertically
  infected  with  HIV.  American Pediatric Society 104th annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting; 1994 May 2-5; Seattle. Tressler RL, et  al.  Pediatr
  AIDS HIV Infect 1994 Oct;5(5):320 (unnumbered abstract)
 Prolonged  influenza  A  infection  responsive  to rimantadine
  therapy in a  human  immunodeficiency  virus-infected  child.
  Evans KD, et al. Pediatr Infect Dis J 1995 Apr;14(4):332-4

 INFORMATION SERVICES

   SUPPLY & DISTRIBUTION

 Assessing the information needs of non-institutionally
  affiliated  AIDS service organizations in Texas. Huber JT, et
  al. Bull Med Libr Assoc 1995 Apr;83(2):240-3

 INFORMATION SYSTEMS

 An 'information-intensive'  strategy  for  drug  discovery  in
  cancer  and  AIDS: relating cell cycle factors to patterns of
  drug activity (Meeting abstract). Myers TG, et al. Proc  Annu
  Meet Am Assoc Cancer Res; 36:A1813 1995

 INFORMED CONSENT

 HIV testing and informed consent [letter] Lawson HH. S Afr Med
  J 1995 Feb;85(2):114

 INPATIENTS

 Inpatient  hospice  care: a new option for the terminally ill.
  Martin EW. R I Med 1995 Apr;78(4):118-9

 INSEMINATION, ARTIFICIAL, HETEROLOGOUS

 [What role is left to sperm banks in 1995?] Demoulin A, et al.
  Rev Med Liege 1995 Jun;50(6):254-8 (15 ref.)            (Fre)

 INSTITUTE OF MEDICINE (U.S.)

 IOM criticises US blood product safety procedures [news]  Rowe
  PM. Lancet 1995 Jul 22;346(8969):243

 INSULIN-LIKE GROWTH FACTOR I

   PHYSIOLOGY

 Growth-promoting actions of parathyroid hormone,
  adrenocorticotrophic hormone, and thyroid-stimulating hormone:
  in vitro studies in normal and pygmy T-lymphoblast cell lines.
  Geffner ME, et al. Pediatr Res 1995 Apr;37(4 Pt 1):507-11

 INSURANCE, HEALTH

   LEGISLATION & JURISPRUDENCE

 Lawsuit against Mason Tenders is heading toward a quiet finale.
  AIDS Policy Law 1995 Mar 24;10(5):6

 INSURANCE, LIFE

   LEGISLATION & JURISPRUDENCE

 Viatical  settlement  tax  reform: Republicans support relief,
  Democrats divided. James JS, et al. AIDS Treat News 1995  Mar
  3;(no 218):7-8

 INTEGRINS

   PHYSIOLOGY

 A  novel canine leukointegrin, alpha d beta 2, is expressed by
  specific macrophage subpopulations in tissue and a minor CD8+
  lymphocyte subpopulation in peripheral blood. Danilenko DM, et
  al. J Immunol 1995 Jul 1;155(1):35-44

 INTENSIVE CARE

 Intensive care for patients with AIDS:  clinical  and  ethical
  issues.  Wachter  RM.  Schweiz  Med  Wochenschr  1995 Jun 10;
  125(23):1119-22 (27 ref.)

 INTERCALATING AGENTS

   PHARMACOLOGY

 Virostatic in vivo effect of elliptinium on Friend's retrovirus
  (a  model  for  HIV  infection).  Mathe  G,  et  al.  Biomed
  Pharmacother 1990;44(1):1-3

 INTERCELLULAR ADHESION MOLECULE-1

   IMMUNOLOGY

 Rapid development of  murine  AIDS  is  dependent  of  signals
  provided  by  CD54 and CD11a. Makino M, et al. J Immunol 1995
  Jul 15;155(2):974-81

   PHYSIOLOGY

 Antibody to ICAM-1 mediates enhancement of HIV-1 infection  of
  human  endothelial  cells. Scheglovitova O, et al. Arch Virol
  1995;140(5):951-8

 INTERFERON-ALPHA

   BLOOD

 Plasma interferon alpha and the wasting syndrome  in  patients
  infected  with  the  human  immunodeficiency  virus  [letter]
  Constans J, et al. Clin Infect Dis 1995 Apr;20(4):1069-70

   PHARMACOLOGY

 Molecular  cloning  of  a  new  interferon-induced factor that
  represses human immunodeficiency virus type 1  long  terminal
  repeat  expression. Tissot C, et al. J Biol Chem 1995 Jun 23;
  270(25):14891-8

 INTERFERON-BETA

   PHARMACOLOGY

 Molecular cloning of  a  new  interferon-induced  factor  that
  represses  human  immunodeficiency virus type 1 long terminal
  repeat expression. Tissot C, et al. J Biol Chem 1995 Jun  23;
  270(25):14891-8

 INTERFERON TYPE II

   BIOSYNTHESIS

 Vitamin A deficiency results in a priming environment conducive
  for  Th1  cell development. Cantorna MT, et al. Eur J Immunol
  1995 Jun;25(6):1673-9
 Cytokine production by highly purified human CD8+ T cells.  Li
  Y, et al. Int Arch Allergy Immunol 1995 May-Jun;107(1-3):354-5
 Staphylococcal  enterotoxin  B affects in vitro IgE synthesis,
  interferon-gamma, interleukin-4 and interleukin-5  production
  in  atopic  eczema. Neuber K, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):179-82
 Cytokine and immunoglobulin  subclass  responses  of  rats  to
  infection   with   Eimeria   nieschulzi.  Smith  NC,  et  al.
  Parasitology 1995 Jul;111 ( Pt 1):51-7

   PHARMACOLOGY

 Interleukin-4 and interferon-gamma regulate differentiation of
  CD8+  T  cells  into  populations  with  divergent   cytokine
  profiles.  Noble  A,  et  al.  Int  Arch Allergy Immunol 1995
  May-Jun;107(1-3):186-8

   PHYSIOLOGY

 Th1 and Th2 T-helper cells exert opposite regulatory effects on
  procoagulant activity and tissue factor production  by  human
  monocytes. Del Prete G, et al. Blood 1995 Jul 1;86(1):250-7
 How  the  TH2  response  is marshaled [news; comment] Cohen J.
  Science 1995 Jul 14;269(5221):161
 Lack of interferon gamma receptor beta chain and the prevention
  of interferon gamma signaling in  TH1  cells  [see  comments]
  Pernis A, et al. Science 1995 Jul 14;269(5221):245-7

 INTERFERONS

   THERAPEUTIC USE

 [Interferon therapy for demyelinating disease] Usuku K, et al.
  No To Shinkei 1995 Jul;47(7):625-31 (70 ref.)           (Jpn)

 INTERINSTITUTIONAL RELATIONS

 High-risk  vulnerable  populations  and volunteers: a model of
  education and service collaboration. Hutchison RR, et  al.  J
  Community Health Nurs 1995;12(2):111-9

 INTERLEUKIN-1

   METABOLISM

 Higher  cytotoxic  activity and increased levels of IL-1 beta,
  IL-6, and TNF-alpha in  patients  undergoing  cardiopulmonary
  bypass. Marti F, et al. Am J Hematol 1995 Jul;49(3):237-9

   PHYSIOLOGY

 Lentiviral infection, immune response peptides and sleep. Darko
  DF, et al. Adv Neuroimmunol 1995;5(1):57-77 (76 ref.)

 INTERLEUKIN-2

   ADMINISTRATION & DOSAGE

 [Tumor  vaccination  in  renal cell carcinoma with and without
  interleukin-2 (IL-2) as adjuvant. A clinical contribution  to
  the  development  of  effective active specific immunization]
  Pomer S, et al. Urologe A 1995 May;34(3):215-20 (Eng. Abstr.)
                                                          (Ger)

   BIOSYNTHESIS

 Roxithromycin: its effects on  concanavalin-A  induced  spleen
  cell proliferation and interleukin production in mice. Adachi
  M, et al. Int Arch Allergy Immunol 1995 May-Jun;107(1-3):427

   METABOLISM

 Characterization   of  the  alloreactivity  and  anti-leukemia
  reactivity of cord blood mononuclear cells. Keever CA, et al.
  Bone Marrow Transplant 1995 Mar;15(3):407-19

   THERAPEUTIC USE

 Role of interleukin-2 in managing infection with the human
  immunodeficiency virus. Piscitelli SC, et al. Am J Health Syst
  Pharm 1995 Mar 1;52(5):541-2

 INTERLEUKIN-4

   BIOSYNTHESIS

 Expression and biological activities of bovine interleukin  4:
  effects  of  recombinant  bovine  interleukin  4  on  T  cell
  proliferation and B cell differentiation and proliferation in
  vitro. Estes DM, et al. Cell Immunol 1995 Jul;163(2):268-79
 Cytokine  production by highly purified human CD8+ T cells. Li
  Y, et al. Int Arch Allergy Immunol 1995 May-Jun;107(1-3):354-5
 Staphylococcal enterotoxin B affects in vitro  IgE  synthesis,
  interferon-gamma,  interleukin-4 and interleukin-5 production
  in atopic eczema. Neuber K, et al. Int Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):179-82

   METABOLISM

 Interleukin-4 is required for the induction of lung Th2 mucosal
  immunity. Coyle AJ, et al. Am J Respir Cell Mol Biol 1995 Jul;
  13(1):54-9

   PHARMACOLOGY

 Serum levels of stem cell factor are increased in asymptomatic
  human   immunodeficiency   virus-infected  patients  and  are
  associated with prolonged survival. Manegold C, et al.  Blood
  1995 Jul 1;86(1):243-9
 Expression  and biological activities of bovine interleukin 4:
  effects  of  recombinant  bovine  interleukin  4  on  T  cell
  proliferation and B cell differentiation and proliferation in
  vitro. Estes DM, et al. Cell Immunol 1995 Jul;163(2):268-79
 Interleukin-4 and interferon-gamma regulate differentiation of
  CD8+  T  cells  into  populations  with  divergent   cytokine
  profiles.  Noble  A,  et  al.  Int  Arch Allergy Immunol 1995
  May-Jun;107(1-3):186-8

   PHYSIOLOGY

 Importance of interleukin-4 and interleukin-12 in
  allergen-induced airway changes in mice. Kips JC, et al.  Int
  Arch Allergy Immunol 1995 May-Jun;107(1-3):115-8

 INTERLEUKIN-5

   BIOSYNTHESIS

 Roxithromycin:  its  effects  on concanavalin-A induced spleen
  cell proliferation and interleukin production in mice. Adachi
  M, et al. Int Arch Allergy Immunol 1995 May-Jun;107(1-3):427
 Staphylococcal enterotoxin B affects in vitro  IgE  synthesis,
  interferon-gamma,  interleukin-4 and interleukin-5 production
  in atopic eczema. Neuber K, et al. Int Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):179-82

 INTERLEUKIN-6

   BIOSYNTHESIS

 The  HIV  membrane gp 120 protein is toxic to human brain cell
  cultures through the induction of  interleukin-6  (IL-6)  and
  tumor  necrosis  factor-alpha(TNF-alpha).  American Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research 63rd annual meeting; 1994 May 2-5; Seattle. Yeung M,
  et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):314  (unnumbered
  abstract)
 Inflammatory mediators increase surface expression of integrin
  ligands, adhesion to lymphocytes, and secretion of interleukin
  6  in  mouse Sertoli cells. Riccioli A, et al. Proc Natl Acad
  Sci U S A 1995 Jun 20;92(13):5808-12
 Tumor  necrosis  factor-alpha  responses  are  depressed   and
  interleukin-6  responses unaltered in feline immunodeficiency
  virus infected cats. Ma J, et al.  Vet  Immunol  Immunopathol
  1995 May;46(1-2):35-50

   METABOLISM

 Higher  cytotoxic  activity and increased levels of IL-1 beta,
  IL-6, and TNF-alpha in  patients  undergoing  cardiopulmonary
  bypass. Marti F, et al. Am J Hematol 1995 Jul;49(3):237-9

   PHARMACOLOGY

 IL-6  induces target cell resistance to HIV-specific cytotoxic
  lysis. Liu  M,  et  al.  J  Acquir  Immune  Defic  Syndr  Hum
  Retrovirol 1995 Aug 1;9(4):321-31

 INTERLEUKIN-8

   BIOSYNTHESIS

 Interleukin-8  and  eicosanoid  production  in the lung during
  moderate to severe Pneumocystis carinii pneumonia in AIDS:  a
  role  of  interleukin-8  in  the  pathogenesis  of P. carinii
  pneumonia.  Benfield  TL,  et  al.  Respir  Med   1995   Apr;
  89(4):285-90

 INTERLEUKIN-10

   ANALYSIS

 Human  and  viral interleukin-10 in Hodgkin's disease, and its
  influence on CD4+ and CD8+ T lymphocytes. Ohshima K,  et  al.
  Int J Cancer 1995 Jul 4;62(1):5-10

   BIOSYNTHESIS

 High level of interleukin-10 production by the activated T cell
  population within the rheumatoid synovial membrane. Cohen SB,
  et al. Arthritis Rheum 1995 Jul;38(7):946-52

 INTERLEUKIN-12

   ANTAGONISTS & INHIBITORS

 Developmental  commitment  to the Th2 lineage by extinction of
  IL-12  signaling.  Szabo  SJ,  et  al.  Immunity  1995   Jun;
  2(6):665-75

   BIOSYNTHESIS

 Vitamin A deficiency results in a priming environment conducive
  for  Th1  cell development. Cantorna MT, et al. Eur J Immunol
  1995 Jun;25(6):1673-9

   BLOOD

 Serum levels of interleukin-12 in adult and paediatric patients
  with HIV-1 infection [letter] Torre D, et al. AIDS 1995  Apr;
  9(4):405-6

   PHYSIOLOGY

 Developmental  commitment  to the Th2 lineage by extinction of
  IL-12  signaling.  Szabo  SJ,  et  al.  Immunity  1995   Jun;
  2(6):665-75
 Importance of interleukin-4 and interleukin-12 in
  allergen-induced  airway changes in mice. Kips JC, et al. Int
  Arch Allergy Immunol 1995 May-Jun;107(1-3):115-8
 Endogenous IL-12 is  required  for  control  of  Th2  cytokine
  responses  capable  of exacerbating leishmaniasis in normally
  resistant mice. Heinzel FP, et al. J  Immunol  1995  Jul  15;
  155(2):730-9

 INTERLEUKIN-2

   THERAPEUTIC USE

 Treatment review. Treat Rev 1995 Mar/Apr;(no 17):8

 INTERLEUKINS

   BIOSYNTHESIS

 Functional significance of CD23- on CD23-transfected Th2 clone.
  Nambu M, et al. Immunol Lett 1995 Jan;44(2-3):163-7

   GENETICS

 Vernal  keratoconjunctivitis:  a  model  of  5q  cytokine gene
  cluster disease. Bonini S, et al. Int  Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):95-8 (26 ref.)

   IMMUNOLOGY

 The  interleukin  network  in  the  immunopathogenesis of oral
  diseases [see comments] Sosroseno  W,  et  al.  Asian  Pac  J
  Allergy Immunol 1994 Dec;12(2):161-8 (92 ref.)

 INTESTINAL DISEASES

   COMPLICATIONS

 Acquired immunodeficiency syndrome enteropathy: a perspective.
  Craig RM, et al. Compr Ther 1995 Apr;21(4):184-8 (34 ref.)

 INTESTINAL MUCOSA

   IMMUNOLOGY

 Age-related  differences  in subset composition and activation
  responses of intestinal intraepithelial and mesenteric  lymph
  node  lymphocytes  from neonatal swine. Whary MT, et al. Cell
  Immunol 1995 Jul;163(2):215-21

 INTRADERMAL TESTS

 Delayed  type  hypersensitivity  (DTH)  skin  testing  in  HIV
  infected (HIV+) children. American  Pediatric  Society  104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Raszka WV, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):320 (unnumbered abstract)

 IODINE

   PHARMACOLOGY

 Iodine-mediated  inactivation of lipid- and nonlipid-enveloped
  viruses in human antithrombin III concentrate. Highsmith F, et
  al. Blood 1995 Jul 15;86(2):791-6

 IOWA

 Service delivery to persons with HIV and AIDS. Saunders E,  et
  al. Iowa Med 1995 Jun;85(6):250-1

 IRON

   METABOLISM

 Iron  in CNS disease. Gelman BB. J Neuropathol Exp Neurol 1995
  Jul;54(4):477-86 (79 ref.)

 ISOANTIGENS

   IMMUNOLOGY

 Autoimmunity following neonatal tolerance to alloantigens: role
  of donor I-A and I-E molecules. Kramar G, et al. J  Autoimmun
  1995 Apr;8(2):177-92

 ISOENZYMES

   ANALYSIS

 Leishmania-human  immunodeficiency  virus  coinfection  in the
  Mediterranean basin:  isoenzymatic  characterization  of  100
  isolates  of  the Leishmania infantum complex. Pratlong F, et
  al. J Infect Dis 1995 Jul;172(1):323-6

 ISOLEUCINE

   ANALOGS & DERIVATIVES

 Flexibility and function  in  HIV-1  protease  [see  comments]
  Nicholson LK, et al. Nat Struct Biol 1995 Apr;2(4):274-80

 ISONIAZID

   THERAPEUTIC USE

 Isoniazid  preventive  therapy  in  areas  of  high  isoniazid
  resistance. Sterling TR, et al. Arch Intern Med 1995 Aug 7-21;
  155(15):1622-8
 Isoniazid prophylactic therapy for tuberculosis in
  HIV-seropositive patients--a least-cost analysis. Masobe P, et
  al. S Afr Med J 1995 Feb;85(2):75-81

 ITALY

 Compulsory  AIDS  testing--a  recent  judgement by the Italian
  Constitutional Court. Cattorini P. Health Care Anal 1995 May;
  3(2):135-8
 Italy. Returning emigres add new  luster  to  AIDS  research
  [news] Balter M. Science 1995 Jul 7;269(5220):24-5

   EPIDEMIOLOGY

 Is   AIDS-related  cryptococcosis  more  frequent  among  men?
  [letter] Manfredi R, et al. AIDS 1995 Apr;9(4):397-8
 Familial clustering of HTLV-I infection in southeastern  Italy
  [letter] Chironna M, et al. Lancet 1995 Jul 15;
  346(8968):179-80

 ITRACONAZOLE

   PHARMACOKINETICS

 [Pharmacokinetics of itraconazole] Cauwenbergh G. Mycoses 1994;
  37 Suppl 2:27-33 (13 ref.) (Eng. Abstr.)                (Ger)

   THERAPEUTIC USE

 [Therapy of invasive aspergillosis with itraconazole: our own
  experiences  and review of the literature] Kreisel W. Mycoses
  1994;37 Suppl 2:42-51 (91 ref.) (Eng. Abstr.)           (Ger)

 JAMAICA

   EPIDEMIOLOGY

 Viral-specific humoral immune responses following
  transfusion-related transmission of human T cell lymphotropic
  virus type-I infection. Manns A, et al. Viral  Immunol  1994;
  7(3):113-20

 JAPAN

 Increase of activated T-cells in BAL fluid of Japanese patients
  with bronchiolitis obliterans organizing pneumonia and chronic
  eosinophilic  pneumonia.  Mukae  H,  et  al.  Chest 1995 Jul;
  108(1):123-8
 Virucidal effects of  the  steam  distillate  from  Houttuynia
  cordata and its components on HSV-1, influenza virus, and HIV.
  Hayashi K, et al. Planta Med 1995 Jun;61(3):237-41

   EPIDEMIOLOGY

 Transmission of hepatitis C virus from mothers to infants: its
  frequency and risk factors revisited. Moriya T, et al. Biomed
  Pharmacother 1995;49(2):59-64
 Anti-Human T-lymphotropic virus type-I antibodies in
  atomic-bomb  survivors. Matsuo T, et al. J Radiat Res (Tokyo)
  1995 Mar;36(1):8-16
 [Discovery of HTLV-I associated  myelopathy]  Igata  A.  Nihon
  Shinkei  Seishin  Yakurigaku  Zasshi  1995 Apr;15(2):185-9 (8
  ref.)                                                   (Jpn)

 JURISPRUDENCE

 Dentist's 'blatant discrimination'  leads  to  landmark  court
  decision. AIDS Policy Law 1995 Apr 7;10(6):1, 10-1

 KANSAS

 Accomplice  in  death  of  gay  man  sentenced to work in AIDS
  hospice. AIDS Policy Law 1995 Mar 24;10(5):9

 KENYA

 Orofacial lesions  as  indicators  of  HIV/AIDS  among  dental
  patients in Kenya. Guthua SW, et al. East Afr Med J 1995 Feb;
  72(2):135-8

   EPIDEMIOLOGY

 Bacteraemia in patients presenting with fever. Petit PL, et al.
  East Afr Med J 1995 Feb;72(2):116-20

 KERATOCONJUNCTIVITIS

   GENETICS

 Vernal  keratoconjunctivitis:  a  model  of  5q  cytokine gene
  cluster disease. Bonini S, et al. Int  Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):95-8 (26 ref.)

 KIDNEY

   VIROLOGY

 Renal  involvement in feline immunodeficiency virus infection:
  p24 antigen detection, virus isolation and PCR analysis. Poli
  A, et al. Vet Immunol Immunopathol 1995 May;46(1-2):13-20
 A determinant of feline  immunodeficiency  virus  involved  in
  Crandell feline kidney cell tropism. Siebelink KH, et al. Vet
  Immunol Immunopathol 1995 May;46(1-2):61-9

 KIDNEY CALCULI

   CHEMICALLY INDUCED

 Reversible  acute  renal  failure  due  to sulfonamide-induced
  lithiasis in an AIDS patient. Farina LA, et al. Arch Esp Urol
  1995 May;48(4):418-9 (12 ref.)

 KIDNEY DISEASES

   VETERINARY

 Renal involvement in feline immunodeficiency virus  infection:
  p24 antigen detection, virus isolation and PCR analysis. Poli
  A, et al. Vet Immunol Immunopathol 1995 May;46(1-2):13-20

 KIDNEY FAILURE, ACUTE

   CHEMICALLY INDUCED

 Reversible  acute  renal  failure  due  to sulfonamide-induced
  lithiasis in an AIDS patient. Farina LA, et al. Arch Esp Urol
  1995 May;48(4):418-9 (12 ref.)

   VIROLOGY

 Cytomegalovirus ureteritis as a cause of renal  failure  in  a
  child infected with the human immunodeficiency virus. Mueller
  BU, et al. Clin Infect Dis 1995 Apr;20(4):1040-3

 KIDNEY FAILURE, CHRONIC

   COMPLICATIONS

 Patients  with  human  immunodeficiency virus infection in the
  hemodialysis  unit.  How  vulnerable  are   the   caregivers?
  [editorial;  comment] Gilbert DN, et al. Arch Intern Med 1995
  Aug 7-21;155(15):1575-6
 Prevalence of viremia in human immunodeficiency virus-infected
  patients with renal disease [see comments] Kimmel PL, et  al.
  Arch Intern Med 1995 Aug 7-21;155(15):1578-84
 [A  hemodialysis  patient  with  HTLV-1-associated  myelopathy
  (HAM)]  Takeda  F,  et  al. Nippon Jinzo Gakkai Shi 1995 May;
  37(5):307-10 (Eng. Abstr.)                              (Jpn)

 KIDNEY NEOPLASMS

   THERAPY

 [Tumor vaccination in renal cell carcinoma  with  and  without
  interleukin-2  (IL-2) as adjuvant. A clinical contribution to
  the development of effective  active  specific  immunization]
  Pomer S, et al. Urologe A 1995 May;34(3):215-20 (Eng. Abstr.)
                                                          (Ger)

 KIDNEY TRANSPLANTATION

   ADVERSE EFFECTS

 Implication of cyclosporine in up-regulation of Bcl-2
  expression and maintenance of CD8 lymphocytosis in
  cytomegalovirus-infected allograft recipients. Labalette M, et
  al. Transplantation 1995 Jun 27;59(12):1714-23

 KILLER CELLS, NATURAL

   IMMUNOLOGY

 Cell  transfer  therapy  of  cancer metastasis with autologous
  lymphocytes. Mikamo S, et al. Cell  Transplant  1995;4  Suppl
  1:S65-7
 Chimeric  zeta-receptors  direct  human  natural  killer  (NK)
  effector  function  to  permit  killing of NK-resistant tumor
  cells and HIV-infected T  lymphocytes.  Tran  AC,  et  al.  J
  Immunol 1995 Jul 15;155(2):1000-9
 Specific  activation  of  natural  killer (NK) cells. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Reichlin A, et al. Pediatr AIDS HIV Infect 1994  Oct;5(5):314
  (unnumbered abstract)
 Evolution  of  natural  killer (NK) function in HIV+ children.
  American Pediatric Society 104th annual meeting  and  Society
  for  Pediatric  Research  63rd  annual meeting; 1994 May 2-5;
  Seattle. Schuval SJ, et al. Pediatr AIDS HIV Infect 1994 Oct;
  5(5):315 (unnumbered abstract)

   PATHOLOGY

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing natural killer cell  leukaemia/lymphoma  and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

   PHYSIOLOGY

 Requirement  for  natural  killer  cells  in  the induction of
  cytotoxic T cells. Kos FJ, et al.  J  Immunol  1995  Jul  15;
  155(2):578-84

   VIROLOGY

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing  natural  killer cell leukaemia/lymphoma and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

 KNOWLEDGE, ATTITUDES, PRACTICE

 Tuberculosis knowledge among  New  York  City  injection  drug
  users. Wolfe H, et al. Am J Public Health 1995 Jul;85(7):985-8
 Illness  cognition of HIV-infected mothers. Regan-Kubinski MJ,
  et al. Issues Ment Health Nurs 1995 Jul-Aug;16(4):327-44
 HIV prevention beliefs  among  urban  African-American  youth.
  Stevenson HC, et al. J Adolesc Health 1995 Apr;16(4):316-23
 Survey to assess dental practitioner's knowledge of infectious
  disease.  Epstein  JB,  et  al.  J  Can  Dent Assoc 1995 Jun;
  61(6):519-25
 Parents' attitudes and beliefs about HIV/AIDS prevention  with
  condom  availability  in  New  York City public high schools.
  Guttmacher S, et al. J Sch Health 1995 Mar;65(3):101-6
 Rolling the dice [editorial] Thomison JB. J Tenn Med Assoc 1995
  May;88(5):198-200
 Behaviour ignores HIV knowledge [news] Occup Health (Lond) 1995
  Jun;47(6):188
 Use of advance directives: a survey in three clinics. Gilligan
  MA, et al. Wis Med J 1995;94(5):239-43

 LABOR UNIONS

 Lawsuit against Mason Tenders is heading toward a quiet finale.
  AIDS Policy Law 1995 Mar 24;10(5):6

 LANGERHANS CELLS

   PHYSIOLOGY

 [Langerhans cells and human aural cholesteatoma] Liu L, et al.
  Chung Hua Erh Pi Yen Hou Ko Tsa  Chih  1995;30(1):33-6  (Eng.
  Abstr.)                                                 (Chi)

 LASERS

   DIAGNOSTIC USE

 [Measuring  retinal nerve fiber density with laser polarimetry
  in patients with AIDS in comparison with health probands with
  reference to computer perimetry findings. A pilot study using
  the nerve fiber analyzer] Thierfelder S, et al. Klin Monatsbl
  Augenheilkd 1995 Mar;206(3):165-9 (Eng. Abstr.)         (Ger)

 LEGIONNAIRES' DISEASE

   ETIOLOGY

 [Pulmonary  legionellosis  disclosing  HIV  infection   in   a
  75-year-old  man  (letter)]  Zenone T, et al. Rev Med Interne
  1995;16(5):370-1                                        (Fre)

 LEGISLATION, MEDICAL

 Is self-sufficiency financially viable and ethically
  justifiable?--legal aspects. Newdick C. Blood Coagul
  Fibrinolysis 1994 Dec;5 Suppl 4:S37-8

 LEISHMANIA

   GENETICS

 PCR and in vitro cultivation for detection of Leishmania  spp.
  in diagnostic samples from humans and dogs. Mathis A, et al. J
  Clin Microbiol 1995 May;33(5):1145-9

   ISOLATION & PURIFICATION

 PCR  and in vitro cultivation for detection of Leishmania spp.
  in diagnostic samples from humans and dogs. Mathis A, et al. J
  Clin Microbiol 1995 May;33(5):1145-9

 LEISHMANIA INFANTUM

 Leishmania-human immunodeficiency  virus  coinfection  in  the
  Mediterranean  basin:  isoenzymatic  characterization  of 100
  isolates of the Leishmania infantum complex. Pratlong  F,  et
  al. J Infect Dis 1995 Jul;172(1):323-6

 LEISHMANIA MAJOR

 Endogenous  IL-12  is  required  for  control  of Th2 cytokine
  responses capable of exacerbating leishmaniasis  in  normally
  resistant  mice.  Heinzel  FP,  et al. J Immunol 1995 Jul 15;
  155(2):730-9

   IMMUNOLOGY

 The regulation of immunity to Leishmania major. Reiner SL,  et
  al. Annu Rev Immunol 1995;13:151-77 (170 ref.)

 LEISHMANIASIS

   DIAGNOSIS

 PCR  and in vitro cultivation for detection of Leishmania spp.
  in diagnostic samples from humans and dogs. Mathis A, et al. J
  Clin Microbiol 1995 May;33(5):1145-9

 LEISHMANIASIS, CUTANEOUS

   COMPLICATIONS

 Cutaneous leishmaniasis in AIDS [letter] Nicolas  M,  et  al.
  Dermatology 1995;190(3):255-6

   THERAPY

 Endogenous  IL-12  is  required  for  control  of Th2 cytokine
  responses capable of exacerbating leishmaniasis  in  normally
  resistant  mice.  Heinzel  FP,  et al. J Immunol 1995 Jul 15;
  155(2):730-9

 LEISHMANIASIS, MUCOCUTANEOUS

   COMPLICATIONS

 Leishmania-human immunodeficiency  virus  coinfection  in  the
  Mediterranean  basin:  isoenzymatic  characterization  of 100
  isolates of the Leishmania infantum complex. Pratlong  F,  et
  al. J Infect Dis 1995 Jul;172(1):323-6

 LENTIVIRUS INFECTIONS

   VETERINARY

 Monocyte function in cattle experimentally infected with bovine
  immunodeficiency-like  virus.  Rovid  AH,  et al. Vet Immunol
  Immunopathol 1995 Mar;45(1-2):31-43
 Seroprevalence of bovine immunodeficiency-virus (BIV)
  antibodies in the cattle population in  Germany.  Muluneh  A.
  Zentralbl Veterinarmed [B] 1994 Dec;41(10):679-84

 LEUKEMIA

   THERAPY

 Expansion of CD8+CD57+ T cells after allogeneic BMT is related
  with  a  low  incidence  of  relapse and with cytomegalovirus
  infection.  Dolstra  H,  et  al.  Br  J  Haematol  1995  Jun;
  90(2):300-7

   VIROLOGY

 Is it possible to catch leukemia from a cat? [letter]  Nowotny
  N, et al. Lancet 1995 Jul 22;346(8969):252-3

 LEUKEMIA, B-CELL, CHRONIC

   PHYSIOPATHOLOGY

 Evidence for involvement of activated CD8+/HLA-DR+ cells in the
  pathogenesis  of  neutropenia in patients with B-cell chronic
  lymphocytic leukaemia. Katrinakis G, et al.  Eur  J  Haematol
  1995 Jul;55(1):33-41

 LEUKEMIA, EXPERIMENTAL

   THERAPY

 Can virostatic chemotherapy and/or adoptive allogeneic
  immunotherapy  eradicate  in  vivo  Friend's virus infection?
  [letter] Mathe G, et al. Biomed Pharmacother 1990;44(1):57-9

 LEUKEMIA, FELINE

 Feline Retroviruses. Proceedings of an international symposium.
  Research Triangle Park, North Carolina, 6-9 October 1993. Vet
  Immunol Immunopathol 1995 May;46(1-2):1-194

   TRANSMISSION

 Is it possible to catch leukemia from a cat? [letter]  Nowotny
  N, et al. Lancet 1995 Jul 22;346(8969):252-3

 LEUKEMIA, LYMPHOCYTIC, ACUTE, L1

   IMMUNOLOGY

 A  case of protracted coxsackie virus meningoencephalitis in a
  marginally immunodeficient child  treated  successfully  with
  intravenous  immunoglobulin.  Geller  TJ, et al. J Neurol Sci
  1995 Apr;129(2):131-3

 LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED

   DIAGNOSIS

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing natural killer cell  leukaemia/lymphoma  and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

   PATHOLOGY

 [Inhibitory effects of menogaril to the proliferation of HTLV-I
  infected T-cell lines and fresh tumor cells from adult T-cell
  leukemia  patients]  Hata  H, et al. Gan To Kagaku Ryoho 1995
  Jul;22(8):1057-61 (Eng. Abstr.)                         (Jpn)

   VIROLOGY

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing natural killer cell  leukaemia/lymphoma  and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

 LEUKEMIA, T-CELL, ACUTE

   PATHOLOGY

 Histopathologic spectrum of AIDS-associated lesions in Maharaj
  Nakorn  Chiang  Mai  Hospital.  Bhoopat L, et al. Asian Pac J
  Allergy Immunol 1994 Dec;12(2):95-104

 LEUKEMIA VIRUS, FELINE

 Feline Retroviruses. Proceedings of an international symposium.
  Research Triangle Park, North Carolina, 6-9 October 1993. Vet
  Immunol Immunopathol 1995 May;46(1-2):1-194

   IMMUNOLOGY

 Is it possible to catch leukemia from a cat? [letter]  Nowotny
  N, et al. Lancet 1995 Jul 22;346(8969):252-3
 Recombinant  FeLV  vaccine: long-term protection and effect on
  course and outcome of FIV infection. Hofmann-Lehmann R, et al.
  Vet Immunol Immunopathol 1995 May;46(1-2):127-37
 Panleukopenia-like syndrome of FeLV caused by co-infection with
  FeLV and feline panleukopenia  virus.  Lutz  H,  et  al.  Vet
  Immunol Immunopathol 1995 May;46(1-2):21-33

 LEUKOCYTE TRANSFUSION

 Human/mouse  radiation chimera are capable of mounting a human
  primary humoral response. Marcus H, et al. Blood 1995 Jul  1;
  86(1):398-406

 LEUKOCYTES

   IMMUNOLOGY

 Analysis  of  leucocytes  and  lymphocyte subsets in cats with
  naturally-occurring cryptococcosis but differing feline
  immunodeficiency virus status. Walker C, et al.  Aust  Vet  J
  1995 Mar;72(3):93-7

 LEUKOCYTES, MONONUCLEAR

   CYTOLOGY

 Crude extract and recombinant protein of Cryptosporidium parvum
  oocysts   induce  proliferation  of  human  peripheral  blood
  mononuclear cells in vitro. Gomez Morales MA, et al. J Infect
  Dis 1995 Jul;172(1):211-6

   DRUG EFFECTS

 In vitro immunomodulatory effects of traditional Kampo medicine
  (sho-saiko-to:  SST)  on  peripheral  mononuclear  cells   in
  patients with AIDS. Inada Y, et al. Biomed Pharmacother 1990;
  44(1):17-9

   METABOLISM

 Th1 and Th2 T-helper cells exert opposite regulatory effects on
  procoagulant  activity  and tissue factor production by human
  monocytes. Del Prete G, et al. Blood 1995 Jul 1;86(1):250-7
 Tumor  necrosis  factor-alpha  responses  are  depressed   and
  interleukin-6  responses unaltered in feline immunodeficiency
  virus infected cats. Ma J, et al.  Vet  Immunol  Immunopathol
  1995 May;46(1-2):35-50

 LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL

   COMPLICATIONS

 AIDS-associated progressive multifocal leukoencephalopathy
  revealed by new-onset seizures. Moulignier A, et al. Am J Med
  1995 Jul;99(1):64-8

 LEUKOPLAKIA, HAIRY

   COMPLICATIONS

 Oral hairy leukoplakia in an HIV-negative woman with Beh¢cet's
  syndrome.  Schiodt  M,  et al. Oral Surg Oral Med Oral Pathol
  Oral Radiol Endod 1995 Jan;79(1):53-6 (20 ref.)

   DRUG THERAPY

 Treatment of HIV-related hairy  leukoplakia  with  podophyllum
  resin  25% solution. Gowdey G, et al. Oral Surg Oral Med Oral
  Pathol Oral Radiol Endod 1995 Jan;79(1):64-7
 Oral hairy leukoplakia in a child with AIDS. Laskaris G, et al.
  Oral Surg Oral Med Oral Pathol Oral Radiol  Endod  1995  May;
  79(5):570-1 (8 ref.)

   PATHOLOGY

 Exfoliative  cytology and electron microscopy in the diagnosis
  of hairy leukoplakia. Epstein JB, et al. Oral Surg  Oral  Med
  Oral Pathol Oral Radiol Endod 1995 May;79(5):564-9

 LEVAMISOLE

   PHARMACOLOGY

 Reversal of ferritin-mediated immunosuppression by levamisole:
  a rationale for its application to management of the acquired
  immune deficiency syndrome (AIDS). Wigginton JM. Med
  Hypotheses 1995 Feb;44(2):85-8 (45 ref.)

 LIABILITY, LEGAL

 Court  puts onus on doctors to warn patients about HIV status.
  AIDS Policy Law 1995 Mar 24;10(5):3-4
 Doctors who discriminate are paying a steep price. AIDS Policy
  Law 1995 Apr 7;10(6):10

 LIFE EXPECTANCY

   TRENDS

 [AIDS mortality in Mexico from 1983 to 1992.  The  trends  and
  years  of potential life lost] Izazola-Licea JA, et al. Salud
  Publica Mex 1995 Mar-Apr;37(2):140-8 (Eng. Abstr.)      (Spa)

 LIGANDS

 Flexible ligand docking using a genetic algorithm. Oshiro  CM,
  et al. J Comput Aided Mol Des 1995 Apr;9(2):113-30

 LIPODYSTROPHY, INTESTINAL

   MICROBIOLOGY

 Detection  of Tropheryma whippelii DNA in a patient with AIDS.
  Maiwald M, et al. J Clin Microbiol 1995 May;33(5):1354-6

 LIPOSOMES

 (Patho)physiologic pathways to drug targeting: artificial viral
  envelopes. Schreier H, et al. J Mol  Recognit  1995  Jan-Apr;
  8(1-2):59-62

 LITHIUM

   PHARMACOLOGY

 Effect  of  lithium  in  immunodeficiency: improved blood cell
  formation in mice with decreased hematopoiesis as the  result
  of LP-BM5 MuLV infection. Gallicchio VS, et al. Antiviral Res
  1995 Mar;26(2):189-202

 LIVER

   DRUG EFFECTS

 Hepatic  toxicity  associated  with  2'-3'  dideoxyinosine  in
  children with AIDS. Lacaille F, et al. J Pediatr Gastroenterol
  Nutr 1995 Apr;20(3):287-90

   METABOLISM

 gp180, a host cell glycoprotein that binds duck hepatitis B
  virus particles, is encoded by a member of the
  carboxypeptidase  gene  family.  Kuroki K, et al. J Biol Chem
  1995 Jun 23;270(25):15022-8

   VIROLOGY

 gp180, a host cell glycoprotein that binds  duck  hepatitis  B
  virus particles, is encoded by a member of the
  carboxypeptidase  gene  family.  Kuroki K, et al. J Biol Chem
  1995 Jun 23;270(25):15022-8

 LIVER NEOPLASMS

   DIAGNOSIS

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing natural killer cell  leukaemia/lymphoma  and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

   PATHOLOGY

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing  natural  killer cell leukaemia/lymphoma and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

 LIVER TRANSPLANTATION

   ADVERSE EFFECTS

 Implication of cyclosporine in up-regulation of Bcl-2
  expression and maintenance of CD8 lymphocytosis in
  cytomegalovirus-infected allograft recipients. Labalette M, et
  al. Transplantation 1995 Jun 27;59(12):1714-23

 LONDON

   EPIDEMIOLOGY

 Estimating the sexual mixing patterns in the general population
  from those in people acquiring gonorrhoea infection:
  theoretical foundation and empirical findings. Renton  A,  et
  al. J Epidemiol Community Health 1995 Apr;49(2):205-13

 LOS ANGELES

 The  prevalence  of  patient  disclosure  of  HIV infection to
  doctors [letter] Marks G, et al. Am J Public Health 1995 Jul;
  85(7):1018-9
 Racial differences in care among  hospitalized  patients  with
  Pneumocystis  carinii  pneumonia  in  Chicago,  New York, Los
  Angeles, Miami, and Raleigh-Durham. Bennett CL, et  al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1586-92

   EPIDEMIOLOGY

 Empirically  treated  Pneumocystis  carinii  pneumonia  in Los
  Angeles, Chicago, and Miami: 1987-1990. Bennett CL, et al.  J
  Infect Dis 1995 Jul;172(1):312-5

 LOVE

 Love,  sex,  and  power.  Considering women's realities in HIV
  prevention. Amaro H. Am  Psychol  1995  Jun;50(6):437-47  (80
  ref.)

 LUNG

   IMMUNOLOGY

 Interleukin-4 is required for the induction of lung Th2 mucosal
  immunity. Coyle AJ, et al. Am J Respir Cell Mol Biol 1995 Jul;
  13(1):54-9

   METABOLISM

 Interleukin-8  and  eicosanoid  production  in the lung during
  moderate to severe Pneumocystis carinii pneumonia in AIDS:  a
  role  of  interleukin-8  in  the  pathogenesis  of P. carinii
  pneumonia.  Benfield  TL,  et  al.  Respir  Med   1995   Apr;
  89(4):285-90

   PATHOLOGY

 Criteria  for open lung biopsy. Focusing on patients with AIDS
  [letter] Trachiotis GD. Chest 1995 Jul;108(1):293-4
 Surgical pathology of pulmonary infections. Travis  WD.  Semin
  Thorac Cardiovasc Surg 1995 Apr;7(2):62-9 (68 ref.)

   VIROLOGY

 Quantitative culture of HIV-1 from bronchoalveolar lavage
  cells. Pinkston P, et al. Am J Respir Crit Care Med 1995 Jul;
  152(1):254-9
 AIDS  and  the  lung:  update  1995.  4.  Role  of  the  human
  immunodeficiency  virus  within  the  lung. Clarke JR, et al.
  Thorax 1995 May;50(5):567-76 (150 ref.)

 LUNG DISEASES

   COMPLICATIONS

 Human immunodeficiency virus infections  and  the  respiratory
  system  in  children.  Bye  MR.  Pediatr  Pulmonol  1995 Apr;
  19(4):231-42 (167 ref.)

   PATHOLOGY

 Criteria for open lung biopsy. Focusing on patients with  AIDS
  [letter] Trachiotis GD. Chest 1995 Jul;108(1):293-4
 Surgical  pathology  of pulmonary infections. Travis WD. Semin
  Thorac Cardiovasc Surg 1995 Apr;7(2):62-9 (68 ref.)

 LUNG DISEASES, FUNGAL

   DIAGNOSIS

 Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and
  pathologic findings. Staples CA, et al. Radiology  1995  Aug;
  196(2):409-14

   IMMUNOLOGY

 Pulmonary infection in the immunocompromised patient. White DA.
  Semin Thorac Cardiovasc Surg 1995 Apr;7(2):78-87 (99 ref.)

   SURGERY

 The  endemic  mycoses: surgical considerations. Johnson PC, et
  al. Semin Thorac Cardiovasc  Surg  1995  Apr;7(2):95-103  (48
  ref.)

 LUNG DISEASES, INTERSTITIAL

   COMPLICATIONS

 An association between HIV infection, Epstein-Barr virus (EBV)
  immune  status,  cardiomyopathy, and lymphocytic interstitial
  pneumonia (LIP).  American  Pediatric  Society  104th  annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting;  1994  May 2-5; Seattle. Valentine M, et al. Pediatr
  AIDS HIV Infect 1994 Oct;5(5):320 (unnumbered abstract)

 LUNG DISEASES, PARASITIC

   IMMUNOLOGY

 Pulmonary infection in the immunocompromised patient. White DA.
  Semin Thorac Cardiovasc Surg 1995 Apr;7(2):78-87 (99 ref.)

 LUNG NEOPLASMS

   DRUG THERAPY

 Treatment of HIV-associated Kaposi's sarcoma with  paclitaxel.
  Saville MW, et al. Lancet 1995 Jul 1;346(8966):26-8

   PATHOLOGY

 [Herpes  simplex  virus  type  II  infection  as  an exophytic
  endobronchial tumor] Armbruster C, et al. Wien Klin Wochenschr
  1995;107(11):344-6 (Eng. Abstr.)                        (Ger)

 LUPUS ERYTHEMATOSUS, SYSTEMIC

   IMMUNOLOGY

 Autoimmunity following neonatal tolerance to alloantigens: role
  of donor I-A and I-E molecules. Kramar G, et al. J  Autoimmun
  1995 Apr;8(2):177-92

 LYMPH NODES

   CYTOLOGY

 Age-related  differences  in subset composition and activation
  responses of intestinal intraepithelial and mesenteric  lymph
  node  lymphocytes  from neonatal swine. Whary MT, et al. Cell
  Immunol 1995 Jul;163(2):215-21

   IMMUNOLOGY

 Response of  the  regional  lymph  node  to  bluetongue  virus
  infection  in  calves.  Barratt-Boyes  SM, et al. Vet Immunol
  Immunopathol 1995 Mar;45(1-2):73-84

   PATHOLOGY

 Quantification of lymphadenopathy  in  experimentally  induced
  feline immunodeficiency virus infection in domestic cats. del
  Fierro   GM,  et  al.  Vet  Immunol  Immunopathol  1995  May;
  46(1-2):3-12

   RADIONUCLIDE IMAGING

 Patterns of Ga-67 citrate accumulation in human
  immunodeficiency virus positive  patients  with  and  without
  Mycobacterium avium intracellulare infection. Buscombe JR, et
  al. Clin Radiol 1995 Jul;50(7):483-8

 LYMPHADENITIS

   ETIOLOGY

 Case reports: pericarditis and lymphadenitis due to Rhodococcus
  equi. Lee-Chiong T, et al. Am J Med Sci 1995 Jul;310(1):31-3

 LYMPHATIC DISEASES

   COMPLICATIONS

 Abdominal  lymphadenopathy in children with AIDS. Chung CJ, et
  al. Pediatr AIDS HIV Infect 1994 Oct;5(5):305-8

   ULTRASONOGRAPHY

 [Abdominal echography in patients with human  immunodeficiency
  virus (HIV) infection. Diagnostic usefulness in the evaluation
  of  associated medico-surgical pathology] Erdozain JC, et al.
  An Med Interna 1995 Mar;12(3):115-21 (Eng. Abstr.)      (Spa)

   VETERINARY

 Quantification of lymphadenopathy  in  experimentally  induced
  feline immunodeficiency virus infection in domestic cats. del
  Fierro   GM,  et  al.  Vet  Immunol  Immunopathol  1995  May;
  46(1-2):3-12

 LYMPHOCYTE COOPERATION

 Autoimmunity following neonatal tolerance to alloantigens: role
  of donor I-A and I-E molecules. Kramar G, et al. J  Autoimmun
  1995 Apr;8(2):177-92

 LYMPHOCYTE COUNT

 Immunologic  changes in the first 6 months of life in subjects
  born to HIV+ women. American Pediatric Society  104th  annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting; 1994 May 2-5; Seattle. Kovacs A, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):319 (unnumbered abstract)

 LYMPHOCYTE DEPLETION

 Depletion of CD4+ and CD8+ cells eliminates immunologic memory
  of   thyroiditogenicity  in  murine  experimental  autoimmune
  thyroiditis. Fuller BE, et al. Autoimmunity 1994;19(3):161-8

 LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1

   IMMUNOLOGY

 Rapid development of  murine  AIDS  is  dependent  of  signals
  provided  by  CD54 and CD11a. Makino M, et al. J Immunol 1995
  Jul 15;155(2):974-81
 Antibody to adhesion molecule LFA-1 enhances plasma
  neutralization of human immunodeficiency virus type 1.  Gomez
  MB, et al. J Virol 1995 Aug;69(8):4628-32

 LYMPHOCYTE SUBSETS

 Quantitative immunofluorescent measurements of surface
  receptors  on  immune  subsets  from  HIV  infected children.
  American Pediatric Society 104th annual meeting  and  Society
  for  Pediatric  Research  63rd  annual meeting; 1994 May 2-5;
  Seattle. Denny TN, et al. Pediatr AIDS HIV Infect  1994  Oct;
  5(5):321 (unnumbered abstract)
 Immunologic  changes in the first 6 months of life in subjects
  born to HIV+ women. American Pediatric Society  104th  annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting; 1994 May 2-5; Seattle. Kovacs A, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):319 (unnumbered abstract)

   CYTOLOGY

 Lymphocyte subsets in bronchoalveolar lavage fluid of children
  without bronchopulmonary disease. Ratjen F, et al. Am J Respir
  Crit Care Med 1995 Jul;152(1):174-8

   DRUG EFFECTS

 High  consumption  of  fatty  fish  from  the  Baltic  Sea  is
  associated  with  changes  in human lymphocyte subset levels.
  Hagmar L, et al. Toxicol Lett 1995 May;77(1-3):335-42

   IMMUNOLOGY

 Effect of qigong  training  on  proportions  of  T  lymphocyte
  subsets in human peripheral blood. Ryu H, et al. Am J Chin Med
  1995;23(1):27-36
 Analysis  of  leucocytes  and  lymphocyte subsets in cats with
  naturally-occurring cryptococcosis but differing feline
  immunodeficiency virus status. Walker C, et al.  Aust  Vet  J
  1995 Mar;72(3):93-7
 Age-related  differences  in subset composition and activation
  responses of intestinal intraepithelial and mesenteric  lymph
  node  lymphocytes  from neonatal swine. Whary MT, et al. Cell
  Immunol 1995 Jul;163(2):215-21
 High  consumption  of  fatty  fish  from  the  Baltic  Sea  is
  associated with changes in human  lymphocyte  subset  levels.
  Hagmar L, et al. Toxicol Lett 1995 May;77(1-3):335-42
 FIV  vaccine  studies.  II.  Clinical  findings, hematological
  changes and kinetics of blood lymphocyte subsets.
  Hofmann-Lehmann R, et al. Vet Immunol Immunopathol 1995  May;
  46(1-2):115-25
 Peripheral  T  cell  receptor  repertoire  among CD4+ and CD8+
  subsets during acute infectious mononucleosis. Slobod KS,  et
  al. Viral Immunol 1994;7(3):151-3

 B-LYMPHOCYTE SUBSETS

   IMMUNOLOGY

 Peripheral  blood  lymphocyte  subsets  after  allogeneic bone
  marrow transplantation: reconstitution and  correlation  with
  the occurrence of acute graft-versus-host disease. Chan EY, et
  al. Asian Pac J Allergy Immunol 1994 Dec;12(2):117-23

 T-LYMPHOCYTE SUBSETS

 Effect  of  splenectomy  on  T  lymphocyte subsets in patients
  infected with the human immunodeficiency virus. Zurlo JJ,  et
  al. Clin Infect Dis 1995 Apr;20(4):768-71

   DRUG EFFECTS

 Interference with thymocyte differentiation by an inhibitor of
  S-adenosylhomocysteine  hydrolase.  Benveniste  P,  et  al. J
  Immunol 1995 Jul 15;155(2):536-44

   IMMUNOLOGY

 Interleukin-4 is required for the induction of lung Th2 mucosal
  immunity. Coyle AJ, et al. Am J Respir Cell Mol Biol 1995 Jul;
  13(1):54-9
 Peripheral blood  lymphocyte  subsets  after  allogeneic  bone
  marrow  transplantation:  reconstitution and correlation with
  the occurrence of acute graft-versus-host disease. Chan EY, et
  al. Asian Pac J Allergy Immunol 1994 Dec;12(2):117-23
 Expansion of CD8+CD57+ T cells after allogeneic BMT is related
  with a low incidence  of  relapse  and  with  cytomegalovirus
  infection.  Dolstra  H,  et  al.  Br  J  Haematol  1995  Jun;
  90(2):300-7
 CD40  ligand  expression is developmentally regulated in human
  thymocytes. Fuleihan R, et al. Clin Immunol Immunopathol 1995
  Jul;76(1 Pt 1):52-8
 Diseases involving the T-cell receptor/CD3 complex.
  Arnaiz-Villena A, et al. Crit Rev  Oncol  Hematol  1995  Jun;
  19(2):131-47 (170 ref.)
 Characterization  of  allergen (Bet v 1)-specific T cell lines
  and clones from non-allergic individuals. Ebner C, et al. Int
  Arch Allergy Immunol 1995 May-Jun;107(1-3):183-5
 Insulin-secretory-granule specific T cell clones in human IDDM.
  Chang JC, et al. J Autoimmun 1995 Apr;8(2):221-34
 The time course and characterization of mercuric
  chloride-induced immunopathology in  the  brown  Norway  rat.
  Qasim FJ, et al. J Autoimmun 1995 Apr;8(2):193-208
 Differential  requirement of CD28 costimulation for activation
  of murine CD8+ intestinal intraepithelial lymphocyte  subsets
  and lymph node cells. Gelfanov V, et al. J Immunol 1995 Jul 1;
  155(1):76-82
 The  predictive value of T cell function in vitro and pre-AIDS
  zidovudine use for survival after AIDS diagnosis in a  cohort
  of  homosexual  men in Amsterdam. Bindels PJ, et al. J Infect
  Dis 1995 Jul;172(1):97-104
 [Effect  of  low  dose  rhTNF-alpha  on  immune  function   of
  lymphocytes in burned rats] Su B, et al. Chung Hua Cheng Hsing
  Shao Shang Wai Ko Tsa Chih 1995 Jan;11(1):36-9 (Eng. Abstr.)
                                                          (Chi)
                              130
1





   METABOLISM

 Generation  and  in  vivo persistence of polarized Th1 and Th2
  memory cells. Swain SL. Immunity 1994 Oct;1(7):543-52

   PHYSIOLOGY

 Increase of activated T-cells in BAL fluid of Japanese patients
  with bronchiolitis obliterans organizing pneumonia and chronic
  eosinophilic pneumonia. Mukae  H,  et  al.  Chest  1995  Jul;
  108(1):123-8

   VIROLOGY

 HIV-1-induced  thymocyte depletion is associated with indirect
  cytopathogenicity and infection of progenitor cells in  vivo.
  Su L, et al. Immunity 1995 Jan;2(1):25-36
 In vivo cellular tropism of human T-lymphotropic virus type II
  is not restricted to CD8+ cells. Lal RB, et al. Virology 1995
  Jul 10;210(2):441-7

 LYMPHOCYTE TRANSFORMATION

 Increase of activated T-cells in BAL fluid of Japanese patients
  with bronchiolitis obliterans organizing pneumonia and chronic
  eosinophilic  pneumonia.  Mukae  H,  et  al.  Chest 1995 Jul;
  108(1):123-8
 Diseases involving the T-cell receptor/CD3 complex.
  Arnaiz-Villena A, et al. Crit Rev  Oncol  Hematol  1995  Jun;
  19(2):131-47 (170 ref.)
 Requirements  for  activation  of  CD8+  murine  T  cells.  I.
  Development  of  cytolytic  activity.  Cronin  DC 2nd, et al.
  Immunol Res 1994;13(4):215-33
 The predictive value of T cell function in vitro and  pre-AIDS
  zidovudine  use for survival after AIDS diagnosis in a cohort
  of homosexual men in Amsterdam. Bindels PJ, et al.  J  Infect
  Dis 1995 Jul;172(1):97-104
 Massive  activation  of  immune  cells  with  an intact T cell
  repertoire in acute human  immunodeficiency  virus  syndrome.
  Cossarizza A, et al. J Infect Dis 1995 Jul;172(1):105-12
 Lymphocyte proliferation and HIV infection: in vitro
  examination  of  potential  therapeutic  strategies. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Krogstad P, et al. Pediatr AIDS HIV Infect 1994  Oct;5(5):319
  (unnumbered abstract)
 Specific  activation  of  natural  killer (NK) cells. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Reichlin A, et al. Pediatr AIDS HIV Infect 1994  Oct;5(5):314
  (unnumbered abstract)

   DRUG EFFECTS

 Roxithromycin:  its  effects  on concanavalin-A induced spleen
  cell proliferation and interleukin production in mice. Adachi
  M, et al. Int Arch Allergy Immunol 1995 May-Jun;107(1-3):427
 Staphylococcal enterotoxin B affects in vitro  IgE  synthesis,
  interferon-gamma,  interleukin-4 and interleukin-5 production
  in atopic eczema. Neuber K, et al. Int Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):179-82
 HIV  gp120  inhibits  T  cell  activation  by interfering with
  expression of costimulatory molecules CD40  ligand  and  CD80
  (B71). Chirmule N, et al. J Immunol 1995 Jul 15;155(2):917-24

   IMMUNOLOGY

 Differential  requirement of CD28 costimulation for activation
  of murine CD8+ intestinal intraepithelial lymphocyte  subsets
  and lymph node cells. Gelfanov V, et al. J Immunol 1995 Jul 1;
  155(1):76-82

   PHYSIOLOGY

 Functional  and  phenotypic  analysis  of  in vitro stimulated
  canine peripheral blood mononuclear cells. Rivas AL,  et  al.
  Vet Immunol Immunopathol 1995 Mar;45(1-2):55-71

 LYMPHOCYTE TRANSFUSION

 Cell  transfer  therapy  of  cancer metastasis with autologous
  lymphocytes. Mikamo S, et al. Cell  Transplant  1995;4  Suppl
  1:S65-7

 LYMPHOCYTES

   IMMUNOLOGY

 Establishment of novel lymphoid cell lines dually infected with
  human T cell lymphotropic viruses types I and II. Kubota T, et
  al. J Infect Dis 1995 Jul;172(1):220-4
 Persistence of immunoglobulin heavy chain/c-myc
  recombination-positive lymphocyte clones in the blood of human
  immunodeficiency virus-infected homosexual men. Muller JR, et
  al. Proc Natl Acad Sci U S A 1995 Jul 3;92(14):6577-81

   METABOLISM

 HIV  infection  decreases  intracellular  nicotinamide adenine
  dinucleotide [NAD] Murray MF,  et  al.  Biochem  Biophys  Res
  Commun 1995 Jul 6;212(1):126-31
 Developmental  and  tissue-specific expression of human CD4 in
  transgenic rabbits. Snyder BW, et al. Mol Reprod Dev 1995 Apr;
  40(4):419-28

   PHYSIOLOGY

 Persistence of immunoglobulin heavy chain/c-myc
  recombination-positive lymphocyte clones in the blood of human
  immunodeficiency virus-infected homosexual men. Muller JR, et
  al. Proc Natl Acad Sci U S A 1995 Jul 3;92(14):6577-81

   VIROLOGY

 HIV infection  decreases  intracellular  nicotinamide  adenine
  dinucleotide  [NAD]  Murray  MF,  et  al. Biochem Biophys Res
  Commun 1995 Jul 6;212(1):126-31

 B-LYMPHOCYTES

   CYTOLOGY

 Expression and biological activities of bovine interleukin  4:
  effects  of  recombinant  bovine  interleukin  4  on  T  cell
  proliferation and B cell differentiation and proliferation in
  vitro. Estes DM, et al. Cell Immunol 1995 Jul;163(2):268-79

   IMMUNOLOGY

 Expression  and biological activities of bovine interleukin 4:
  effects  of  recombinant  bovine  interleukin  4  on  T  cell
  proliferation and B cell differentiation and proliferation in
  vitro. Estes DM, et al. Cell Immunol 1995 Jul;163(2):268-79
 Selective variations in  vivo  of  VH3  and  VH1  gene  family
  expression  in  peripheral B cell IgM, IgD and IgG during HIV
  infection. David D, et al. Eur J Immunol 1995 Jun;25(6):1524-8
 In the absence of a CD40  signal,  B  cells  are  tolerogenic.
  Buhlmann JE, et al. Immunity 1995 Jun;2(6):645-53

   METABOLISM

 In  vitro activation leads to the binding of T-cell markers to
  the surface of  B-lymphocytes.  Rabinowitz  R,  et  al.  Clin
  Immunol Immunopathol 1995 Aug;76(2):148-54

   PHYSIOLOGY

 Functional  and  phenotypic  analysis  of  in vitro stimulated
  canine peripheral blood mononuclear cells. Rivas AL,  et  al.
  Vet Immunol Immunopathol 1995 Mar;45(1-2):55-71

 T-LYMPHOCYTES

   CHEMISTRY

 Age-dependent  reduction  of  Bcl-2 expression in peripheral T
  cells of lpr and gld mutant mice. Tamura A, et al. J  Immunol
  1995 Jul 1;155(1):499-507

   CYTOLOGY

 Characterization   of  the  alloreactivity  and  anti-leukemia
  reactivity of cord blood mononuclear cells. Keever CA, et al.
  Bone Marrow Transplant 1995 Mar;15(3):407-19
 Expression and biological activities of bovine interleukin  4:
  effects  of  recombinant  bovine  interleukin  4  on  T  cell
  proliferation and B cell differentiation and proliferation in
  vitro. Estes DM, et al. Cell Immunol 1995 Jul;163(2):268-79
 Human  neonatal  thymic  organ  culture:  an  ex vivo model of
  thymocyte ontogeny and HIV-1 infection. Rosenzweig M, et  al.
  Pathobiology 1994;62(5-6):245-51

   DRUG EFFECTS

 Effects of inhalative exposure to dioxins in wood preservatives
  on cell-mediated immunity in day-care center teachers. Wolf N,
  et al. Environ Res 1995 Feb;68(2):96-105
 Growth-promoting actions of parathyroid hormone,
  adrenocorticotrophic hormone, and thyroid-stimulating hormone:
  in vitro studies in normal and pygmy T-lymphoblast cell lines.
  Geffner ME, et al. Pediatr Res 1995 Apr;37(4 Pt 1):507-11

   IMMUNOLOGY

 Effect  of  qigong  training  on  proportions  of T lymphocyte
  subsets in human peripheral blood. Ryu H, et al. Am J Chin Med
  1995;23(1):27-36
 Principles for adoptive T cell therapy of human viral diseases.
  Riddell SR, et al. Annu Rev Immunol 1995;13:545-86 (249 ref.)
 Expression and biological activities of bovine interleukin  4:
  effects  of  recombinant  bovine  interleukin  4  on  T  cell
  proliferation and B cell differentiation and proliferation in
  vitro. Estes DM, et al. Cell Immunol 1995 Jul;163(2):268-79
 T  cells  in regenerating feathers of Smyth line chickens with
  vitiligo. Erf GF, et al. Clin Immunol Immunopathol 1995  Aug;
  76(2):120-6
 In  vitro activation leads to the binding of T-cell markers to
  the surface of  B-lymphocytes.  Rabinowitz  R,  et  al.  Clin
  Immunol Immunopathol 1995 Aug;76(2):148-54
 Cross-linking  of  CD30  induces HIV expression in chronically
  infected T  cells.  Biswas  P,  et  al.  Immunity  1995  Jun;
  2(6):587-96
 Altered  peptidase  and viral-specific T cell response in LMP2
  mutant mice. Van Kaer L, et al. Immunity 1994 Oct;1(7):533-41
 The predictive value of T cell function in vitro and  pre-AIDS
  zidovudine  use for survival after AIDS diagnosis in a cohort
  of homosexual men in Amsterdam. Bindels PJ, et al.  J  Infect
  Dis 1995 Jul;172(1):97-104
 Massive  activation  of  immune  cells  with  an intact T cell
  repertoire in acute human  immunodeficiency  virus  syndrome.
  Cossarizza A, et al. J Infect Dis 1995 Jul;172(1):105-12
 In  vitro  T cell function, delayed-type hypersensitivity skin
  testing, and CD4+ T  cell  subset  phenotyping  independently
  predict   survival  time  in  patients  infected  with  human
  immunodeficiency virus. Dolan MJ, et al. J  Infect  Dis  1995
  Jul;172(1):79-87
 Malignant and normal T cells show random use of T-cell receptor
  alpha chain variable regions in patients with cutaneous T-cell
  lymphoma.  Longley  J,  et  al.  J  Invest Dermatol 1995 Jul;
  105(1):62-4
 Tuberculosis, HIV, hormones and children [editorial;  comment]
  Wilkinson  RJ,  et al. J R Coll Physicians Lond 1995 Mar-Apr;
  29(2):86-8
 The expression of  adhesion  molecules,  including  CD11a  and
  CD11b, on the human T lymphocyte surface membrane in patients
  with bronchial asthma. Sumida S. Kurume Med J 1995;42(1):21-32
 Oligomerization of CD4 is required for stable binding to class
  II  major  histocompatibility  complex  proteins  but not for
  interaction with human immunodeficiency virus gp120. Sakihama
  T, et al. Proc Natl Acad Sci U S A 1995 Jul 3;92(14):6444-8
 Synergy between T-cell immunity and  inhibition  of  paracrine
  stimulation causes tumor rejection. Seung LP, et al. Proc Natl
  Acad Sci U S A 1995 Jul 3;92(14):6254-8
 [Effect   of  low  dose  rhTNF-alpha  on  immune  function  of
  lymphocytes in burned rats] Su B, et al. Chung Hua Cheng Hsing
  Shao Shang Wai Ko Tsa Chih 1995 Jan;11(1):36-9 (Eng. Abstr.)
                                                          (Chi)

   METABOLISM

 High level of interleukin-10 production by the activated T cell
  population within the rheumatoid synovial membrane. Cohen SB,
  et al. Arthritis Rheum 1995 Jul;38(7):946-52
 In vitro activation leads to the binding of T-cell markers  to
  the  surface  of  B-lymphocytes.  Rabinowitz  R,  et al. Clin
  Immunol Immunopathol 1995 Aug;76(2):148-54
 Induction of MMP9 (92 kDa gelatinase) activity and  expression
  of  tissue  inhibitor of metalloproteinase-2 mRNA (TIMP-2) in
  primitive  neuroectodermal  cells  infected  with  retrovirus
  HTLV-I. Giraudon P,  et  al.  Eur  J  Neurosci  1995  May  1;
  7(5):841-8
 Interaction of nuclear protein p140 with human immunodeficiency
  virus  type  1  TAR  RNA in mitogen-activated primary human T
  lymphocytes.  Rothblum  CJ,  et  al.  J   Virol   1995   Aug;
  69(8):5156-63

   MICROBIOLOGY

 Protection  of a T-cell line from human immunodeficiency virus
  replication by the stable expression of a short antisense RNA
  sequence carried by a shuttle RNA molecule. Cagnon L, et al. J
  Acquir  Immune  Defic  Syndr  Hum  Retrovirol  1995  Aug   1;
  9(4):349-58

   PATHOLOGY

 gp120-induced  programmed  cell  death in recently activated T
  cells without subsequent ligation of  the  T  cell  receptor.
  Foster S, et al. Eur J Immunol 1995 Jun;25(6):1778-82

   PHYSIOLOGY

 Mast  cells and T lymphocytes in chronic urticaria. Barlow RJ,
  et al. Clin Exp Allergy 1995 Apr;25(4):317-22
 Anti-CD3-induced apoptosis in T-cells from young and old mice.
  Chrest FJ, et al. Cytometry 1995 May 1;20(1):33-42
 The CD4-associated tyrosine  kinase  p56lck  is  required  for
  lymphocyte chemoattractant factor-induced T lymphocyte
  migration.  Ryan  TC,  et  al.  J  Biol  Chem  1995  Jul  21;
  270(29):17081-6

   VIROLOGY

 The   relationship  between  HTLV-I-infected  cell  lines  and
  uveitis. Fukushima A, et al. Graefes Arch Clin Exp Ophthalmol
  1995 Apr;233(4):231-5
 The peri-kappa B site mediates  human  immunodeficiency  virus
  type  2  enhancer activation in monocytes but not in T cells.
  Clark NM, et al. J Virol 1995 Aug;69(8):4854-62
 Constitutively activated Jak-STAT pathway in T cells
  transformed with HTLV-I. Migone TS, et al. Science 1995 Jul 7;
  269(5220):79-81
 Dehydroepiandrosterone inhibits replication of feline
  immunodeficiency virus in chronically infected cells. Bradley
  WG, et al. Vet Immunol Immunopathol 1995 May;46(1-2):159-68
 The feline lymphoid cell line  MBM  and  its  use  for  feline
  immunodeficiency  virus isolation and quantitation. Matteucci
  D, et al. Vet Immunol Immunopathol 1995 May;46(1-2):71-82
 Amino acid substitutions in the V3 loop  are  responsible  for
  adaptation to growth in transformed T-cell lines of a primary
  human  immunodeficiency  virus  type  1.  Harrowe  G,  et al.
  Virology 1995 Jul 10;210(2):490-4

 T-LYMPHOCYTES, CYTOTOXIC

   CYTOLOGY

 Requirement for natural  killer  cells  in  the  induction  of
  cytotoxic  T  cells.  Kos  FJ,  et al. J Immunol 1995 Jul 15;
  155(2):578-84

   IMMUNOLOGY

 Quantitative correlation between HLA class I allele expression
  and  recognition  of  melanoma  cells   by   antigen-specific
  cytotoxic  T lymphocytes. Rivoltini L, et al. Cancer Res 1995
  Jul 15;55(14):3149-57
 Requirement for natural  killer  cells  in  the  induction  of
  cytotoxic  T  cells.  Kos  FJ,  et al. J Immunol 1995 Jul 15;
  155(2):578-84
 Antigen-presenting T cells induce the development of cytotoxic
  CD4+ T  cells.  I.  Involvement  of  the  CD80-CD28  adhesion
  molecules. Mauri D, et al. J Immunol 1995 Jul 1;155(1):118-27
 Ontogeny of HIV-1 specific CTL in vertical infection. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Holmes  DR,  et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):314
  (unnumbered abstract)
 Why can't cytotoxic T cells handle HIV? [comment] Bevan MJ, et
  al. Proc Natl Acad Sci U S A 1995  Jun  20;92(13):5765-7  (27
  ref.)
 Persistent high frequency of human immunodeficiency
  virus-specific  cytotoxic  T  cells  in  peripheral  blood of
  infected donors. Moss PA, et al. Proc Natl Acad Sci U S A 1995
  Jun 20;92(13):5773-7
 Synergy between T-cell immunity and  inhibition  of  paracrine
  stimulation causes tumor rejection. Seung LP, et al. Proc Natl
  Acad Sci U S A 1995 Jul 3;92(14):6254-8

   VIROLOGY

 Why can't cytotoxic T cells handle HIV? [comment] Bevan MJ, et
  al.  Proc  Natl  Acad Sci U S A 1995 Jun 20;92(13):5765-7 (27
  ref.)
 Persistent high frequency of human immunodeficiency
  virus-specific cytotoxic  T  cells  in  peripheral  blood  of
  infected donors. Moss PA, et al. Proc Natl Acad Sci U S A 1995
  Jun 20;92(13):5773-7

 T-LYMPHOCYTES, HELPER-INDUCER

   DRUG EFFECTS

 Progesterone  favors  the  development of human T helper cells
  producing Th2-type cytokines and promotes both IL-4 production
  and membrane CD30 expression in established Th1 cell  clones.
  Piccinni MP, et al. J Immunol 1995 Jul 1;155(1):128-33

   IMMUNOLOGY

 Vitamin A deficiency results in a priming environment conducive
  for  Th1  cell development. Cantorna MT, et al. Eur J Immunol
  1995 Jun;25(6):1673-9
 Sudden  infant  death  syndrome  (SIDS):  immunoglobulins  and
  hypoxia. Reid GM, et al. Med Hypotheses 1995  Mar;44(3):202-6
  (46 ref.)

 T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR

   PHYSIOLOGY

 Genetic modification of T cell clones to improve the safety and
  efficacy of adoptive T cell therapy. Greenberg PD, et al. Ciba
  Found Symp 1994;187:212-23; discussion 224-8

 LYMPHOCYTOSIS

   VIROLOGY

 Implication of cyclosporine in up-regulation of Bcl-2
  expression and maintenance of CD8 lymphocytosis in
  cytomegalovirus-infected allograft recipients. Labalette M, et
  al. Transplantation 1995 Jun 27;59(12):1714-23

 LYMPHOID TISSUE

   PATHOLOGY

 Skin-associated  lymphoid  tissue  in  human  immunodeficiency
  virus-1,  human  papillomavirus,  and  herpes  simplex  virus
  infections. Memar OM, et al. J Invest Dermatol 1995 Jul;105(1
  Suppl):99S-104S (56 ref.)

 LYMPHOKINES

   PHARMACOLOGY

 The  CD4-associated  tyrosine  kinase  p56lck  is required for
  lymphocyte chemoattractant factor-induced T lymphocyte
  migration.  Ryan  TC,  et  al.  J  Biol  Chem  1995  Jul  21;
  270(29):17081-6

   SECRETION

 Interleukin-4 and interferon-gamma regulate differentiation of
  CD8+  T  cells  into  populations  with  divergent   cytokine
  profiles.  Noble  A,  et  al.  Int  Arch Allergy Immunol 1995
  May-Jun;107(1-3):186-8

 LYMPHOMA

   VIROLOGY

 [Detection  of  STLV-1  integration  in  DNA  extracted   from
  formalin-fixed and paraffin-embedded material from M.
  arctoides lymphoma by the polymerase chain reaction] Chikobava
  MG, et al. Biull Eksp Biol Med 1995 Mar;119(3):314-6    (Rus)

 LYMPHOMA, AIDS-RELATED

 Hodgkin's  disease and human immunodeficiency virus infection:
  clinicopathologic and virologic features of 114 patients from
  the Italian Cooperative Group on AIDS and Tumors. Tirelli  U,
  et al. J Clin Oncol 1995 Jul;13(7):1758-67
 Human immunodeficiency virus associated non-Hodgkin's lymphoma
  (HIV-NHL). American Pediatric Society 104th annual meeting and
  Society  for Pediatric Research 63rd annual meeting; 1994 May
  2-5; Seattle. Miller ST, et al. Pediatr AIDS HIV Infect  1994
  Oct;5(5):324 (unnumbered abstract)

   EPIDEMIOLOGY

 HIV  positive  patients first presenting with an AIDS defining
  illness: characteristics and survival. Poznansky MC,  et  al.
  BMJ 1995 Jul 15;311(6998):156-8

   ETIOLOGY

 AIDS-related lymphomas: from pathogenesis to pathology. Gaidano
  G, et al. Br J Haematol 1995 Jun;90(2):235-43 (65 ref.)

   GENETICS

 High  expression  of latent membrane protein 1 of Epstein-Barr
  virus and  BCL-2  oncoprotein  in  acquired  immunodeficiency
  syndrome-related primary brain lymphomas. Camilleri-Broet S,
  et al. Blood 1995 Jul 15;86(2):432-5

   PATHOLOGY

 Histopathologic spectrum of AIDS-associated lesions in Maharaj
  Nakorn  Chiang  Mai  Hospital.  Bhoopat L, et al. Asian Pac J
  Allergy Immunol 1994 Dec;12(2):95-104
 AIDS-related lymphomas: from pathogenesis to pathology. Gaidano
  G, et al. Br J Haematol 1995 Jun;90(2):235-43 (65 ref.)
 Gingival mass lesions in a patient with HIV infection [clinical
  conference] Gowdey G, et al. Oral Surg Oral Med  Oral  Pathol
  Oral Radiol Endod 1995 Jan;79(1):7-9

   THERAPY

 Management of human immunodeficiency virus-associated
  malignancies.  Conant  MA.  Recent  Results  Cancer Res 1995;
  139:423-32 (12 ref.)

 LYMPHOMA, B-CELL

   GENETICS

 High expression of latent membrane protein 1  of  Epstein-Barr
  virus  and  BCL-2  oncoprotein  in  acquired immunodeficiency
  syndrome-related primary brain lymphomas. Camilleri-Broet S,
  et al. Blood 1995 Jul 15;86(2):432-5

 LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC

   PATHOLOGY

 Gingival mass lesions in a patient with HIV infection [clinical
  conference] Gowdey G, et al. Oral Surg Oral Med  Oral  Pathol
  Oral Radiol Endod 1995 Jan;79(1):7-9

 LYMPHOMA, LARGE-CELL, KI-1

   VIROLOGY

 [Large-cell  anaplastic  malignant  CD30/Ki-1-positive  T-type
  lymphoma,  associated  with  STLV-1  virus  (baboon malignant
  lymphoma model] Iakovleva LA, et al. Gematol Transfuziol 1995
  Jan-Feb;40(1):10-6 (Eng. Abstr.)                        (Rus)

 LYMPHOMA, NON-HODGKIN'S

 Human immunodeficiency virus associated non-Hodgkin's lymphoma
  (HIV-NHL). American Pediatric Society 104th annual meeting and
  Society for Pediatric Research 63rd annual meeting; 1994  May
  2-5;  Seattle. Miller ST, et al. Pediatr AIDS HIV Infect 1994
  Oct;5(5):324 (unnumbered abstract)

   ETIOLOGY

 Does zidovudine cause non-Hodgkin's lymphoma?  [letter]  Cote
  TR, et al. AIDS 1995 Apr;9(4):404-5

   THERAPY

 Prospects  for  immunotoxin therapy of non-Hodgkin's lymphoma.
  Grossbard ML, et al.  Clin  Immunol  Immunopathol  1995  Aug;
  76(2):107-14 (51 ref.)

 LYMPHOMA, T-CELL

   DIAGNOSIS

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing  natural  killer cell leukaemia/lymphoma and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

   PATHOLOGY

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing natural killer cell  leukaemia/lymphoma  and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

   VIROLOGY

 [Large-cell  anaplastic  malignant  CD30/Ki-1-positive  T-type
  lymphoma,  associated  with  STLV-1  virus  (baboon malignant
  lymphoma model] Iakovleva LA, et al. Gematol Transfuziol 1995
  Jan-Feb;40(1):10-6 (Eng. Abstr.)                        (Rus)

 LYMPHOMA, T-CELL, CUTANEOUS

 New perspectives in experimental  and  clinical  research  for
  cutaneous  T  cell  lymphomas.  Burg G, et al. Recent Results
  Cancer Res 1995;139:225-37 (48 ref.)

   IMMUNOLOGY

 Malignant and normal T cells show random use of T-cell receptor
  alpha chain variable regions in patients with cutaneous T-cell
  lymphoma. Longley J, et  al.  J  Invest  Dermatol  1995  Jul;
  105(1):62-4

 LYMPHOPENIA

   COMPLICATIONS

 Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with
  hemophilia   and   sex  partners  of  HIV  seropositive  men.
  Multicenter Hemophilia Cohort Study. O'Brien TR, et al. Am  J
  Hematol 1995 Jul;49(3):201-6

 LYMPHOPROLIFERATIVE DISORDERS

   CHEMICALLY INDUCED

 The time course and characterization of mercuric
  chloride-induced  immunopathology  in  the  brown Norway rat.
  Qasim FJ, et al. J Autoimmun 1995 Apr;8(2):193-208

   RADIOGRAPHY

 Imaging the gastrointestinal  tract  of  children  with  AIDS.
  Haller JO. Pediatr Radiol 1995;25(2):94-6 (25 ref.)

   VIROLOGY

 Epstein-Barr virus associated lymphoproliferative disorder with
  fatal involvement of the gastrointestinal tract in an infant.
  Pan LX, et al. J Clin Pathol 1995 Apr;48(4):390-2

 MACROPHAGE ACTIVATION

 Murine   Th1  and  Th2  cell  clones  differentially  regulate
  macrophage nitric oxide production. Taub DD, et al. J  Leukoc
  Biol 1995 Jul;58(1):80-9

 MACROPHAGES

   CHEMISTRY

 A  novel canine leukointegrin, alpha d beta 2, is expressed by
  specific macrophage subpopulations in tissue and a minor CD8+
  lymphocyte subpopulation in peripheral blood. Danilenko DM, et
  al. J Immunol 1995 Jul 1;155(1):35-44

   MICROBIOLOGY

 The macrophage mannose receptor  can  mediate  the  uptake  of
  Mycobacterium avium-intracellulare. American Pediatric Society
  104th  annual meeting and Society for Pediatric Research 63rd
  annual meeting; 1994 May 2-5; Seattle.  Kruskal  BA,  et  al.
  Pediatr   AIDS   HIV  Infect  1994  Oct;5(5):319  (unnumbered
  abstract)

   VIROLOGY

 HIV-1 V3 envelope sequences required for macrophage  infection
  [letter] Henkel T, et al. AIDS 1995 Apr;9(4):399-401
 FIV  infection of macrophages: in vitro and in vivo inhibition
  by dideoxycytidine 5'-triphosphate. Magnani  M,  et  al.  Vet
  Immunol Immunopathol 1995 May;46(1-2):151-8

 MACROPHAGES, ALVEOLAR

   METABOLISM

 Nitric  oxide  production by alveolar macrophages from newborn
  versus infant and adult rats. American Pediatric Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Sherman MP,  et  al.  Pediatr
  AIDS HIV Infect 1994 Oct;5(5):315 (unnumbered abstract)

 MACROPHAGES, PERITONEAL

   METABOLISM

 Murine   Th1  and  Th2  cell  clones  differentially  regulate
  macrophage nitric oxide production. Taub DD, et al. J  Leukoc
  Biol 1995 Jul;58(1):80-9

 MAGNETIC RESONANCE IMAGING

 Role  of  CT  and  MR imaging in the management of tuberculous
  spondylitis. Sharif HS, et al. Radiol Clin North Am 1995 Jul;
  33(4):787-804 (80 ref.)
 MR imaging and CT of central nervous system tuberculosis in the
  patient with AIDS. Villoria MF, et al. Radiol Clin  North  Am
  1995 Jul;33(4):805-20 (93 ref.)

 MALARIA

   COMPLICATIONS

 Fever as the presenting complaint of travellers returning from
  the tropics. Doherty JF, et al. QJM 1995 Apr;88(4):277-81

 MAMMARY TUMOR VIRUSES, MOUSE

   IMMUNOLOGY

 The role of superantigens in the immunobiology of retroviruses.
  Huber  BT, et al. Ciba Found Symp 1994;187:132-40; discussion
  140-3 (43 ref.)

 MANAGED CARE PROGRAMS

 Community-based HIV case management: challenges and
  opportunities. Sowell RL.  J  Assoc  Nurses  AIDS  Care  1995
  Mar-Apr;6(2):33-40

   ORGANIZATION & ADMINISTRATION

 A case management program for chemically dependent clients with
  multiple  needs.  Brindis C, et al. J Case Manag 1995 Spring;
  4(1):22-8
 Integrated case management: the AID Atlanta Model. Sowell  RL,
  et al. J Case Manag 1995 Spring;4(1):15-21

 MANDATORY TESTING

   LEGISLATION & JURISPRUDENCE

 Testing  health  care workers for AIDS in England. Health Care
  Anal 1995 May;3(2):138-40
 Compulsory AIDS testing--a recent  judgement  by  the  Italian
  Constitutional Court. Cattorini P. Health Care Anal 1995 May;
  3(2):135-8
 Do  our  children need to die of AIDS for politics? Fischer C.
  Internist 1995 Jun;36(6):29-30
 'No compulsory HIV tests'. Young N. Nurs Stand 1995 Jun  7-13;
  9(37):17

 MARRIAGE

   LEGISLATION & JURISPRUDENCE

 'No  compulsory HIV tests'. Young N. Nurs Stand 1995 Jun 7-13;
  9(37):17

 MARYLAND

 HIV-positive father wins visitation battle in  Maryland.  AIDS
  Policy Law 1995 Mar 24;10(5):9
 Patterns  in  Maryland  Medicaid enrollment among persons with
  AIDS. Bartnyska LM, et al. Inquiry 1995 Summer;32(2):184-95

 MASON-PFIZER MONKEY VIRUS

   ENZYMOLOGY

 Cloning, bacterial expression,  and  characterization  of  the
  Mason-Pfizer monkey virus proteinase.
  Hruskova-Heidingsfeldova O, et al. J Biol Chem 1995 Jun 23;
  270(25):15053-8

 MASS CHEST X-RAY

 [Could  tuberculosis  again  be an endemic disease in Hungary?
  (Model study 1968-1993)] Abraham E, et al. Orv Hetil 1995 Jun
  18;136(25):1329-32 (Eng. Abstr.)                        (Hun)

 MASS SCREENING

 Diagnosis and screening of HIV/AIDS using clinical criteria in
  Tanzanian adults. Miller WC, et al.  J  Acquir  Immune  Defic
  Syndr Hum Retrovirol 1995 Aug 1;9(4):408-14
 [Predictive  values  of  the  usual  biologic  tests  for  the
  detection of human immunodeficiency virus infection.
  Consequences  for  screening] Gremy F, et al. Bull Acad Natl
  Med 1995 Feb;179(2):317-31; discussion 331-3 (Eng. Abstr.)
                                                          (Fre)

   ECONOMICS

 Benefits of HIV screening of  blood  transfusions  in  Zambia.
  Foster S, et al. Lancet 1995 Jul 22;346(8969):225-7

 MASSACHUSETTS

   EPIDEMIOLOGY

 The incidence of herpes zoster. Donahue JG, et al. Arch Intern
  Med 1995 Aug 7-21;155(15):1605-9

 MAST CELLS

   PHYSIOLOGY

 Mast  cells and T lymphocytes in chronic urticaria. Barlow RJ,
  et al. Clin Exp Allergy 1995 Apr;25(4):317-22

 MEASLES

   COMPLICATIONS

 Acute necrotizing measles encephalitis in a  child  with  AIDS
  [letter] Lacroix C, et al. J Neurol 1995 Mar;242(4):249-51

 MEASLES VACCINE

   IMMUNOLOGY

 Measles  immunity  in HIV-infected children. Walter EB, et al.
  Pediatr AIDS HIV Infect 1994 Oct;5(5):300-4

 MEDICAID

   ECONOMICS

 The ratio of AIDS to non-AIDS Medicaid medical costs from 1992
  to 2000. Kotzan JA, et al. Clin Ther 1995 Mar-Apr;17(2):320-9

   UTILIZATION

 Patterns in Maryland Medicaid enrollment  among  persons  with
  AIDS. Bartnyska LM, et al. Inquiry 1995 Summer;32(2):184-95

 MEDICAL STAFF

   LEGISLATION & JURISPRUDENCE

 What   administrators   need  to  know  about  the  rights  of
  HIV-infected employees. Riley JB  Jr,  et  al.  Nephrol  News
  Issues 1995 Mar;9(3):18-24

 MEDICINE, CHINESE TRADITIONAL

 Differential inhibition of the activities of reverse
  transcriptase  and  various  cellular  DNA  polymerases  by a
  traditional Kampo drug, sho-saiko-to. Ono K,  et  al.  Biomed
  Pharmacother 1990;44(1):13-6

 MEDICINE, TRADITIONAL

 Inhibitory   effects  of  Egyptian  folk  medicines  on  human
  immunodeficiency virus (HIV) reverse transcriptase. el-Mekkawy
  S, et al. Chem Pharm Bull (Tokyo) 1995 Apr;43(4):641-8

 MEGESTROL

   ANALOGS & DERIVATIVES

 Megace for AIDS cachexia: food for thought. Novak J, et al. Am
  J Gastroenterol 1995 Jul;90(7):1180-1
 The Bristol-Myers Anorexia/Cachexia Recovery Instrument
  (BACRI): a brief assessment of patients' subjective  response
  to treatment for anorexia/cachexia. Cella DF, et al. Qual Life
  Res 1995 Jun;4(3):221-31

 MEIOSIS

   DRUG EFFECTS

 The  inhibitor  of  calcium activated neutral proteinase is an
  anti-meiotic agent. The spermicidal  and  anti-viral  action.
  Logothetou-Rella H. Histol Histopathol 1995 Apr;10(2):271-82

 MELANOMA

   EPIDEMIOLOGY

 Conjunctival  malignant  disease  with  AIDS  in  USA [letter]
  Goedert JJ, et al. Lancet 1995 Jul 22;346(8969):257-8

   GENETICS

 Quantitative correlation between HLA class I allele expression
  and  recognition  of  melanoma  cells   by   antigen-specific
  cytotoxic  T lymphocytes. Rivoltini L, et al. Cancer Res 1995
  Jul 15;55(14):3149-57

   IMMUNOLOGY

 Quantitative correlation between HLA class I allele expression
  and  recognition  of  melanoma  cells   by   antigen-specific
  cytotoxic  T lymphocytes. Rivoltini L, et al. Cancer Res 1995
  Jul 15;55(14):3149-57

 MEMBRANE GLYCOPROTEINS

   BIOSYNTHESIS

 CD40 ligand expression is developmentally regulated  in  human
  thymocytes. Fuleihan R, et al. Clin Immunol Immunopathol 1995
  Jul;76(1 Pt 1):52-8

   DRUG EFFECTS

 HIV  gp120  inhibits  T  cell  activation  by interfering with
  expression of costimulatory molecules CD40  ligand  and  CD80
  (B71). Chirmule N, et al. J Immunol 1995 Jul 15;155(2):917-24

   GENETICS

 gp180,  a  host  cell glycoprotein that binds duck hepatitis B
  virus particles, is encoded by a member of the
  carboxypeptidase gene family. Kuroki K, et al.  J  Biol  Chem
  1995 Jun 23;270(25):15022-8

   IMMUNOLOGY

 Neutralization  of feline immunodeficiency virus by polyclonal
  feline antibody: simultaneous  involvement  of  hypervariable
  regions 4 and 5 of the surface glycoprotein. Siebelink KH, et
  al. J Virol 1995 Aug;69(8):5124-7

   METABOLISM

 gp180,  a  host  cell glycoprotein that binds duck hepatitis B
  virus particles, is encoded by a member of the
  carboxypeptidase gene family. Kuroki K, et al.  J  Biol  Chem
  1995 Jun 23;270(25):15022-8
 Analysis  of  the  cleavage site of the human immunodeficiency
  virus type 1 glycoprotein: requirement of precursor  cleavage
  for glycoprotein incorporation. Dubay JW, et al. J Virol 1995
  Aug;69(8):4675-82

   PHYSIOLOGY

 The  molecular mechanism of FasL-mediated cytotoxicity by CD4+
  Th1 clones. el-Khatib  M,  et  al.  Cell  Immunol  1995  Jul;
  163(2):237-44

 MEMBRANE PROTEINS

   IMMUNOLOGY

 Chimeric  zeta-receptors  direct  human  natural  killer  (NK)
  effector  function  to  permit  killing of NK-resistant tumor
  cells and HIV-infected T  lymphocytes.  Tran  AC,  et  al.  J
  Immunol 1995 Jul 15;155(2):1000-9

   METABOLISM

 Tetrahydropyrimidine derivatives inhibit binding of a Tat-like,
  arginine-containing peptide, to HIV TAR RNA in vitro. Lapidot
  A, et al. FEBS Lett 1995 Jun 19;367(1):33-8

 MEMORY DISORDERS

   PSYCHOLOGY

 Qualitative features of the memory deficit associated with HIV
  infection   and  AIDS:  cross-validation  of  a  discriminant
  function classification scheme. Becker JT, et al. J Clin  Exp
  Neuropsychol 1995 Feb;17(1):134-42

 MENINGITIS, CRYPTOCOCCAL

   MICROBIOLOGY

 Asymptomatic  neurocysticercosis  in  a  patient with AIDS and
  cryptococcal meningitis. White AC Jr, et al. Am  J  Med  1995
  Jul;99(1):101-2

 MENINGOENCEPHALITIS

   THERAPY

 A  case of protracted coxsackie virus meningoencephalitis in a
  marginally immunodeficient child  treated  successfully  with
  intravenous  immunoglobulin.  Geller  TJ, et al. J Neurol Sci
  1995 Apr;129(2):131-3

 MENOGARIL

   PHARMACOLOGY

 [Inhibitory effects of menogaril to the proliferation of HTLV-I
  infected T-cell lines and fresh tumor cells from adult T-cell
  leukemia patients] Hata H, et al. Gan To  Kagaku  Ryoho  1995
  Jul;22(8):1057-61 (Eng. Abstr.)                         (Jpn)

 MENTAL DISORDERS

   EPIDEMIOLOGY

 Psychiatric morbidity associated with acquired immune
  deficiency  syndrome-related  grief resolution. Summers J, et
  al. J Nerv Ment Dis 1995 Jun;183(6):384-9

 MERCURIC CHLORIDE

   TOXICITY

 The time course and characterization of mercuric
  chloride-induced immunopathology in  the  brown  Norway  rat.
  Qasim FJ, et al. J Autoimmun 1995 Apr;8(2):193-208

 METHADONE

   ADMINISTRATION & DOSAGE

 Adherence  to  zidovudine  (AZT)  among HIV-infected methadone
  patients: a pilot study of supervised therapy and  dispensing
  compared  to  usual care. Wall TL, et al. Drug Alcohol Depend
  1995 Mar;37(3):261-9
 Attentional difficulties and the  effectiveness  of  a  visual
  representation strategy for counseling drug-addicted clients.
  Dansereau DF, et al. Int J Addict 1995 Mar;30(4):371-86

   THERAPEUTIC USE

 Mortality  among  HIV-infected  intravenous  drug  addicts  in
  Stockholm in relation to methadone treatment. Fugelstad A, et
  al. Addiction 1995 May;90(5):711-6
 Methadone  treatment  and  risk of HIV infection in drug users
  without legal access to clean injection equipment. Wietlisbach
  V, et al. Soz Praventivmed 1995;40(3):183-90

 MEXICO

   EPIDEMIOLOGY

 [The principle results of the mortality statistics in  Mexico,
  1993] Salud Publica Mex 1995 Mar-Apr;37(2):171-8        (Spa)
 [AIDS  mortality  in  Mexico from 1983 to 1992. The trends and
  years of potential life lost] Izazola-Licea JA, et al.  Salud
  Publica Mex 1995 Mar-Apr;37(2):140-8 (Eng. Abstr.)      (Spa)

 MICROBIAL SENSITIVITY TESTS

   METHODS

 Sensitivity/resistance  profile  of  a simian immunodeficiency
  virus containing the  reverse  transcriptase  gene  of  human
  immunodeficiency virus type 1 (HIV-1) toward the
  HIV-1-specific non-nucleoside reverse transcriptase
  inhibitors.  Balzarini  J,  et al. Biochem Biophys Res Commun
  1995 Jun 26;211(3):850-6
 A micro-suspension-test for evaluation of disinfectants against
  human immunodeficiency virus. Shimakoshi Y, et al.
  Kansenshogaku Zasshi 1995 May;69(5):532-8

 MICROFILAMENT PROTEINS

   IMMUNOLOGY

 Humoral immune responses to recombinant tree pollen  allergens
  (Bet  v  I and Bet v II) in mice: construction of a live oral
  allergy vaccine. Vrtala S, et al. Int  Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):290-4 (15 ref.)

 MICROGLIA

   PHYSIOLOGY

 HIV-gp120 activates large-conductance apamin-sensitive
  potassium  channels in rat astrocytes. Bubien JK, et al. Am J
  Physiol 1995 Jun;268(6 Pt 1):C1440-9

 MICROSPHERES

 Determination of CD4+ and CD8+ lymphocytes with the cytosphere
  assay: a  comparative  study  with  flow  cytometry  and  the
  immunoalkaline  phosphatase  method.  Gernow  A,  et al. Clin
  Immunol Immunopathol 1995 Aug;76(2):135-41

 MICROSPORA INFECTIONS

   COMPLICATIONS

 Prevalence  of  intestinal  microsporidiosis  in  HIV-infected
  individuals [letter] Carlson SJ, et al.  Am  J  Gastroenterol
  1995 Jul;90(7):1184-5

 MICROSPORIDA

 Prevalence  of  intestinal  microsporidiosis  in  HIV-infected
  individuals  [letter]  Carlson  SJ, et al. Am J Gastroenterol
  1995 Jul;90(7):1184-5

   ISOLATION & PURIFICATION

 [Microsporidiosis: a new protozoan disease in persons infected
  with human immunodeficiency virus (HIV)]  Rogowska-Szadkowska
  D,  et al. Przegl Epidemiol 1994;48(4):449-53 (29 ref.) (Eng.
  Abstr.)                                                 (Pol)

 MILITARY PERSONNEL

   STATISTICS & NUMERICAL DATA

 [Rate of HIV infection in the French army is still  relatively
  low (news)] Fortschr Med 1995 May 30;113(15):12         (Ger)

 MINNESOTA

 Uninfected  patient  can't  win damages from doctor with AIDS.
  AIDS Policy Law 1995 Apr 7;10(6):3-4

 MINORITY GROUPS

   STATISTICS & NUMERICAL DATA

 Racial differences in care among  hospitalized  patients  with
  Pneumocystis  carinii  pneumonia  in  Chicago,  New York, Los
  Angeles, Miami, and Raleigh-Durham. Bennett CL, et  al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1586-92

 MISSOURI

 Case management of HIV-infected children in Missouri. Scott DE,
  et al. Public Health Rep 1995 May-Jun;110(3):355-6

 MODELS, ECONOMIC

 An  economic  analysis  of  AIDS--towards  a proposed model of
  costing: a Singapore experience. Lim JY, et al.  Asia  Pac  J
  Public Health 1994;7(3):143-50

 MODELS, GENETIC

 Flexible  ligand docking using a genetic algorithm. Oshiro CM,
  et al. J Comput Aided Mol Des 1995 Apr;9(2):113-30

 MODELS, MOLECULAR

 Structure of HIV-1 reverse transcriptase in a complex with the
  non-nucleoside  inhibitor  alpha-APA  R  95845   at   2.8   A
  resolution. Ding J, et al. Structure 1995 Apr 15;3(4):365-79
 Comparative analysis of the X-ray structures of HIV-1 and HIV-2
  proteases  in complex with CGP 53820, a novel pseudosymmetric
  inhibitor.  Priestle  JP,  et  al.  Structure  1995  Apr  15;
  3(4):381-9

 MODELS, ORGANIZATIONAL

 Integrated case management: the AID Atlanta Model. Sowell  RL,
  et al. J Case Manag 1995 Spring;4(1):15-21
 High-risk  vulnerable  populations  and volunteers: a model of
  education and service collaboration. Hutchison RR, et  al.  J
  Community Health Nurs 1995;12(2):111-9

 MODELS, STATISTICAL

 [Problems  of  HIV infection and tuberculosis (TB) in Asia--an
  epidemetric model analysis of the impact of HIV infection  on
  TB  control]  Mori T. Nippon Kyobu Shikkan Gakkai Zasshi 1994
  Dec;32 Suppl:216-22 (Eng. Abstr.)                       (Jpn)

 MODELS, THEORETICAL

 Modelling AIDS reduction strategies. Kault DA. Int J Epidemiol
  1995 Feb;24(1):188-97
 A model for HIV in Asia. Busenberg S, et al. Math Biosci  1995
  Jul-Aug;128(1-2):185-210
 The  impact  of  sexual mixing patterns on the spread of AIDS.
  Kault DA. Math Biosci 1995 Jul-Aug;128(1-2):211-41

 MOLECULAR CONFORMATION

 Comparative analysis of the X-ray structures of HIV-1 and HIV-2
  proteases in complex with CGP 53820, a novel  pseudosymmetric
  inhibitor.  Priestle  JP,  et  al.  Structure  1995  Apr  15;
  3(4):381-9

 MONOCYTES

   METABOLISM

 Differential  expression  of  Fas antigen and Bcl-2 protein on
  CD4+ T cells, CD8+ T cells, and monocytes. Shinohara S, et al.
  Cell Immunol 1995 Jul;163(2):303-8

   PHYSIOLOGY

 Monocyte function in cattle experimentally infected with bovine
  immunodeficiency-like virus. Rovid AH,  et  al.  Vet  Immunol
  Immunopathol 1995 Mar;45(1-2):31-43

   VIROLOGY

 The  peri-kappa  B  site mediates human immunodeficiency virus
  type 2 enhancer activation in monocytes but not in  T  cells.
  Clark NM, et al. J Virol 1995 Aug;69(8):4854-62

 MORTALITY

 [The  principle results of the mortality statistics in Mexico,
  1993] Salud Publica Mex 1995 Mar-Apr;37(2):171-8        (Spa)

   TRENDS

 In search of a contemporary theory for understanding mortality
  change [letter] Bulterys M. Soc Sci Med 1995 Apr;40(8):1165

 MOTHERS

   EDUCATION

 Illness cognition of HIV-infected mothers. Regan-Kubinski  MJ,
  et al. Issues Ment Health Nurs 1995 Jul-Aug;16(4):327-44

   PSYCHOLOGY

 Illness  cognition of HIV-infected mothers. Regan-Kubinski MJ,
  et al. Issues Ment Health Nurs 1995 Jul-Aug;16(4):327-44

 MOTIVATION

 Attentional difficulties and the  effectiveness  of  a  visual
  representation strategy for counseling drug-addicted clients.
  Dansereau DF, et al. Int J Addict 1995 Mar;30(4):371-86

 MOUTH

   VIROLOGY

 Oral infection of neonatal rhesus monkeys with cell-free simian
  immunodeficiency  virus.  American  Pediatric  Society  104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting;  1994 May 2-5; Seattle. Baba TW, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):323 (unnumbered abstract)

 MOUTH DISEASES

   ETIOLOGY

 The interleukin network  in  the  immunopathogenesis  of  oral
  diseases  [see  comments]  Sosroseno  W,  et  al. Asian Pac J
  Allergy Immunol 1994 Dec;12(2):161-8 (92 ref.)

   VIROLOGY

 Orofacial lesions  as  indicators  of  HIV/AIDS  among  dental
  patients in Kenya. Guthua SW, et al. East Afr Med J 1995 Feb;
  72(2):135-8

 MOVEMENT DISORDERS

   ETIOLOGY

 [A  case  of  amnesia  and  walking  disorder  associated with
  subacute progression of HIV encephalopathy] Fujii T,  et  al.
  Nippon Naika Gakkai Zasshi 1995 May 10;84(5):798-9      (Jpn)

 MUCOCUTANEOUS LYMPH NODE SYNDROME

   ETIOLOGY

 Kawasaki's  syndrome  in a man with the human immunodeficiency
  virus. Wolf  CV  2nd,  et  al.  Am  J  Ophthalmol  1995  Jul;
  120(1):117-8

 MULTIPLE SCLEROSIS

   BLOOD

 A   soluble   form  of  tumour  necrosis  factor  receptor  in
  cerebrospinal fluid and serum of HTLV-I-associated myelopathy
  and other neurological diseases. Puccioni-Sohler M, et al.  J
  Neurol 1995 Mar;242(4):239-42

   CEREBROSPINAL FLUID

 A   soluble   form  of  tumour  necrosis  factor  receptor  in
  cerebrospinal fluid and serum of HTLV-I-associated myelopathy
  and other neurological diseases. Puccioni-Sohler M, et al.  J
  Neurol 1995 Mar;242(4):239-42

   METABOLISM

 Increased  levels of soluble vascular cell adhesion molecule-1
  (VCAM-1) in the cerebrospinal fluid and sera of patients with
  multiple sclerosis and human T lymphotropic virus
  type-1-associated myelopathy. Matsuda M, et al. J Neuroimmunol
  1995 Jun;59(1-2):35-40

 MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME

   DRUG THERAPY

 Effect of lithium in  immunodeficiency:  improved  blood  cell
  formation  in mice with decreased hematopoiesis as the result
  of LP-BM5 MuLV infection. Gallicchio VS, et al. Antiviral Res
  1995 Mar;26(2):189-202

   IMMUNOLOGY

 Rapid development of  murine  AIDS  is  dependent  of  signals
  provided  by  CD54 and CD11a. Makino M, et al. J Immunol 1995
  Jul 15;155(2):974-81

   VIROLOGY

 Rapid development of  murine  AIDS  is  dependent  of  signals
  provided  by  CD54 and CD11a. Makino M, et al. J Immunol 1995
  Jul 15;155(2):974-81

 MUSCLE, SKELETAL

   DRUG EFFECTS

 Metabolic  abnormalities  in  skeletal  muscle   of   patients
  receiving zidovudine therapy observed by 31P in vivo magnetic
  resonance spectroscopy. Sinnwell TM, et al. J Clin Invest 1995
  Jul;96(1):126-31

 MUTAGENESIS, SITE-DIRECTED

 Catalytic  domain  of  human  immunodeficiency  virus  type  1
  integrase:  identification  of a soluble mutant by systematic
  replacement of hydrophobic residues. Jenkins TM, et al.  Proc
  Natl Acad Sci U S A 1995 Jun 20;92(13):6057-61

 MUTATION

 Lower  in  vivo  mutation rate of human immunodeficiency virus
  type 1 than that predicted  from  the  fidelity  of  purified
  reverse  transcriptase.  Mansky  LM, et al. J Virol 1995 Aug;
  69(8):5087-94
 A single mutation within the V3 envelope neutralization domain
  of feline immunodeficiency virus determines its  tropism  for
  CRFK cells. Verschoor EJ, et al. J Virol 1995 Aug;69(8):4752-7

   PHYSIOLOGY

 Effects of mutations in constant regions 3 and 4 of envelope of
  simian  immunodeficiency  virus. Morrison HG, et al. Virology
  1995 Jul 10;210(2):448-55

 MYCOBACTERIUM

   GROWTH & DEVELOPMENT

 Growth-deficient mycobacteria in patients with AIDS: diagnosis
  by analysis of DNA amplified from blood or tissue. Emler S, et
  al. Clin Infect Dis 1995 Apr;20(4):772-5

 MYCOBACTERIUM AVIUM

   ISOLATION & PURIFICATION

 Evaluation of the relatedness of strains of Mycobacterium avium
  using pulsed-field gel electrophoresis. Burki DR, et al. Eur J
  Clin Microbiol Infect Dis 1995 Mar;14(3):212-7

 MYCOBACTERIUM AVIUM COMPLEX

   CLASSIFICATION

 Use of restriction fragment length polymorphism as  a  genetic
  marker for typing Mycobacterium avium strains. Roiz MP, et al.
  J Clin Microbiol 1995 May;33(5):1389-91

   GENETICS

 Use  of  restriction fragment length polymorphism as a genetic
  marker for typing Mycobacterium avium strains. Roiz MP, et al.
  J Clin Microbiol 1995 May;33(5):1389-91

 MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION

   DRUG THERAPY

 Long-term  resolution  of  disseminated  Mycobacterium   avium
  complex  infection in a patient with AIDS [letter] Farber HW.
  Clin Infect Dis 1995 Apr;20(4):1067-8
 [Uveitis associated with rifabutin  treatment.  Apropos  of  3
  patients] Chevalley GF, et al. Klin Monatsbl Augenheilkd 1995
  May;206(5):388-90 (Eng. Abstr.)                         (Fre)

   MICROBIOLOGY

 The  macrophage  mannose  receptor  can  mediate the uptake of
  Mycobacterium avium-intracellulare. American Pediatric Society
  104th annual meeting and Society for Pediatric Research  63rd
  annual  meeting;  1994  May  2-5; Seattle. Kruskal BA, et al.
  Pediatr  AIDS  HIV  Infect  1994   Oct;5(5):319   (unnumbered
  abstract)

   RADIONUCLIDE IMAGING

 Patterns of Ga-67 citrate accumulation in human
  immunodeficiency  virus  positive  patients  with and without
  Mycobacterium avium intracellulare infection. Buscombe JR, et
  al. Clin Radiol 1995 Jul;50(7):483-8

 MYCOBACTERIUM BOVIS

 Disseminated Mycobacterium bovis (BCG) in  a  child  with  HIV
  infection. American Pediatric Society 104th annual meeting and
  Society  for Pediatric Research 63rd annual meeting; 1994 May
  2-5; Seattle. Ellaurie M, et al. Pediatr AIDS HIV Infect 1994
  Oct;5(5):321 (unnumbered abstract)

   ISOLATION & PURIFICATION

 A case of disseminated Mycobacterium bovis infection in an AIDS
  patient. Albrecht H, et al. Eur J Clin Microbiol  Infect  Dis
  1995 Mar;14(3):226-9

 MYCOBACTERIUM INFECTIONS

   EPIDEMIOLOGY

 Evaluation of the relatedness of strains of Mycobacterium avium
  using pulsed-field gel electrophoresis. Burki DR, et al. Eur J
  Clin Microbiol Infect Dis 1995 Mar;14(3):212-7

 MYCOBACTERIUM TUBERCULOSIS

   GENETICS

 Transmission  of  multidrug-resistant  tuberculosis in a large
  urban setting. Friedman CR, et al. Am J Respir Crit Care  Med
  1995 Jul;152(1):355-9
 DNA fingerprinting and phenotyping of Mycobacterium
  tuberculosis   isolates  from  human  immunodeficiency  virus
  (HIV)-seropositive and HIV-seronegative patients in Tanzania.
  Yang ZH, et al. J Clin Microbiol 1995 May;33(5):1064-9

 MYCOPLASMA INFECTIONS

   COMPLICATIONS

 Links and interactions between mycoplasmas and  viruses:  past
  confusions and present realities. Chastel C. Arch Virol 1995;
  140(5):811-26 (101 ref.)

 MYCOSES

   DIAGNOSIS

 Disseminated  Penicillium  marneffei:  presenting  illness  of
  advanced HIV infection; a clinicopathological review,
  illustrated by a case report. Heath TC, et al. Pathology 1995
  Jan;27(1):101-5 (31 ref.)
 [Aspects in the diagnosis of deep-seated opportunistic mycoses]
  Fegeler  W.  Mycoses  1994;37  Suppl  2:8-19  (67 ref.) (Eng.
  Abstr.)                                                 (Ger)

   DRUG THERAPY

 [Pharmacokinetics of itraconazole] Cauwenbergh G. Mycoses 1994;
  37 Suppl 2:27-33 (13 ref.) (Eng. Abstr.)                (Ger)

   EPIDEMIOLOGY

 [Epidemiology of deep-seated,  domestic  mycoses]  Muller  J.
  Mycoses 1994;37 Suppl 2:1-7 (10 ref.) (Eng. Abstr.)     (Ger)

 MYELITIS

   COMPLICATIONS

 Myeloradiculitis due to Cryptococcus curvatus in AIDS [letter]
  Dromer F, et al. AIDS 1995 Apr;9(4):395-6

 MYELOBLASTOSIS VIRUS, AVIAN

   ENZYMOLOGY

 Continuous   RT-PCR  using  AMV-RT  and  Taq  DNA  polymerase:
  characterization  and  comparison  to  uncoupled  procedures.
  Mallet F, et al. Biotechniques 1995 Apr;18(4):678-87

 MYOCARDIAL DISEASES

   COMPLICATIONS

 An association between HIV infection, Epstein-Barr virus (EBV)
  immune status, cardiomyopathy, and  lymphocytic  interstitial
  pneumonia  (LIP).  American  Pediatric  Society  104th annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting; 1994 May 2-5; Seattle. Valentine M, et  al.  Pediatr
  AIDS HIV Infect 1994 Oct;5(5):320 (unnumbered abstract)

 MYOCARDIAL ISCHEMIA

   ETIOLOGY

 Transient  severe myocardial ischemia during septic shock in a
  young woman with AIDS. Raggi P, et al. J Natl Med Assoc  1995
  Jun;87(6):441-2

 MYTHOLOGY

 Technology,  medicine & health, Part 6. Exploding the myths of
  medicine.  Davidson  SN.  Healthc  Forum  J   1995   Jul-Aug;
  38(4):54-7, 59, 61-2

 NAD

   METABOLISM

 HIV  infection  decreases  intracellular  nicotinamide adenine
  dinucleotide [NAD] Murray MF,  et  al.  Biochem  Biophys  Res
  Commun 1995 Jul 6;212(1):126-31

 NAPHTHOQUINONES

   THERAPEUTIC USE

 [Treatment  of toxoplasmosis retinochoroiditis with atovaquone
  in  an  AIDS  patient]  Schimkat  M,  et  al.  Klin  Monatsbl
  Augenheilkd 1995 Mar;206(3):173-7 (Eng. Abstr.)         (Ger)

 NARCOTIC DEPENDENCE

   REHABILITATION

 Attentional difficulties and the  effectiveness  of  a  visual
  representation strategy for counseling drug-addicted clients.
  Dansereau DF, et al. Int J Addict 1995 Mar;30(4):371-86

 NATIONAL INSTITUTES OF HEALTH (U.S.)

   ECONOMICS

 Future  of  AIDS  research  office  threatened [news] Appel A.
  Nature 1995 Jul 20;376(6537):205-6
 Top scientists come to defense of AIDS research office  [news]
  Science 1995 Jul 14;269(5221):151
 AIDS research: who should hold the purse strings? [news] Cohen
  J. Science 1995 Jul 21;269(5222):292

 NEDOCROMIL

   PHARMACOLOGY

 Pharmacologic  modulation  of  Th1  and  Th2  cell  subsets by
  nedocromil sodium. Farrar JR, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):414-5 (13 ref.)

 NEEDLESTICK INJURIES

   COMPLICATIONS

 Finding suggests AZT therapy may help prevent occupational HIV
  infection. AIDS Alert 1995 Apr;10(4):45-7 (3 ref.)

   EPIDEMIOLOGY

 Occupation risk of needlestick injuries among health care
  personnel in Saudi Arabia. Shanks NJ, et al.  J  Hosp  Infect
  1995 Mar;29(3):221-6

 NEGROID RACE

 Rates  of  p24  antigenemia  and viral isolation in comparable
  white  and  black  HIV-infected  subjects.  Military  Medical
  Consortium for Applied Retroviral Research. Brown AE, et  al.
  AIDS 1995 Apr;9(4):325-8

 NEOPLASM METASTASIS

 Cell  transfer  therapy  of  cancer metastasis with autologous
  lymphocytes. Mikamo S, et al. Cell  Transplant  1995;4  Suppl
  1:S65-7

 NEOPLASM PROTEINS

   BIOSYNTHESIS

 High  expression  of latent membrane protein 1 of Epstein-Barr
  virus and  BCL-2  oncoprotein  in  acquired  immunodeficiency
  syndrome-related primary brain lymphomas. Camilleri-Broet S,
  et al. Blood 1995 Jul 15;86(2):432-5

 NEOPLASMS

 Inpatient  hospice  care: a new option for the terminally ill.
  Martin EW. R I Med 1995 Apr;78(4):118-9

   DRUG THERAPY

 An 'information-intensive'  strategy  for  drug  discovery  in
  cancer  and  AIDS: relating cell cycle factors to patterns of
  drug activity (Meeting abstract). Myers TG, et al. Proc  Annu
  Meet Am Assoc Cancer Res; 36:A1813 1995

   PATHOLOGY

 Cell  transfer  therapy  of  cancer metastasis with autologous
  lymphocytes. Mikamo S, et al. Cell  Transplant  1995;4  Suppl
  1:S65-7

   THERAPY

 Cell  transfer  therapy  of  cancer metastasis with autologous
  lymphocytes. Mikamo S, et al. Cell  Transplant  1995;4  Suppl
  1:S65-7
 Poxvirus-based  vaccine candidates for cancer, AIDS, and other
  infectious diseases. Perkus ME, et al. J Leukoc Biol 1995 Jul;
  58(1):1-13 (154 ref.)
 Sharing the challenge: the integration  of  cancer  and  AIDS.
  Fraser J. J Palliat Care 1995 Summer;11(2):23-5

 NEOPLASMS, MULTIPLE PRIMARY

 Multifocal  lower  genital  tract  neoplasia in women with HIV
  disease. Abercrombie PD, et al. Nurse Pract 1995 May;20(5):68,
  74, 76

 NEOPLASMS, RADIATION-INDUCED

   IMMUNOLOGY

 A unique  tumor  antigen  produced  by  a  single  amino  acid
  substitution. Monach PA, et al. Immunity 1995 Jan;2(1):45-59
 Synergy  between  T-cell  immunity and inhibition of paracrine
  stimulation causes tumor rejection. Seung LP, et al. Proc Natl
  Acad Sci U S A 1995 Jul 3;92(14):6254-8

 NEOVASCULARIZATION

   DRUG THERAPY

 Treatment review. Treat Rev 1995 Mar/Apr;(no 17):8

 NERVE FIBERS

   PATHOLOGY

 [Measuring retinal nerve fiber density with laser  polarimetry
  in patients with AIDS in comparison with health probands with
  reference to computer perimetry findings. A pilot study using
  the nerve fiber analyzer] Thierfelder S, et al. Klin Monatsbl
  Augenheilkd 1995 Mar;206(3):165-9 (Eng. Abstr.)         (Ger)

 NERVOUS SYSTEM DISEASES

   COMPLICATIONS

 Prediction of pediatric neuro-AIDS. American Pediatric Society
  104th  annual meeting and Society for Pediatric Research 63rd
  annual meeting; 1994 May 2-5; Seattle.  Wachtel  RC,  et  al.
  Pediatr   AIDS   HIV  Infect  1994  Oct;5(5):315  (unnumbered
  abstract)

   PHYSIOPATHOLOGY

 Serum neopterin level predicts HIV-related mortality  but  not
  progression to AIDS or development of neurological disease in
  gay  men  and  parenteral  drug users. Sacktor N, et al. Arch
  Neurol 1995 Jul;52(7):676-9

   VIROLOGY

 Cytomegalovirus infections of the nervous system  in  patients
  with AIDS. McCutchan JA. Clin Infect Dis 1995 Apr;20(4):747-54
  (64 ref.)

 NETHERLANDS

 An  outbreak of hepatitis A among homosexual men in Amsterdam,
  1991-1993. Leentvaar-Kuijpers A, et al. Int J Epidemiol  1995
  Feb;24(1):218-22
 The  predictive value of T cell function in vitro and pre-AIDS
  zidovudine use for survival after AIDS diagnosis in a  cohort
  of  homosexual  men in Amsterdam. Bindels PJ, et al. J Infect
  Dis 1995 Jul;172(1):97-104

 NEUROIMMUNOMODULATION

   PHYSIOLOGY

 Lentiviral infection, immune response peptides and sleep. Darko
  DF, et al. Adv Neuroimmunol 1995;5(1):57-77 (76 ref.)

 NEUROSYPHILIS

   CEREBROSPINAL FLUID

 Lumbar puncture for evaluation of latent syphilis in
  hospitalized patients. High prevalence of cerebrospinal fluid
  abnormalities unrelated to syphilis. Carey LA,  et  al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1657-62

   DIAGNOSIS

 Neurosyphilis   in  HIV-positive  and  HIV-negative  patients:
  neuroimaging findings.  Brightbill  TC,  et  al.  AJNR  Am  J
  Neuroradiol 1995 Apr;16(4):703-11

 NEUTROPENIA

   DRUG THERAPY

 Lenograstim.  A  review  of its pharmacological properties and
  therapeutic efficacy  in  neutropenia  and  related  clinical
  settings. Frampton JE, et al. Drugs 1995 May;49(5):767-93 (109
  ref.)

   PHYSIOPATHOLOGY

 Evidence for involvement of activated CD8+/HLA-DR+ cells in the
  pathogenesis  of  neutropenia in patients with B-cell chronic
  lymphocytic leukaemia. Katrinakis G, et al.  Eur  J  Haematol
  1995 Jul;55(1):33-41

 NEW JERSEY

 Lawsuit   brought  by  US  HIV-infected  haemophiliacs  [news]
  Washburn L. Lancet 1995 Jul 8;346(8967):110

 NEW YORK

 Do our children need to die of AIDS for politics?  Fischer  C.
  Internist 1995 Jun;36(6):29-30
 Prenatal  care  of HIV-infected women: analysis of a large New
  York State cohort. Turner BJ, et al. J  Acquir  Immune  Defic
  Syndr Hum Retrovirol 1995 Aug 1;9(4):371-8

 NEW YORK CITY

 Lawsuit  charges New York City is denying basic AIDS services.
  AIDS Policy Law 1995 Mar 24;10(5):7-8
 Six city clients tell their stories. AIDS Policy Law 1995  Mar
  24;10(5):8
 Racial  differences  in  care among hospitalized patients with
  Pneumocystis carinii pneumonia  in  Chicago,  New  York,  Los
  Angeles,  Miami,  and Raleigh-Durham. Bennett CL, et al. Arch
  Intern Med 1995 Aug 7-21;155(15):1586-92
 Incidence of venereal warts in human immunodeficiency
  virus-infected and uninfected women. Chirgwin KD,  et  al.  J
  Infect Dis 1995 Jul;172(1):235-8
 Parents'  attitudes and beliefs about HIV/AIDS prevention with
  condom availability in New York  City  public  high  schools.
  Guttmacher S, et al. J Sch Health 1995 Mar;65(3):101-6

   EPIDEMIOLOGY

 Is   AIDS-related  cryptococcosis  more  frequent  among  men?
  [letter] Manfredi R, et al. AIDS 1995 Apr;9(4):397-8
 Tuberculosis knowledge among  New  York  City  injection  drug
  users. Wolfe H, et al. Am J Public Health 1995 Jul;85(7):985-8
 Transmission  of  multidrug-resistant  tuberculosis in a large
  urban setting. Friedman CR, et al. Am J Respir Crit Care  Med
  1995 Jul;152(1):355-9
 Evaluation  of  infection  control  measures in preventing the
  nosocomial transmission of multidrug-resistant  Mycobacterium
  tuberculosis  in  a New York City hospital. Stroud LA, et al.
  Infect Control Hosp Epidemiol 1995 Mar;16(3):141-7

 NF-KAPPA B

   METABOLISM

 The peri-kappa B site mediates  human  immunodeficiency  virus
  type  2  enhancer activation in monocytes but not in T cells.
  Clark NM, et al. J Virol 1995 Aug;69(8):4854-62

   PHYSIOLOGY

 Sodium butyrate stimulation of HIV-1 gene expression: a  novel
  mechanism of induction independent of NF-kappa B. Laughlin MA,
  et al. J Acquir Immune Defic Syndr Hum Retrovirol 1995 Aug 1;
  9(4):332-9

 NIGERIA

   EPIDEMIOLOGY

 Evidence of serological cross-reactivities with human
  immunodeficiency virus types 1 and 2 and human T-lymphotropic
  virus  types  I  and  II in sera of pregnant women in Ibadan,
  Nigeria. Olaleye  DO,  et  al.  Int  J  Epidemiol  1995  Feb;
  24(1):198-203

 NITRIC OXIDE

   BIOSYNTHESIS

 Murine   Th1  and  Th2  cell  clones  differentially  regulate
  macrophage nitric oxide production. Taub DD, et al. J  Leukoc
  Biol 1995 Jul;58(1):80-9

   METABOLISM

 Nitric  oxide  production by alveolar macrophages from newborn
  versus infant and adult rats. American Pediatric Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Sherman MP,  et  al.  Pediatr
  AIDS HIV Infect 1994 Oct;5(5):315 (unnumbered abstract)

 NITROSO COMPOUNDS

   CHEMICAL SYNTHESIS

 Synthesis  and  anti-HIV  activity of new urea and nitrosourea
  derivatives of diamino acids. Dulude H, et al. Bioorg Med Chem
  1995 Feb;3(2):151-60

 NOCODAZOLE

   PHARMACOLOGY

 Antitubulin  drugs  inhibit  HIV-1  replication  by   blocking
  tyrosine  phosphorylases.  American  Pediatric  Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Nquyen QV, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):324 (unnumbered abstract)

 NOMA

 Cancrum oris in an HIV-positive patient. Barrios TJ, et al.  J
  Oral Maxillofac Surg 1995 Jul;53(7):851-5

 NORTH CAROLINA

 Racial  differences  in  care among hospitalized patients with
  Pneumocystis carinii pneumonia  in  Chicago,  New  York,  Los
  Angeles,  Miami,  and Raleigh-Durham. Bennett CL, et al. Arch
  Intern Med 1995 Aug 7-21;155(15):1586-92
 Fear and trembling in North Carolina. The barriers to  primary
  medical and dental care for AIDS patients. Simmons JD, et al.
  N C Med J 1995 Jun;56(6):252-5

 NORTHWESTERN UNITED STATES

 Physicians'  ability  to  provide  initial  primary care to an
  HIV-infected patient. Curtis JR, et al. Arch Intern Med  1995
  Aug 7-21;155(15):1613-8

 NOSE

   SURGERY

 [Analysis   of  the  possibility  of  transmitting  the  human
  immunodeficiency virus when using cartilage grafts] Bujia  J,
  et  al.  Acta  Otorrinolaringol  Esp 1995 Mar-Apr;46(2):75-81
  (Eng. Abstr.)                                           (Spa)

 NUCLEAR PROTEINS

   METABOLISM

 Interaction of nucleolar protein B23 with peptides related  to
  nuclear  localization signals. Szebeni A, et al. Biochemistry
  1995 Jun 27;34(25):8037-42
 Identification of transcriptional activation domain of TREB5, a
  CREB/ATF  family  protein  that  binds  to  HTLV-1  enhancer.
  Matsuzaki Y, et al. J Biochem (Tokyo) 1995 Feb;117(2):303-8
 Inhibition of RNA splicing at the Rous sarcoma  virus  src  3'
  splice  site is mediated by an interaction between a negative
  cis element and a chicken embryo fibroblast  nuclear  factor.
  Amendt BA, et al. J Virol 1995 Aug;69(8):5068-76
 Interaction of nuclear protein p140 with human immunodeficiency
  virus  type  1  TAR  RNA in mitogen-activated primary human T
  lymphocytes.  Rothblum  CJ,  et  al.  J   Virol   1995   Aug;
  69(8):5156-63

 NUCLEAR WARFARE

 Anti-Human T-lymphotropic virus type-I antibodies in
  atomic-bomb  survivors. Matsuo T, et al. J Radiat Res (Tokyo)
  1995 Mar;36(1):8-16

 NUCLEIC ACID CONFORMATION

 Properties of base-pairing  in  the  stem  region  of  hairpin
  antisense  oligonucleotides containing 2'-methoxynucleosides.
  Hosono  K,  et  al.  Biochim  Biophys  Acta   1995   Jun   9;
  1244(2-3):339-44
 The  bend  in  RNA  created  by  the trans-activation response
  element bulge of human immunodeficiency virus is straightened
  by arginine and by Tat-derived peptide. Zacharias M,  et  al.
  Proc Natl Acad Sci U S A 1995 Jun 20;92(13):6052-6

 NURSE ADMINISTRATORS

 A  conversation  with Kristine Gebbie: the first national AIDS
  policy coordinator [interview by Susan Gaskins] Gebbie  K.  J
  Assoc Nurses AIDS Care 1995 Mar-Apr;6(2):47-9

 NURSE MIDWIVES

   TRENDS

 Report  from  the  front  lines:  interview with Janet Spinner
  [interview by Ina May  Gaskin]  Spinner  J.  Birth  Gaz  1995
  Spring;11(2):14-20

 NURSE-PATIENT RELATIONS

 HIV and tuberculosis: noncompliance revisited. Anastasio CJ. J
  Assoc Nurses AIDS Care 1995 Mar-Apr;6(2):11-23

 NURSES

 Nursing: empowerment and the problem of power. Gilbert T. J Adv
  Nurs 1995 May;21(5):865-71 (27 ref.)
 The  negative  attitudes  of  some general nurses towards drug
  misusers. Carroll J. Nurs Stand 1995 May 17-23;9(34):36-8

 NURSES' AIDES

 Auxiliary accused of making 'HIV  list'  may  return  to  work
  [news] Taylor A. Nurs Times 1995 May 31-Jun 6;91(22):6

 NURSING ASSESSMENT

 Assessing  patients with HIV-associated dementia. Lennox S, et
  al. Prof Nurse 1995 Jun;10(9):588-9

 NURSING STAFF, HOSPITAL

 Infection control: a survey to determine knowledge of nurses in
  a clinical setting. Gould D. Nurs Stand 1995  May  31-Jun  6;
  9(36):35-8

   EDUCATION

 [Attitude  of  nursing  personnel  towards patients with AIDS:
  impact of an awareness program] Paquin L, et al.  Sante  Ment
  Que 1994 Fall;19(2):191-209 (Eng. Abstr.)               (Fre)

   LEGISLATION & JURISPRUDENCE

 Eleventh  Circuit affirms decision involving nurse who refused
  to care for an HIV-positive  patient.  Armstrong  v.  Flowers
  Hospital, Inc. Hosp Law Newsl 1995 Jul;12(9):8

   PSYCHOLOGY

 [Attitude  of  nursing  personnel  towards patients with AIDS:
  impact of an awareness program] Paquin L, et al.  Sante  Ment
  Que 1994 Fall;19(2):191-209 (Eng. Abstr.)               (Fre)

 NURSING THEORY

 The  lived  experience  of  grieving, for families living with
  AIDS. Cody WK. NLN Publ 1994 Dec;(15-2670):197-242
 True presence with families living with HIV disease. Cody  WK.
  NLN Publ 1994 Dec;(15-2670):115-33

 OCCUPATIONAL DISEASES

   ETIOLOGY

 Risks  of HIV infection in the health care setting. Fraser VJ,
  et al. Annu Rev Med 1995;46:203-11 (25 ref.)

   PREVENTION & CONTROL

 Protection against  hospital-acquired  tuberculosis,  American
  style:  a report on the 4th Annual Meeting of the Society for
  Hospital Epidemiology of America (SHEA), New  Orleans,  1994.
  Wilcox MH. J Hosp Infect 1995 Mar;29(3):165-8

 OCCUPATIONAL EXPOSURE

 Finding suggests AZT therapy may help prevent occupational HIV
  infection. AIDS Alert 1995 Apr;10(4):45-7 (3 ref.)
 Universal precautions for the otolaryngologist: techniques and
  equipment  for  minimizing exposure risk. Murr AH, et al. Ear
  Nose Throat J 1995 May;74(5):338, 341-6
 Dentistry and tuberculosis in the 1900s. Riben PD, et al. J Can
  Dent Assoc 1995 Jun;61(6):492, 495-8 (40 ref.)

   ADVERSE EFFECTS

 Effects of inhalative exposure to dioxins in wood preservatives
  on cell-mediated immunity in day-care center teachers. Wolf N,
  et al. Environ Res 1995 Feb;68(2):96-105

   STATISTICS & NUMERICAL DATA

 Occupation risk of  needlestick  injuries  among  health  care
  personnel  in  Saudi  Arabia. Shanks NJ, et al. J Hosp Infect
  1995 Mar;29(3):221-6

 OCCUPATIONAL HEALTH

 OSHA standards for blood-borne pathogens--strategies to
  increase compliance among otolaryngologists. Wagner RL, et al.
  Ear Nose Throat J 1995 May;74(5):348-52

 OHIO

 Doctors who discriminate are paying a steep price. AIDS Policy
  Law 1995 Apr 7;10(6):10
 Infection control guidelines from  Ohio  State  Dental  Board.
  Tomasi NJ. Cincinnati Dent Soc Bull 1986 Sep;55(7):21, 23-4

 OLIGODEOXYRIBONUCLEOTIDES

   CHEMISTRY

 Recognition by viral and cellular DNA polymerases of
  nucleosides  bearing  bases with nonstandard hydrogen bonding
  patterns. Horlacher J, et al. Proc Natl Acad Sci U S  A  1995
  Jul 3;92(14):6329-33

   METABOLISM

 Recognition by viral and cellular DNA polymerases of
  nucleosides  bearing  bases with nonstandard hydrogen bonding
  patterns. Horlacher J, et al. Proc Natl Acad Sci U S  A  1995
  Jul 3;92(14):6329-33

 OLIGONUCLEOTIDES

   PHARMACOKINETICS

 In  vivo  stability,  pharmacokinetics,  and  metabolism  of a
  'hybrid' oligonucleotide phosphorothioate  in  rats  (Meeting
  abstract).  Lu  Z, et al. Proc Annu Meet Am Assoc Cancer Res;
  36:A2450 1995

 OLIGONUCLEOTIDES, ANTISENSE

   ADMINISTRATION & DOSAGE

 Advances in antisense efficacy and delivery. Agrawal S, et al.
  Trends Biotechnol 1995 Jun;13(6):197-9

   CHEMISTRY

 Properties of base-pairing  in  the  stem  region  of  hairpin
  antisense  oligonucleotides containing 2'-methoxynucleosides.
  Hosono  K,  et  al.  Biochim  Biophys  Acta   1995   Jun   9;
  1244(2-3):339-44

   PHARMACOLOGY

 Phosphorothioate  oligonucleotides block reverse transcription
  by the Rnase H activity associated with the HIV-1 polymerase.
  Hatta T, et al. Biochem  Biophys  Res  Commun  1995  Jun  26;
  211(3):1041-6

   THERAPEUTIC USE

 Advances in antisense efficacy and delivery. Agrawal S, et al.
  Trends Biotechnol 1995 Jun;13(6):197-9

 OLIGOPEPTIDES

   PHARMACOLOGY

 Antiherpetic activities of N-alpha-acetyl-nona-D-arginine amide
  acetate.  Sumner-Smith  M,  et  al.  Drugs Exp Clin Res 1995;
  21(1):1-6

 ONTARIO

 The  law  and  ethics  in  relation   to   dentists   treating
  HIV-positive  patients: two recent court cases. Graham PE, et
  al. J Can Dent Assoc 1995 Jun;61(6):487-91
 AIDS and discrimination [letter] Swaine TJ. J Can  Dent  Assoc
  1995 Jun;61(6):473
 AIDS  palliative  care--challenging  the  palliative paradigm.
  Foley FJ, et al. J Palliat Care 1995 Summer;11(2):19-22

 OPPORTUNISTIC INFECTIONS

   DIAGNOSIS

 [Aspects in the diagnosis of deep-seated opportunistic mycoses]
  Fegeler W. Mycoses  1994;37  Suppl  2:8-19  (67  ref.)  (Eng.
  Abstr.)                                                 (Ger)

   DRUG THERAPY

 [Pharmacokinetics of itraconazole] Cauwenbergh G. Mycoses 1994;
  37 Suppl 2:27-33 (13 ref.) (Eng. Abstr.)                (Ger)
 [Therapy  of invasive aspergillosis with itraconazole: our own
  experiences and review of the literature] Kreisel W.  Mycoses
  1994;37 Suppl 2:42-51 (91 ref.) (Eng. Abstr.)           (Ger)
 [Treatment of invasive aspergillosis] Martino P. Mycoses 1994;
  37 Suppl 2:20-6 (18 ref.) (Eng. Abstr.)                 (Ger)
 [Therapy  of  systemic candidiasis] Meunier F. Mycoses 1994;37
  Suppl 2:52-5 (10 ref.) (Eng. Abstr.)                    (Ger)

 ORGANIC MENTAL DISORDERS, PSYCHOTIC

   EPIDEMIOLOGY

 [Incidence and etiology of psychotic disorders in HIV infected
  patients]  Niederecker  M,  et  al.  Nervenarzt   1995   May;
  66(5):367-71 (Eng. Abstr.)                              (Ger)

 ORGANIZATIONS

 Assessing the information needs of non-institutionally
  affiliated  AIDS service organizations in Texas. Huber JT, et
  al. Bull Med Libr Assoc 1995 Apr;83(2):240-3

 OROSOMUCOID

   METABOLISM

 alpha 1-Acid glycoprotein binds human immunodeficiency virus
  type 1 (HIV-1) envelope glycoprotein  via  N-linked  glycans.
  Rabehi L, et al. Glycoconj J 1995 Feb;12(1):7-16

 ORTHOMYXOVIRIDAE

   DRUG EFFECTS

 Quo  vadis  antiviral  agents  for  herpes, influenza and HIV?
  [editorial] Oxford JS. J Med Microbiol 1995 Jul;43(1):1-3

 ORTHOMYXOVIRUS TYPE A, HUMAN

 Prolonged influenza  A  infection  responsive  to  rimantadine
  therapy  in  a  human  immunodeficiency virus-infected child.
  Evans KD, et al. Pediatr Infect Dis J 1995 Apr;14(4):332-4

   DRUG EFFECTS

 Virucidal effects of  the  steam  distillate  from  Houttuynia
  cordata and its components on HSV-1, influenza virus, and HIV.
  Hayashi K, et al. Planta Med 1995 Jun;61(3):237-41

 OTITIS MEDIA

   IMMUNOLOGY

 [Langerhans cells and human aural cholesteatoma] Liu L, et al.
  Chung  Hua  Erh  Pi Yen Hou Ko Tsa Chih 1995;30(1):33-6 (Eng.
  Abstr.)                                                 (Chi)

 OTOLARYNGOLOGY

 The implications of acquired immunodeficiency syndrome  (AIDS)
  in otolaryngology [editorial] Pulec JL. Ear Nose Throat J 1995
  May;74(5):313
 AIDS in the field of otolaryngology. Tami TA. Ear Nose Throat J
  1995 May;74(5):328
 OSHA standards for blood-borne pathogens--strategies to
  increase compliance among otolaryngologists. Wagner RL, et al.
  Ear Nose Throat J 1995 May;74(5):348-52

   MANPOWER

 Universal precautions for the otolaryngologist: techniques and
  equipment  for  minimizing exposure risk. Murr AH, et al. Ear
  Nose Throat J 1995 May;74(5):338, 341-6

 OUTPATIENT CLINICS, HOSPITAL

   ORGANIZATION & ADMINISTRATION

 A model clinic for the initial evaluation and establishment of
  primary care for persons infected with human immunodeficiency
  virus. Samet JH, et  al.  Arch  Intern  Med  1995  Aug  7-21;
  155(15):1629-33

 OXIDATIVE STRESS

 [Oxidative stress and infectious pathology] Romero Alvira D, et
  al.  An  Med  Interna  1995 Mar;12(3):139-49 (172 ref.) (Eng.
  Abstr.)                                                 (Spa)

 OXYGENASES

   METABOLISM

 Frontal cortex indoleamine-2,3-dioxygenase activity is
  increased in HIV-1-associated dementia.  Sardar  AM,  et  al.
  Neurosci Lett 1995 Feb 24;187(1):9-12

 PACLITAXEL

   ADMINISTRATION & DOSAGE

 Treatment  of HIV-associated Kaposi's sarcoma with paclitaxel.
  Saville MW, et al. Lancet 1995 Jul 1;346(8966):26-8

 PAIN

   THERAPY

 Dancing across the lines: people in pain. Kuhl  D.  J  Palliat
  Care 1995 Summer;11(2):26-9

 PALLIATIVE TREATMENT

 AIDS  palliative  care--challenging  the  palliative paradigm.
  Foley FJ, et al. J Palliat Care 1995 Summer;11(2):19-22
 Sharing the challenge: the integration  of  cancer  and  AIDS.
  Fraser J. J Palliat Care 1995 Summer;11(2):23-5
 Palliative care for HIV disease: the desirable vs the possible.
  Goldstone I. J Palliat Care 1995 Summer;11(2):54-7
 AIDS  and  palliative  medicine: medical treatment issues. von
  Gunten CF, et al. J Palliat Care 1995 Summer;11(2):5-9

   METHODS

 Palliative care in the home? Johnson AS. J Palliat  Care  1995
  Summer;11(2):42-4
 Dancing  across  the  lines: people in pain. Kuhl D. J Palliat
  Care 1995 Summer;11(2):26-9
 Palliative care for women with AIDS: identifying  the  issues.
  Lobb D. J Palliat Care 1995 Summer;11(2):45-7
 Dementia  in  HIV  disease--a  challenge  for palliative care?
  McKeogh M. J Palliat Care 1995 Summer;11(2):30-3
 Working on the edge: palliative care for substance users  with
  AIDS. Robb V. J Palliat Care 1995 Summer;11(2):50-3

 PANCREATIC DISEASES

   COMPLICATIONS

 Tuberculous  pancreatic  abscess  as  an initial AIDS-defining
  disorder in a patient infected with the human immunodeficiency
  virus: case report and review. Jaber B, et al. Clin Infect Dis
  1995 Apr;20(4):890-4 (15 ref.)

 PANCREATIC PSEUDOCYST

   ETIOLOGY

 Recurrent acute pancreatitis and pancreatic pseudocyst as  the
  presenting manifestation of HIV infection. Kordossis T, et al.
  J Clin Gastroenterol 1995 Apr;20(3):261-2

 PANCREATITIS

   ETIOLOGY

 Recurrent  acute pancreatitis and pancreatic pseudocyst as the
  presenting manifestation of HIV infection. Kordossis T, et al.
  J Clin Gastroenterol 1995 Apr;20(3):261-2

 PANCYTOPENIA

   PHYSIOPATHOLOGY

 Serum levels of stem cell factor are increased in asymptomatic
  human  immunodeficiency  virus-infected  patients   and   are
  associated  with prolonged survival. Manegold C, et al. Blood
  1995 Jul 1;86(1):243-9

 PAPILLOMAVIRUS, HUMAN

   DRUG EFFECTS

 Fast, complete and persistent eradication of papilloma warts as
  additional activity of an anti-infective against RNA  viruses
  (Meeting  abstract). Wirth-Bronkowska LE, et al. Experientia;
  50:A26 1994

 PAPIO

 Baboon/man transplant backed for HIV victim [news] Lehrman  S.
  Nature 1995 Jul 20;376(6537):204
 FDA  panel  OKs  baboon  marrow  transplant  [news] Pennisi E.
  Science 1995 Jul 21;269(5222):293-4

 PAPOVAVIRIDAE INFECTIONS

   PATHOLOGY

 Skin-associated  lymphoid  tissue  in  human  immunodeficiency
  virus-1,  human  papillomavirus,  and  herpes  simplex  virus
  infections. Memar OM, et al. J Invest Dermatol 1995 Jul;105(1
  Suppl):99S-104S (56 ref.)

 PARAINFLUENZA VIRUS TYPE 1

   IMMUNOLOGY

 Subverting lymph node trafficking by treatment with the Mel-14
  monoclonal  antibody  to  L-selectin  does  not  prevent   an
  effective  host  response  to  Sendai  virus. Hou S, et al. J
  Immunol 1995 Jul 1;155(1):252-8

 PARAPARESIS, TROPICAL SPASTIC

 [Discovery of HTLV-I associated  myelopathy]  Igata  A.  Nihon
  Shinkei  Seishin  Yakurigaku  Zasshi  1995 Apr;15(2):185-9 (8
  ref.)                                                   (Jpn)

   BLOOD

 A  soluble  form  of  tumour  necrosis  factor   receptor   in
  cerebrospinal fluid and serum of HTLV-I-associated myelopathy
  and  other neurological diseases. Puccioni-Sohler M, et al. J
  Neurol 1995 Mar;242(4):239-42

   CEREBROSPINAL FLUID

 A  soluble  form  of  tumour  necrosis  factor   receptor   in
  cerebrospinal fluid and serum of HTLV-I-associated myelopathy
  and  other neurological diseases. Puccioni-Sohler M, et al. J
  Neurol 1995 Mar;242(4):239-42

   ETIOLOGY

 Brazilian studies on tropical spastic paraparesis. A
  meta-analysis. De Castro Costa CM, et al. Arq  Neuropsiquiatr
  1994 Dec;52(4):585-91
 [A  hemodialysis  patient  with  HTLV-1-associated  myelopathy
  (HAM)]  Takeda  F,  et  al. Nippon Jinzo Gakkai Shi 1995 May;
  37(5):307-10 (Eng. Abstr.)                              (Jpn)

   GENETICS

 X-linked pure familial spastic paraparesis. Characterization of
  a large kindred with magnetic resonance imaging studies. Cambi
  F, et al. Arch Neurol 1995 Jul;52(7):665-9

   IMMUNOLOGY

 IgA antiphospholipid antibodies in HTLV-1-associated  tropical
  spastic  paraparesis.  Wilson  WA,  et  al.  Lupus  1995 Apr;
  4(2):138-41
 [Anti HTLV-I antibody titers in seropositive infected
  individuals]  Galeno  H,  et  al.  Rev  Med  Chil  1994  Sep;
  122(9):1004-7 (Eng. Abstr.)                             (Spa)

   METABOLISM

 Increased levels of soluble vascular cell adhesion  molecule-1
  (VCAM-1) in the cerebrospinal fluid and sera of patients with
  multiple sclerosis and human T lymphotropic virus
  type-1-associated myelopathy. Matsuda M, et al. J Neuroimmunol
  1995 Jun;59(1-2):35-40

   PATHOLOGY

 Symptomatic  arachnoiditis  ossificans  of the thoracic spine.
  Case report.  Toribatake  Y,  et  al.  Paraplegia  1995  Apr;
  33(4):224-7

   PHYSIOPATHOLOGY

 Progression  of  neurological  disability in HTLV-I-associated
  myelopathy/tropical spastic paraparesis (HAM/TSP). Araujo AQ,
  et al. J Neurol Sci 1995 Apr;129(2):147-51

   THERAPY

 [Treatment of spastic paraparesis with  botulinum  toxin  with
  reference   to   beneficial  effects,  disease  severity  and
  long-term treatment] Takenaga S, et  al.  Rinsho  Shinkeigaku
  1995 Mar;35(3):251-5 (Eng. Abstr.)                      (Jpn)

 PARATHYROID HORMONES

   PHARMACOLOGY

 Growth-promoting actions of parathyroid hormone,
  adrenocorticotrophic hormone, and thyroid-stimulating hormone:
  in vitro studies in normal and pygmy T-lymphoblast cell lines.
  Geffner ME, et al. Pediatr Res 1995 Apr;37(4 Pt 1):507-11

 PARENT-CHILD RELATIONS

 Unseen  and unheard [news] Plant F. Nurs Times 1995 Jun 14-20;
  91(24):17

 PARENTS

   PSYCHOLOGY

 Parents' attitudes and beliefs about HIV/AIDS prevention  with
  condom  availability  in  New  York City public high schools.
  Guttmacher S, et al. J Sch Health 1995 Mar;65(3):101-6

 PARVOVIRUS, FELINE

   IMMUNOLOGY

 Panleukopenia-like syndrome of FeLV caused by co-infection with
  FeLV and feline panleukopenia  virus.  Lutz  H,  et  al.  Vet
  Immunol Immunopathol 1995 May;46(1-2):21-33

 PASTORAL CARE

 The new congregation: reflections by an AIDS hospice chaplain.
  Driscoll F. J Palliat Care 1995 Summer;11(2):61-3
 "Only connect"--some thoughts towards the spiritual care of HIV
  disease. Gray N. J Palliat Care 1995 Summer;11(2):58-60

 PATIENT ACCEPTANCE OF HEALTH CARE

   STATISTICS & NUMERICAL DATA

 Strategies  for  dealing  with problems associated with use of
  services for HIV infection and AIDS out of region:  views  of
  providers  and  users.  Coyle  A,  et  al.  BMJ  1995 Jun 24;
  310(6995):1636-8

 PATIENT ADVOCACY

   LEGISLATION & JURISPRUDENCE

 Legal obligations to human immunodeficiency virus--seropositive
  patients and health care providers. Smith MH. J Prof Nurs 1995
  May-Jun;11(3):183-91

 PATIENT CARE PLANNING

 Case management of HIV-infected children in Missouri. Scott DE,
  et al. Public Health Rep 1995 May-Jun;110(3):355-6

   STANDARDS

 Racial differences in care among  hospitalized  patients  with
  Pneumocystis  carinii  pneumonia  in  Chicago,  New York, Los
  Angeles, Miami, and Raleigh-Durham. Bennett CL, et  al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1586-92

 PATIENT CARE TEAM

 Adherence  to  zidovudine  (AZT)  among HIV-infected methadone
  patients: a pilot study of supervised therapy and  dispensing
  compared  to  usual care. Wall TL, et al. Drug Alcohol Depend
  1995 Mar;37(3):261-9

 PATIENT SATISFACTION

   STATISTICS & NUMERICAL DATA

 Satisfaction  with  ambulatory  care  of  persons  with  AIDS:
  predictors of patient ratings of quality. Stone VE, et al.  J
  Gen Intern Med 1995 May;10(5):239-45

 PATIENT SELECTION

 Criteria  for open lung biopsy. Focusing on patients with AIDS
  [letter] Trachiotis GD. Chest 1995 Jul;108(1):293-4

 PEER GROUP

 HIV/AIDS knowledge, attitudes, and comfort in adolescent  peer
  listeners. American Pediatric Society 104th annual meeting and
  Society  for Pediatric Research 63rd annual meeting; 1994 May
  2-5; Seattle. Marlowe AL, et al. Pediatr AIDS HIV Infect 1994
  Oct;5(5):316 (unnumbered abstract)

 PENICILLINS

   THERAPEUTIC USE

 Syphilis and neurosyphilis in a human  immunodeficiency  virus
  type-1 seropositive population: evidence for frequent
  serologic  relapse  after therapy. Malone JL, et al. Am J Med
  1995 Jul;99(1):55-63

 PENICILLIUM

   PATHOGENICITY

 Disseminated  Penicillium  marneffei:  presenting  illness  of
  advanced HIV infection; a clinicopathological review,
  illustrated by a case report. Heath TC, et al. Pathology 1995
  Jan;27(1):101-5 (31 ref.)

 PENNSYLVANIA

 What  administrators  need  to  know  about  the   rights   of
  HIV-infected  employees.  Riley  JB  Jr,  et al. Nephrol News
  Issues 1995 Mar;9(3):18-24

 PENTAMIDINE

   ADVERSE EFFECTS

 Changes in taste associated with intravenous administration of
  pentamidine  (revised)  [corrected  and  republished  article
  originally  printed  in  J  Assoc  Nurses  AIDS   Care   1995
  Jan-Feb;6(1):43-8]  Glover J, et al. J Assoc Nurses AIDS Care
  1995 Mar-Apr;6(2):41-6

 PEPTIDE FRAGMENTS

   CHEMISTRY

 Correlation of antiviral activity with beta-turn types for  V3
  synthetic multibranched peptides from HIV-1 gp120. Mabrouk K,
  et al. Biochemistry 1995 Jul 4;34(26):8294-8

   GENETICS

 HIV-1  V3 envelope sequences required for macrophage infection
  [letter] Henkel T, et al. AIDS 1995 Apr;9(4):399-401
 Amino acid substitutions in the V3 loop  are  responsible  for
  adaptation to growth in transformed T-cell lines of a primary
  human  immunodeficiency  virus  type  1.  Harrowe  G,  et al.
  Virology 1995 Jul 10;210(2):490-4

   PHARMACOLOGY

 Correlation of antiviral activity with beta-turn types for  V3
  synthetic multibranched peptides from HIV-1 gp120. Mabrouk K,
  et al. Biochemistry 1995 Jul 4;34(26):8294-8
 The  bend  in  RNA  created  by  the trans-activation response
  element bulge of human immunodeficiency virus is straightened
  by arginine and by Tat-derived peptide. Zacharias M,  et  al.
  Proc Natl Acad Sci U S A 1995 Jun 20;92(13):6052-6

   THERAPEUTIC USE

 Peptide-mediated  immunoregulation.  Hetzel C, et al. Int Arch
  Allergy Immunol 1995 May-Jun;107(1-3):275-7 (32 ref.)

 PEPTIDE HYDROLASES

   METABOLISM

 Altered peptidase and viral-specific T cell response  in  LMP2
  mutant mice. Van Kaer L, et al. Immunity 1994 Oct;1(7):533-41

 PEPTIDE PEPTIDOHYDROLASES

   METABOLISM

 Cloning,  bacterial  expression,  and  characterization of the
  Mason-Pfizer monkey virus proteinase.
  Hruskova-Heidingsfeldova O, et al. J Biol Chem 1995 Jun 23;
  270(25):15053-8

 PEPTIDES

   CHEMICAL SYNTHESIS

 Synthesis  of  peptide  analogues  containing  phosphonamidate
  methyl  ester  functionality:  HIV-1  proteinase   inhibitors
  possessing  unique  cell  uptake  properties. Camp NP, et al.
  Bioorg Med Chem 1995 Mar;3(3):297-12

   CHEMISTRY

 Investigation  of  the  structural  components  governing  the
  polarity-dependent refolding of a  CD4-binding  peptide  from
  gp120.  Graf  von  Stosch  A,  et al. J Mol Biol 1995 Jul 21;
  250(4):507-13

   METABOLISM

 Proline motifs in peptides and  their  biological  processing.
  Vanhoof G, et al. FASEB J 1995 Jun;9(9):736-44 (68 ref.)

   PHARMACOLOGY

 The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human
  erythrocytes. Mobley PW, et al. Biochim Biophys Acta 1995 Jun
  9;1271(2-3):304-14

 PERICARDITIS

   ETIOLOGY

 Case reports: pericarditis and lymphadenitis due to Rhodococcus
  equi. Lee-Chiong T, et al. Am J Med Sci 1995 Jul;310(1):31-3

 PERICARDITIS, TUBERCULOUS

   DIAGNOSIS

 Serodiagnosis  of  pericardial tuberculosis. Ng TT, et al. QJM
  1995 May;88(5):317-20

 PERIMETRY

   INSTRUMENTATION

 [Measuring retinal nerve fiber density with laser  polarimetry
  in patients with AIDS in comparison with health probands with
  reference to computer perimetry findings. A pilot study using
  the nerve fiber analyzer] Thierfelder S, et al. Klin Monatsbl
  Augenheilkd 1995 Mar;206(3):165-9 (Eng. Abstr.)         (Ger)

 PERIPHERAL NERVOUS SYSTEM DISEASES

   ETIOLOGY

 Unifying  hypothesis  for  the  pathogenesis of HIV-associated
  dementia complex, vacuolar myelopathy, and sensory neuropathy.
  Tyor WR, et al. J Acquir Immune Defic  Syndr  Hum  Retrovirol
  1995 Aug 1;9(4):379-88 (135 ref.)

 PERITONEAL DIALYSIS

 Isolation and quantitation of human immunodeficiency virus type
  1   (HIV-1)   from  peritoneal  dialysate:  implications  for
  infection control [letter] Breyer JA, et al. Perit  Dial  Int
  1995;15(2):179-80

   NURSING

 Infection  control  for peritoneal dialysis patients with HIV.
  Baldasseroni A. ANNA J 1995 Feb;22(1):56, 62

 PERSONAL CONSTRUCT THEORY

 Anxiety in community-based AIDS caregivers  before  and  after
  personal construct counseling. Viney LL, et al. J Clin Psychol
  1995 Mar;51(2):274-80

 PERSONALITY ASSESSMENT

 Murder  and  cover  up  could explain the Florida AIDS mystery
  [letter] Lewis DL. Br Dent J 1995 Jun 24;178(12):446-7
 Murder and cover up could explain  the  Florida  AIDS  mystery
  [letter]  Thorogood  N,  et  al.  Br  Dent  J  1995  Jun  24;
  178(12):446: discussion 447

 PERSONALITY DISORDERS

   REHABILITATION

 Use  of  a brief behavioral skills intervention to prevent HIV
  infection among chronic mentally ill adults. Kalichman SC, et
  al. Psychiatr Serv 1995 Mar;46(3):275-80

 PERSONNEL, HOSPITAL

 Occupation risk of  needlestick  injuries  among  health  care
  personnel  in  Saudi  Arabia. Shanks NJ, et al. J Hosp Infect
  1995 Mar;29(3):221-6
 Protection against  hospital-acquired  tuberculosis,  American
  style:  a report on the 4th Annual Meeting of the Society for
  Hospital Epidemiology of America (SHEA), New  Orleans,  1994.
  Wilcox MH. J Hosp Infect 1995 Mar;29(3):165-8

 PHARYNGEAL NEOPLASMS

   IMMUNOLOGY

 Immune  parameters of mice bearing human head and neck cancer.
  Taitz  A,  et  al.  Cancer  Immunol  Immunother   1995   May;
  40(5):283-91

 PHILADELPHIA

 Jobless benefits denied to teacher who failed to seek alternate
  work. AIDS Policy Law 1995 Apr 7;10(6):9
 Two  Philadelphia  AIDS agencies face their share of problems.
  AIDS Policy Law 1995 Apr 7;10(6):8

 PHOSPHOPROTEINS

   ANTAGONISTS & INHIBITORS

 Antitubulin  drugs  inhibit  HIV-1  replication  by   blocking
  tyrosine  phosphorylases.  American  Pediatric  Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Nquyen QV, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):324 (unnumbered abstract)

 PHYSICIAN-PATIENT RELATIONS

 The prevalence of  patient  disclosure  of  HIV  infection  to
  doctors [letter] Marks G, et al. Am J Public Health 1995 Jul;
  85(7):1018-9
 California  expands  the  duty to warn patients exposed to and
  infected with HIV. Reisner v. Regents of  the  University  of
  California.  Ferguson  RT,  et al. Health Care Law Newsl 1995
  Jun;10(6):5-7
 Communication between adolescents  and  doctors  about  sexual
  behavior and risk prevention. American Pediatric Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting;  1994  May 2-5; Seattle. Schuster MA, et al. Pediatr
  AIDS HIV Infect 1994 Oct;5(5):317 (unnumbered abstract)
 Adolescents' preferences regarding human immunodeficiency virus
  (HIV)-related physician counseling and HIV testing. Rawitscher
  LA, et al. Pediatrics 1995 Jul;96(1 Pt 1):52-8

 PHYSICIANS

 Doctors who discriminate are paying a steep price. AIDS Policy
  Law 1995 Apr 7;10(6):10
 Doctor's wife can't win damages arising  from  publication  of
  studies. AIDS Policy Law 1995 Apr 7;10(6):4
 Court  puts onus on doctors to warn patients about HIV status.
  AIDS Policy Law 1995 Mar 24;10(5):3-4

   PSYCHOLOGY

 Physician attitudes towards delivering STD/HIV-related
  preventive services to teens. American Pediatric Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Igra V, et al.  Pediatr  AIDS
  HIV Infect 1994 Oct;5(5):316 (unnumbered abstract)
 Physicians'   attitudes  towards  a  notification  program  of
  transfusion-related HIV risk in  pediatric  cardiac  surgical
  patients. American Pediatric Society 104th annual meeting and
  Society  for Pediatric Research 63rd annual meeting; 1994 May
  2-5; Seattle. McCrindle BW, et al. Pediatr  AIDS  HIV  Infect
  1994 Oct;5(5):317 (unnumbered abstract)

 PHYSICIAN'S PRACTICE PATTERNS

 The need for physician education regarding pediatric
  immunization  practices.  American  Pediatric  Society  104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Matson CC, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):314 (unnumbered abstract)

 PIPERAZINES

   PHARMACOKINETICS

 Time- and dose-dependent pharmacokinetics of L-754,394, an HIV
  protease inhibitor, in rats, dogs and monkeys. Lin JH, et al.
  J Pharmacol Exp Ther 1995 Jul;274(1):264-9

 PLANT EXTRACTS

   PHARMACOLOGY

 Inhibitory   effects  of  Egyptian  folk  medicines  on  human
  immunodeficiency virus (HIV) reverse transcriptase. el-Mekkawy
  S, et al. Chem Pharm Bull (Tokyo) 1995 Apr;43(4):641-8
 Virucidal effects of  the  steam  distillate  from  Houttuynia
  cordata and its components on HSV-1, influenza virus, and HIV.
  Hayashi K, et al. Planta Med 1995 Jun;61(3):237-41

   THERAPEUTIC USE

 Boxwood. Treat Rev 1995 Mar/Apr;(no 17):7

 PLANT PROTEINS

   IMMUNOLOGY

 Characterization  of  allergen (Bet v 1)-specific T cell lines
  and clones from non-allergic individuals. Ebner C, et al. Int
  Arch Allergy Immunol 1995 May-Jun;107(1-3):183-5
 Humoral immune responses to recombinant tree pollen  allergens
  (Bet  v  I and Bet v II) in mice: construction of a live oral
  allergy vaccine. Vrtala S, et al. Int  Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):290-4 (15 ref.)

 PLANTS, MEDICINAL

 Virucidal  effects  of  the  steam  distillate from Houttuynia
  cordata and its components on HSV-1, influenza virus, and HIV.
  Hayashi K, et al. Planta Med 1995 Jun;61(3):237-41

 PLASMA

 Do safety issues of plasma products constrain self-sufficiency?
  Savidge  GF.  Blood  Coagul  Fibrinolysis  1994  Dec;5  Suppl
  4:S67-70

 PLASMA SUBSTITUTES

   THERAPEUTIC USE

 Effect of resuscitation solutions on the immune status of dogs
  in hemorrhagic shock. Brown E,  et  al.  Am  Surg  1995  Aug;
  61(8):669-72; discussion 672-3

 PLASMIDS

   GENETICS

 A   new   plasmid  cloning  vector  for  direct  detection  of
  recombinant clones, based on inactivation of a bacterial acid
  phosphatase-encoding gene. Burioni R, et  al.  Microbiologica
  1995 Apr;18(2):201-6

 PNEUMOCYSTIS CARINII

   GENETICS

 PCR  for  detection  of  Pneumocystis  carinii  in blood cells
  [letter] Contini  C,  et  al.  J  Clin  Microbiol  1995  May;
  33(5):1431-2

   ISOLATION & PURIFICATION

 Use of the polymerase chain reaction technique on
  induced-sputum  samples  for  the  diagnosis  of Pneumocystis
  carinii pneumonia in HIV-infected patients.  A  clinical  and
  cost-analysis  study. Chouaid C, et al. Am J Clin Pathol 1995
  Jul;104(1):72-5
 PCR for detection  of  Pneumocystis  carinii  in  blood  cells
  [letter]  Contini  C,  et  al.  J  Clin  Microbiol  1995 May;
  33(5):1431-2

 PNEUMOCYSTIS CARINII INFECTIONS

   COMPLICATIONS

 [Pneumocystis carinii pneumonia  in  infants  with  vertically
  acquired  HIV  infection  in  Switzerland]  Berger  C, et al.
  Schweiz  Med  Wochenschr  1995  Jun  10;125(23):1162-7  (Eng.
  Abstr.)                                                 (Ger)

   PATHOLOGY

 [Disseminated Pneumocystis carinii infection:
  clinico-pathologic findings in an AIDS patient] Valdes E, et
  al. Pathologica 1994 Dec;86(6):659-64 (Eng. Abstr.)     (Ita)

 PNEUMONIA, BACTERIAL

   IMMUNOLOGY

 Pulmonary infection in the immunocompromised patient. White DA.
  Semin Thorac Cardiovasc Surg 1995 Apr;7(2):78-87 (99 ref.)

 PNEUMONIA, PNEUMOCYSTIS CARINII

   DIAGNOSIS

 Use of the polymerase chain reaction technique on
  induced-sputum samples  for  the  diagnosis  of  Pneumocystis
  carinii  pneumonia  in  HIV-infected patients. A clinical and
  cost-analysis study. Chouaid C, et al. Am J Clin Pathol  1995
  Jul;104(1):72-5
 Racial  differences  in  care among hospitalized patients with
  Pneumocystis carinii pneumonia  in  Chicago,  New  York,  Los
  Angeles,  Miami,  and Raleigh-Durham. Bennett CL, et al. Arch
  Intern Med 1995 Aug 7-21;155(15):1586-92
 Pneumocystis in infants and children [letter] Hughes WT. N Engl
  J Med 1995 Aug 3;333(5):320-1

   DRUG THERAPY

 Changes in taste associated with intravenous administration of
  pentamidine  (revised)  [corrected  and  republished  article
  originally  printed  in  J  Assoc  Nurses  AIDS   Care   1995
  Jan-Feb;6(1):43-8]  Glover J, et al. J Assoc Nurses AIDS Care
  1995 Mar-Apr;6(2):41-6

   EPIDEMIOLOGY

 Empirically treated  Pneumocystis  carinii  pneumonia  in  Los
  Angeles,  Chicago, and Miami: 1987-1990. Bennett CL, et al. J
  Infect Dis 1995 Jul;172(1):312-5

   METABOLISM

 Interleukin-8 and eicosanoid production  in  the  lung  during
  moderate  to severe Pneumocystis carinii pneumonia in AIDS: a
  role of interleukin-8  in  the  pathogenesis  of  P.  carinii
  pneumonia.   Benfield   TL,  et  al.  Respir  Med  1995  Apr;
  89(4):285-90

   PREVENTION & CONTROL

 Rapid oral  desensitization  to  trimethoprim-sulfamethoxazole
  (TMP-SMZ):   use  in  prophylaxis  for  Pneumocystis  carinii
  pneumonia in patients with AIDS who were previously intolerant
  to TMP-SMZ. Gluckstein D, et al. Clin Infect  Dis  1995  Apr;
  20(4):849-53

   RADIOGRAPHY

 [Atypical   presentation  of  Pneumocystis  carinii  pneumonia
  (letter)]  Adrian  M,  et  al.  An  Med  Interna  1995  Mar;
  12(3):151-2                                             (Spa)

   THERAPY

 Racial differences in care among  hospitalized  patients  with
  Pneumocystis  carinii  pneumonia  in  Chicago,  New York, Los
  Angeles, Miami, and Raleigh-Durham. Bennett CL, et  al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1586-92

 PNEUMONIA, VIRAL

 Viral  pulmonary  infections  in  thoracic  and cardiovascular
  surgery. Avery RK, et al. Semin Thorac Cardiovasc  Surg  1995
  Apr;7(2):88-94 (83 ref.)

   IMMUNOLOGY

 Pulmonary infection in the immunocompromised patient. White DA.
  Semin Thorac Cardiovasc Surg 1995 Apr;7(2):78-87 (99 ref.)

 PODOPHYLLIN

   THERAPEUTIC USE

 Treatment  of  HIV-related  hairy leukoplakia with podophyllum
  resin 25% solution. Gowdey G, et al. Oral Surg Oral Med  Oral
  Pathol Oral Radiol Endod 1995 Jan;79(1):64-7

 POINT MUTATION

 A  unique  tumor  antigen  produced  by  a  single  amino acid
  substitution. Monach PA, et al. Immunity 1995 Jan;2(1):45-59
 The pre-S domain of the large viral envelope protein determines
  host range in avian hepatitis B viruses. Ishikawa T,  et  al.
  Proc Natl Acad Sci U S A 1995 Jul 3;92(14):6259-63
 Catalytic  domain  of  human  immunodeficiency  virus  type  1
  integrase:  identification  of a soluble mutant by systematic
  replacement of hydrophobic residues. Jenkins TM, et al.  Proc
  Natl Acad Sci U S A 1995 Jun 20;92(13):6057-61
 Two  different  mutations  in  the  envelope protein of feline
  immunodeficiency  virus  allow  the  virus  to  escape   from
  neutralization  by  feline serum antibodies. Siebelink KH, et
  al. Vet Immunol Immunopathol 1995 May;46(1-2):51-9

 POLICE

 Rebuked by judge, Chicago settles suit charging police with job
  bias. AIDS Policy Law 1995 Mar 24;10(5):4-5

 POLIOMYELITIS

   HISTORY

 Jonas  Salk  (1914-95).  Dulbecco  R.  Nature  1995  Jul   20;
  376(6537):216

 POLIOVIRUS VACCINE

 Polio  vaccines and the origin of AIDS: clarification [letter]
  Elswood B, et al. Med Hypotheses 1995 Mar;44(3):226

   HISTORY

 Jonas Salk (1914-95). Dulbecco R. Nature 1995 Jul 20;
  376(6537):216

 POLIOVIRUSES

   GENETICS

 Construction and genetic analysis of dicistronic  polioviruses
  containing   open   reading  frames  for  epitopes  of  human
  immunodeficiency virus type 1 gp120. Lu HH, et  al.  J  Virol
  1995 Aug;69(8):4797-806

 POLITICS

 Two  key  programs  are  kept intact, but HOPWA's fate remains
  uncertain. AIDS Policy Law 1995 Mar 24;10(5):1, 10
 HOPWA's death in the House sets stage  for  negotiations  with
  Senate. AIDS Policy Law 1995 Apr 7;10(6):1-2
 Viatical  settlement  tax  reform: Republicans support relief,
  Democrats divided. James JS, et al. AIDS Treat News 1995  Mar
  3;(no 218):7-8

 POLLEN

 Peripheral  blood  T lymphocytes in seasonal bronchial asthma.
  Monteseirin J, et al. Allergy 1995 Feb;50(2):152-6

   IMMUNOLOGY

 Characterization of allergen (Bet v 1)-specific T  cell  lines
  and clones from non-allergic individuals. Ebner C, et al. Int
  Arch Allergy Immunol 1995 May-Jun;107(1-3):183-5
 Humoral  immune responses to recombinant tree pollen allergens
  (Bet v I and Bet v II) in mice: construction of a  live  oral
  allergy  vaccine.  Vrtala  S, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):290-4 (15 ref.)

 POLYMERASE CHAIN REACTION

 The polymerase chain reaction in the diagnosis and  evaluation
  of pulmonary infections. Schluger NW, et al. Am J Respir Crit
  Care Med 1995 Jul;152(1):11-6 (40 ref.)

   METHODS

 Continuous   RT-PCR  using  AMV-RT  and  Taq  DNA  polymerase:
  characterization  and  comparison  to  uncoupled  procedures.
  Mallet F, et al. Biotechniques 1995 Apr;18(4):678-87
 Detection of Aspergillus species DNA in bronchoalveolar lavage
  samples by  competitive  PCR.  Bretagne  S,  et  al.  J  Clin
  Microbiol 1995 May;33(5):1164-8
 PCR  for  detection  of  Pneumocystis  carinii  in blood cells
  [letter] Contini  C,  et  al.  J  Clin  Microbiol  1995  May;
  33(5):1431-2
 PCR  and in vitro cultivation for detection of Leishmania spp.
  in diagnostic samples from humans and dogs. Mathis A, et al. J
  Clin Microbiol 1995 May;33(5):1145-9
 Genomic fingerprinting of  Bartonella  species  by  repetitive
  element PCR for distinguishing species and isolates.
  Rodriguez-Barradas  MC,  et  al.  J  Clin Microbiol 1995 May;
  33(5):1089-93
 Quantitative analysis of HIV-1 RNA in plasma preparations. Zhu
  YS, et al. J Virol Methods 1995 Apr;52(3):287-99

   STANDARDS

 Use of the polymerase chain reaction technique on
  induced-sputum samples  for  the  diagnosis  of  Pneumocystis
  carinii  pneumonia  in  HIV-infected patients. A clinical and
  cost-analysis study. Chouaid C, et al. Am J Clin Pathol  1995
  Jul;104(1):72-5

   VETERINARY

 Competitive reverse transcription-polymerase chain reaction for
  quantitation of feline immunodeficiency virus. Vahlenkamp TW,
  et al. J Virol Methods 1995 Apr;52(3):335-46

 POLYMORPHISM, RESTRICTION FRAGMENT LENGTH

 Use  of  restriction fragment length polymorphism as a genetic
  marker for typing Mycobacterium avium strains. Roiz MP, et al.
  J Clin Microbiol 1995 May;33(5):1389-91

 POLYRADICULITIS

   COMPLICATIONS

 Myeloradiculitis due to Cryptococcus curvatus in AIDS [letter]
  Dromer F, et al. AIDS 1995 Apr;9(4):395-6

 POPULATION SURVEILLANCE

 Validating population surveys for the measurement  of  HIV/STD
  prevention  indicators.  Konings  E,  et  al.  AIDS 1995 Apr;
  9(4):375-82

 PORPHYRIA CUTANEA TARDA

   VIROLOGY

 Porphyria cutanea tarda and hepatitis  C  viral  infection.  A
  clinical and virologic study. Cribier B, et al. Arch Dermatol
  1995 Jul;131(7):801-4

 PORTUGAL

 Leishmania-human  immunodeficiency  virus  coinfection  in the
  Mediterranean basin:  isoenzymatic  characterization  of  100
  isolates  of  the Leishmania infantum complex. Pratlong F, et
  al. J Infect Dis 1995 Jul;172(1):323-6

 POTASSIUM CHANNELS

   PHYSIOLOGY

 HIV-gp120 activates large-conductance apamin-sensitive
  potassium channels in rat astrocytes. Bubien JK, et al. Am  J
  Physiol 1995 Jun;268(6 Pt 1):C1440-9

 POULTRY DISEASES

   PREVENTION & CONTROL

 Poxvirus-based  vaccine candidates for cancer, AIDS, and other
  infectious diseases. Perkus ME, et al. J Leukoc Biol 1995 Jul;
  58(1):1-13 (154 ref.)

 POVERTY

 Is there nothing between us? [editorial] Roy DJ. J Palliat Care
  1995 Summer;11(2):3-4
 Access to medical care and health-related quality of life  for
  low-income  persons  with  symptomatic human immunodeficiency
  virus. Cunningham WE, et al. Med Care 1995 Jul;33(7):739-54

 POWER (PSYCHOLOGY)

 Love, sex, and power. Considering  women's  realities  in  HIV
  prevention.  Amaro  H.  Am  Psychol 1995 Jun;50(6):437-47 (80
  ref.)
 Nursing: empowerment and the problem of power. Gilbert T. J Adv
  Nurs 1995 May;21(5):865-71 (27 ref.)

 POXVIRIDAE

   IMMUNOLOGY

 Poxvirus-based vaccine candidates for cancer, AIDS, and  other
  infectious diseases. Perkus ME, et al. J Leukoc Biol 1995 Jul;
  58(1):1-13 (154 ref.)

 PRASTERONE

   PHARMACOLOGY

 Dehydroepiandrosterone inhibits replication of feline
  immunodeficiency virus in chronically infected cells. Bradley
  WG, et al. Vet Immunol Immunopathol 1995 May;46(1-2):159-68

 PREGNANCY COMPLICATIONS, CARDIOVASCULAR

   PHYSIOPATHOLOGY

 The   natural  history  and  spectrum  of  idiopathic  dilated
  cardiomyopathy, including HIV and peripartum  cardiomyopathy.
  Cetta  F,  et  al. Curr Opin Cardiol 1995 May;10(3):332-8 (38
  ref.)

 PREGNANCY COMPLICATIONS, INFECTIOUS

 Frequency of early in  utero  HIV-1  infection:  a  blind  DNA
  polymerase  chain  reaction  study  on  100  fetal  thymuses.
  Brossard Y, et al. AIDS 1995 Apr;9(4):359-66
 Framework  for counseling pregnant women presented. AIDS Alert
  1995 Apr;10(4):57-8
 Evidence of serological cross-reactivities with human
  immunodeficiency virus types 1 and 2 and human T-lymphotropic
  virus types I and II in sera of  pregnant  women  in  Ibadan,
  Nigeria.  Olaleye  DO,  et  al.  Int  J  Epidemiol  1995 Feb;
  24(1):198-203
 Maternal-infant transmission of HIV infection: use of
  zidovudine [news] Klaus BD. Nurse Pract 1995 Apr;20(4):70-2
 HIV infection and neonatal & maternal characteristics. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Fuchs G, et al. Pediatr AIDS  HIV  Infect  1994  Oct;5(5):321
  (unnumbered abstract)
 Immunologic  changes in the first 6 months of life in subjects
  born to HIV+ women. American Pediatric Society  104th  annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting; 1994 May 2-5; Seattle. Kovacs A, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):319 (unnumbered abstract)
 HIV-specific  IgA  in  infants born to HIV seropositive women.
  American Pediatric Society 104th annual meeting  and  Society
  for  Pediatric  Research  63rd  annual meeting; 1994 May 2-5;
  Seattle. Livingston RA, et al. Pediatr AIDS HIV  Infect  1994
  Oct;5(5):321 (unnumbered abstract)
 Early determination of HIV infection status among infants born
  to HIV seropositive mothers. American Pediatric Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting;  1994  May 2-5; Seattle. Paul M, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):319 (unnumbered abstract)

   BLOOD

 Cord blood hCG levels in infants born to HIV  positive  women:
  correlation  with  transmission.  American  Pediatric Society
  104th annual meeting and Society for Pediatric Research  63rd
  annual  meeting;  1994  May  2-5, Seattle. Nachman SA, et al.
  Pediatr  AIDS  HIV  Infect  1994   Oct;5(5):324   (unnumbered
  abstract)

   EPIDEMIOLOGY

 Transmission of hepatitis C virus from mothers to infants: its
  frequency and risk factors revisited. Moriya T, et al. Biomed
  Pharmacother 1995;49(2):59-64

   PREVENTION & CONTROL

 Screening  for  unsuspected HIV in infants [news] Evans JA, et
  al. Nurs Times 1995 Jun 7-13;91(23):10

   THERAPY

 Prenatal care of HIV-infected women: analysis of a  large  New
  York  State  cohort.  Turner BJ, et al. J Acquir Immune Defic
  Syndr Hum Retrovirol 1995 Aug 1;9(4):371-8

   VIROLOGY

 HIV-1 in cervico-vaginal secretions of infected mothers and in
  the gastric aspirates of their  infants.  American  Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research  63rd annual meeting; 1994 May 2-5; Seattle. Nielsen
  K,  et  al.  Pediatr  AIDS  HIV  Infect   1994   Oct;5(5):322
  (unnumbered abstract)

 PREGNANCY COMPLICATIONS, PARASITIC

   EPIDEMIOLOGY

 Toxoplasma  gondii  antibodies  in  pregnant  women  and their
  newborns in Dar es Salaam, Tanzania. Doehring E, et al. Am  J
  Trop Med Hyg 1995 Jun;52(6):546-8

 PREGNANCY IN ADOLESCENCE

 Congenital syphilis in infants of adolescent mothers. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Risser  WL,  et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):316
  (unnumbered abstract)

 PREGNANCY TESTS

 Coordination, comprehensiveness  and  access  to  reproductive
  health  services  in school-based clinics. American Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research 63rd annual meeting; 1994 May 2-5; Seattle. Klein JD,
  et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):316  (unnumbered
  abstract)

 PREJUDICE

 Dentist's  'blatant  discrimination'  leads  to landmark court
  decision. AIDS Policy Law 1995 Apr 7;10(6):1, 10-1

 PRENATAL CARE

 Prenatal care of HIV-infected women: analysis of a  large  New
  York  State  cohort.  Turner BJ, et al. J Acquir Immune Defic
  Syndr Hum Retrovirol 1995 Aug 1;9(4):371-8
 Maternal-infant transmission of HIV infection: use of
  zidovudine [news] Klaus BD. Nurse Pract 1995 Apr;20(4):70-2

 PRENATAL DIAGNOSIS

 CDC recommends wider prenatal HIV screening [news] McCarthy M.
  Lancet 1995 Jul 15;346(8968):172

 PRIMARY HEALTH CARE

 Fear and trembling in North Carolina. The barriers to  primary
  medical and dental care for AIDS patients. Simmons JD, et al.
  N C Med J 1995 Jun;56(6):252-5

   ORGANIZATION & ADMINISTRATION

 A model clinic for the initial evaluation and establishment of
  primary care for persons infected with human immunodeficiency
  virus.  Samet  JH,  et  al.  Arch  Intern  Med 1995 Aug 7-21;
  155(15):1629-33

   STANDARDS

 Physicians' ability to provide  initial  primary  care  to  an
  HIV-infected  patient. Curtis JR, et al. Arch Intern Med 1995
  Aug 7-21;155(15):1613-8

 PROFESSIONAL AUTONOMY

 Should  clinical  freedom  be  constrained  in  the  name   of
  self-sufficiency?  Schimpf  K. Blood Coagul Fibrinolysis 1994
  Dec;5 Suppl 4:S47-9

 PROFESSIONAL-FAMILY RELATIONS

 Physicians'  attitudes  towards  a  notification  program   of
  transfusion-related  HIV  risk  in pediatric cardiac surgical
  patients. American Pediatric Society 104th annual meeting and
  Society for Pediatric Research 63rd annual meeting; 1994  May
  2-5;  Seattle.  McCrindle  BW, et al. Pediatr AIDS HIV Infect
  1994 Oct;5(5):317 (unnumbered abstract)
 What do families know  about  blood  product  exposure  during
  pediatric  cardiac  surgery  and  the  risk of HIV infection?
  American Pediatric Society 104th annual meeting  and  Society
  for  Pediatric  Research  63rd  annual meeting; 1994 May 2-5;
  Seattle. McCrindle BW, et al. Pediatr AIDS  HIV  Infect  1994
  Oct;5(5):317 (unnumbered abstract)

 PROGESTERONE

   PHARMACOLOGY

 Progesterone  favors  the  development of human T helper cells
  producing Th2-type cytokines and promotes both IL-4 production
  and membrane CD30 expression in established Th1 cell  clones.
  Piccinni MP, et al. J Immunol 1995 Jul 1;155(1):128-33

 PROGRAM DEVELOPMENT

 Parents'  attitudes and beliefs about HIV/AIDS prevention with
  condom availability in New York  City  public  high  schools.
  Guttmacher S, et al. J Sch Health 1995 Mar;65(3):101-6

 PROLINE

   METABOLISM

 Proline  motifs  in  peptides and their biological processing.
  Vanhoof G, et al. FASEB J 1995 Jun;9(9):736-44 (68 ref.)

 PROMOTER REGIONS (GENETICS)

 A conserved  motif  in  the  promoters  of  several  cytokines
  expressed  by  human Th2-type lymphocytes. Staynov DZ, et al.
  Int Arch Allergy Immunol 1995 May-Jun;107(1-3):217-9 (14 ref.)
 Human herpesvirus 6A ts suppresses both transformation by H-ras
  and transcription by the  H-ras  and  human  immunodeficiency
  virus  type  1 promoters. Araujo JC, et al. J Virol 1995 Aug;
  69(8):4933-40
 Improved accumulation and activity of ribozymes expressed from
  a tRNA-based RNA polymerase III promoter. Thompson JD, et al.
  Nucleic Acids Res 1995 Jun 25;23(12):2259-68

 PROPAGANDA

 [Effective knowledge propaganda  is  the  chief  strategy  for
  preventing HIV infection among adolescents] Usenko AD, et al.
  Vrach Delo 1994 Sep-Dec;(9-12):192-6                    (Rus)

 PROSTITUTION

 Prevalence, incidence, and risks for HIV-1 infection in female
  sex  workers  in  Miami, Florida. Onorato IM, et al. J Acquir
  Immune Defic Syndr Hum Retrovirol 1995 Aug 1;9(4):395-400

   STATISTICS & NUMERICAL DATA

 Crack, crack house sex, and HIV risk. Inciardi  JA.  Arch  Sex
  Behav 1995 Jun;24(3):249-69

 PROTECTIVE CLOTHING

   UTILIZATION

 Compliance to recommended infection control procedures: changes
  over six years among British Columbia dentists. Gibson GB, et
  al. J Can Dent Assoc 1995 Jun;61(6):526-32

 PROTEIN CONFORMATION

 Correlation  of antiviral activity with beta-turn types for V3
  synthetic multibranched peptides from HIV-1 gp120. Mabrouk K,
  et al. Biochemistry 1995 Jul 4;34(26):8294-8
 NMR solution structure of the RNA-binding peptide  from  human
  immunodeficiency  virus  (type  1)  Rev.  Scanlon  MJ, et al.
  Biochemistry 1995 Jul 4;34(26):8242-9
 Conformation and stability of recombinant HIV-1 capsid protein
  p24 (rp24). Misselwitz R, et al. Biochim Biophys Acta 1995 Jul
  3;1250(1):9-18
 Proline motifs in peptides and  their  biological  processing.
  Vanhoof G, et al. FASEB J 1995 Jun;9(9):736-44 (68 ref.)
 Flap  opening  in  HIV-1  protease  simulated  by  'activated'
  molecular  dynamics.  Collins JR, et al. Nat Struct Biol 1995
  Apr;2(4):334-8
 Mechanism of inhibition  of  HIV-1  reverse  transcriptase  by
  non-nucleoside  inhibitors.  Esnouf R, et al. Nat Struct Biol
  1995 Apr;2(4):303-8
 Flexibility and function  in  HIV-1  protease  [see  comments]
  Nicholson LK, et al. Nat Struct Biol 1995 Apr;2(4):274-80
 High  resolution structures of HIV-1 RT from four RT-inhibitor
  complexes. Ren J, et al. Nat Struct Biol 1995 Apr;2(4):293-302
 The importance of being floppy [news; comment] Wagner  G.  Nat
  Struct Biol 1995 Apr;2(4):255-7
 Catalytic  domain  of  human  immunodeficiency  virus  type  1
  integrase:  identification  of a soluble mutant by systematic
  replacement of hydrophobic residues. Jenkins TM, et al.  Proc
  Natl Acad Sci U S A 1995 Jun 20;92(13):6057-61
 Structure of HIV-1 reverse transcriptase in a complex with the
  non-nucleoside   inhibitor   alpha-APA   R  95845  at  2.8  A
  resolution. Ding J, et al. Structure 1995 Apr 15;3(4):365-79
 Comparative analysis of the X-ray structures of HIV-1 and HIV-2
  proteases in complex with CGP 53820, a novel  pseudosymmetric
  inhibitor.  Priestle  JP,  et  al.  Structure  1995  Apr  15;
  3(4):381-9

 PROTEIN-ENERGY MALNUTRITION

   PATHOLOGY

 Effect  of  nutritional  and  HIV  status  on  bacteraemia  in
  Zimbabwean  children  who died at home. Wolf BH, et al. Eur J
  Pediatr 1995 Apr;154(4):299-303

 PROTEIN FOLDING

 Investigation  of  the  structural  components  governing  the
  polarity-dependent refolding of a  CD4-binding  peptide  from
  gp120.  Graf  von  Stosch  A,  et al. J Mol Biol 1995 Jul 21;
  250(4):507-13

 PROTEIN PRECURSORS

 (Patho)physiologic pathways to drug targeting: artificial viral
  envelopes. Schreier H, et al. J Mol  Recognit  1995  Jan-Apr;
  8(1-2):59-62

   IMMUNOLOGY

 Characterization  of a soluble, oligomeric HIV-1 gp160 protein
  as a potential immunogen. VanCott TC, et al. J Immunol Methods
  1995 Jun 14;183(1):103-17

   METABOLISM

 Analysis of the cleavage site of  the  human  immunodeficiency
  virus  type 1 glycoprotein: requirement of precursor cleavage
  for glycoprotein incorporation. Dubay JW, et al. J Virol 1995
  Aug;69(8):4675-82

   PHARMACOLOGY

 Human  immunodeficiency  virus-1  gp120  and  gp160   envelope
  proteins  modulate  mesangial  cell  gelatinolytic  activity.
  Singhal PC, et al. Am J Pathol 1995 Jul;147(1):25-32
 Induction  of  hematopoietic  cytokines  by  HIV gp160 in cord
  blood. American Pediatric Society 104th  annual  meeting  and
  Society  for Pediatric Research 63rd annual meeting; 1994 May
  2-5; Seattle. Than S, et al. Pediatr AIDS HIV Infect 1994 Oct;
  5(5):315 (unnumbered abstract)

 PROTEIN PROCESSING, POST-TRANSLATIONAL

 Proline motifs in peptides and  their  biological  processing.
  Vanhoof G, et al. FASEB J 1995 Jun;9(9):736-44 (68 ref.)
 A  kinetic model for comparing proteolytic processing activity
  and inhibitor resistance potential of mutant HIV-1 proteases.
  Tang J, et al. FEBS Lett 1995 Jun 26;367(2):112-6

 PROTEIN-SERINE-THREONINE KINASES

   METABOLISM

 A conserved domain and membrane targeting of Nef from HIV  and
  SIV are required for association with a cellular serine kinase
  activity.  Sawai  ET,  et  al.  J  Biol  Chem  1995  Jun  23;
  270(25):15307-14

 PROTEIN STRUCTURE, SECONDARY

 Correlation  of antiviral activity with beta-turn types for V3
  synthetic multibranched peptides from HIV-1 gp120. Mabrouk K,
  et al. Biochemistry 1995 Jul 4;34(26):8294-8
 Flap  opening  in  HIV-1  protease  simulated  by  'activated'
  molecular dynamics. Collins JR, et al. Nat Struct  Biol  1995
  Apr;2(4):334-8
 Mechanism  of  inhibition  of  HIV-1  reverse transcriptase by
  non-nucleoside inhibitors. Esnouf R, et al. Nat  Struct  Biol
  1995 Apr;2(4):303-8

 PROTEIN-TYROSINE KINASE

   METABOLISM

 Constitutively activated Jak-STAT pathway in T cells
  transformed with HTLV-I. Migone TS, et al. Science 1995 Jul 7;
  269(5220):79-81

   PHYSIOLOGY

 The  CD4-associated  tyrosine  kinase  p56lck  is required for
  lymphocyte chemoattractant factor-induced T lymphocyte
  migration.  Ryan  TC,  et  al.  J  Biol  Chem  1995  Jul  21;
  270(29):17081-6

 PROTEINS

   METABOLISM

 Induction of MMP9 (92 kDa gelatinase) activity and  expression
  of  tissue  inhibitor of metalloproteinase-2 mRNA (TIMP-2) in
  primitive  neuroectodermal  cells  infected  with  retrovirus
  HTLV-I. Giraudon P,  et  al.  Eur  J  Neurosci  1995  May  1;
  7(5):841-8

   PHYSIOLOGY

 Altered  peptidase  and viral-specific T cell response in LMP2
  mutant mice. Van Kaer L, et al. Immunity 1994 Oct;1(7):533-41

 PROTEINURIA

 Quantitation of proteinuria in children with  HIV-nephropathy.
  American  Pediatric  Society 104th annual meeting and Society
  for Pediatric Research 63rd annual  meeting;  1994  May  2-5;
  Seattle.  Abitbol C, et al. Pediatr AIDS HIV Infect 1994 Oct;
  5(5):318 (unnumbered abstract)
 Characterization  of  proteinuria  in  HIV-infected   infants.
  American  Pediatric  Society 104th annual meeting and Society
  for Pediatric Research 63rd annual  meeting;  1994  May  2-5;
  Seattle.  Abitol  C, et al. Pediatr AIDS HIV Infect 1994 Oct;
  5(5):318 (unnumbered abstract)

 PROTO-ONCOGENE PROTEINS

   ANALYSIS

 Age-dependent reduction of Bcl-2 expression  in  peripheral  T
  cells  of lpr and gld mutant mice. Tamura A, et al. J Immunol
  1995 Jul 1;155(1):499-507

   BIOSYNTHESIS

 High expression of latent membrane protein 1  of  Epstein-Barr
  virus  and  BCL-2  oncoprotein  in  acquired immunodeficiency
  syndrome-related primary brain lymphomas. Camilleri-Broet S,
  et al. Blood 1995 Jul 15;86(2):432-5
 Differential expression of Fas antigen and  Bcl-2  protein  on
  CD4+ T cells, CD8+ T cells, and monocytes. Shinohara S, et al.
  Cell Immunol 1995 Jul;163(2):303-8
 Age-dependent  reduction  of  Bcl-2 expression in peripheral T
  cells of lpr and gld mutant mice. Tamura A, et al. J  Immunol
  1995 Jul 1;155(1):499-507

   PHYSIOLOGY

 Implication of cyclosporine in up-regulation of Bcl-2
  expression and maintenance of CD8 lymphocytosis in
  cytomegalovirus-infected allograft recipients. Labalette M, et
  al. Transplantation 1995 Jun 27;59(12):1714-23

 PROTO-ONCOGENE PROTEINS C-ERBB-2

   IMMUNOLOGY

 Immunity  to the HER-2/neu oncogenic protein. Disis ML, et al.
  Ciba Found Symp 1994;187:198-207; discussion 207-11 (33 ref.)

 PROTOZOAN PROTEINS

   PHARMACOLOGY

 Crude extract and recombinant protein of Cryptosporidium parvum
  oocysts  induce  proliferation  of  human  peripheral   blood
  mononuclear cells in vitro. Gomez Morales MA, et al. J Infect
  Dis 1995 Jul;172(1):211-6

 PROVIRUSES

   GENETICS

 LTR-directed  homologous  recombination  of  full-length HIV-1
  provirus clone in recA(-) bacteria. Yamada  K,  et  al.  Arch
  Virol 1995;140(6):1007-14
 Nef stimulates human immunodeficiency virus type 1 proviral DNA
  synthesis. Aiken C, et al. J Virol 1995 Aug;69(8):5048-56

   ISOLATION & PURIFICATION

 Low  prevalence  of  HIV-1  proviral  DNA  in peripheral blood
  monocytes and dendritic cells from HIV-1-infected individuals
  [letter] Hsia K, et al. AIDS 1995 Apr;9(4):398-9

   PHYSIOLOGY

 Reduced provirus burden and enhanced humoral immune function in
  AZT-treated SCID-feline mice inoculated with feline
  immunodeficiency  virus.  Johnson  CM,  et  al.  Vet  Immunol
  Immunopathol 1995 May;46(1-2):169-80

 PRURITUS

   COMPLICATIONS

 Intolerable pruritis in an HIV-infected man. Zuger A. AIDS Clin
  Care 1995 Mar;7(3):23, 26 (1 ref.)

 PSEUDOMONAS INFECTIONS

   MICROBIOLOGY

 Recovery of Pseudomonas aeruginosa  in  respiratory  specimens
  from  HIV  positive patients being evaluated for Pneumocystis
  carinii  pneumonia.  Doyle  RL,  et  al.  Thorax  1995   May;
  50(5):548-50

 PSYCHOMOTOR PERFORMANCE

 Reaction  time  slowing in HIV-1-infected individuals: role of
  the  preparatory  interval.  Law  WA,  et  al.  J  Clin   Exp
  Neuropsychol 1995 Feb;17(1):122-33

 PSYCHOTHERAPY

 Anxiety  in  community-based  AIDS caregivers before and after
  personal construct counseling. Viney LL, et al. J Clin Psychol
  1995 Mar;51(2):274-80
 [Coping with HIV  infection  and  motivation  for  therapy  in
  multi-drug  dependent patients] Grube M. Nervenarzt 1995 May;
  66(5):361-6 (Eng. Abstr.)                               (Ger)

 PSYCHOTHERAPY, BRIEF

   METHODS

 Use of a brief behavioral skills intervention to  prevent  HIV
  infection among chronic mentally ill adults. Kalichman SC, et
  al. Psychiatr Serv 1995 Mar;46(3):275-80

 PSYCHOTIC DISORDERS

   REHABILITATION

 Use  of  a brief behavioral skills intervention to prevent HIV
  infection among chronic mentally ill adults. Kalichman SC, et
  al. Psychiatr Serv 1995 Mar;46(3):275-80

 PUBLIC ASSISTANCE

   LEGISLATION & JURISPRUDENCE

 Lawsuit charges New York City is denying basic AIDS  services.
  AIDS Policy Law 1995 Mar 24;10(5):7-8
 Six  city clients tell their stories. AIDS Policy Law 1995 Mar
  24;10(5):8

 PUERPERAL DISORDERS

   PHYSIOPATHOLOGY

 The  natural  history  and  spectrum  of  idiopathic   dilated
  cardiomyopathy,  including HIV and peripartum cardiomyopathy.
  Cetta F, et al. Curr Opin Cardiol  1995  May;10(3):332-8  (38
  ref.)

 PULMONARY EOSINOPHILIA

   PHYSIOPATHOLOGY

 Increase of activated T-cells in BAL fluid of Japanese patients
  with bronchiolitis obliterans organizing pneumonia and chronic
  eosinophilic  pneumonia.  Mukae  H,  et  al.  Chest 1995 Jul;
  108(1):123-8

 PULMONARY FIBROSIS

   METABOLISM

 Eosinophil activation in  patients  with  pulmonary  fibrosis.
  Fujimoto K, et al. Chest 1995 Jul;108(1):48-54

 PYRIDINES

   CHEMICAL SYNTHESIS

 Synthesis and biological investigations of some new
  thiazolylbenzimidazoles and
  benzimidazolylthiazolo[3,2-a]pyridines.  Rida SM, et al. Arch
  Pharm (Weinheim) 1995 Apr;328(4):325-8

   METABOLISM

 High resolution structures of HIV-1 RT from four  RT-inhibitor
  complexes. Ren J, et al. Nat Struct Biol 1995 Apr;2(4):293-302

   THERAPEUTIC USE

 Protease  inhibitor studies enrolling. Treat Rev 1995 Mar/Apr;
  (no 17):3

 PYRIMETHAMINE

   ADMINISTRATION & DOSAGE

 Twice-weekly maintenance therapy with
  sulfadiazine-pyrimethamine to prevent  recurrent  toxoplasmic
  encephalitis  in  patients  with  AIDS. Spanish Toxoplasmosis
  Study Group [see comments] Podzamczer D, et al. Ann Intern Med
  1995 Aug 1;123(3):175-80

   BLOOD

 Pyrimethamine analysis by enzyme inhibition and  HPLC  assays.
  Roberts WL, et al. Am J Clin Pathol 1995 Jul;104(1):82-8

   THERAPEUTIC USE

 Toxoplasmosis in AIDS: keeping the lid on [editorial; comment]
  Kovacs JA. Ann Intern Med 1995 Aug 1;123(3):230-1

 PYRIMIDINE NUCLEOSIDES

 Recognition by viral and cellular DNA polymerases of
  nucleosides  bearing  bases with nonstandard hydrogen bonding
  patterns. Horlacher J, et al. Proc Natl Acad Sci U S  A  1995
  Jul 3;92(14):6329-33

 PYRIMIDINES

   PHARMACOLOGY

 Tetrahydropyrimidine derivatives inhibit binding of a Tat-like,
  arginine-containing peptide, to HIV TAR RNA in vitro. Lapidot
  A, et al. FEBS Lett 1995 Jun 19;367(1):33-8

 QUALITY OF HEALTH CARE

 Quality  of  AIDS  care  in  a  changing  health  care  system
  [editorial] Aiken LH. J Gen Intern Med 1995 May;10(5):294-5

   STATISTICS & NUMERICAL DATA

 Satisfaction  with  ambulatory  care  of  persons  with  AIDS:
  predictors  of patient ratings of quality. Stone VE, et al. J
  Gen Intern Med 1995 May;10(5):239-45

 QUALITY OF LIFE

 Access to medical care and health-related quality of life  for
  low-income  persons  with  symptomatic human immunodeficiency
  virus. Cunningham WE, et al. Med Care 1995 Jul;33(7):739-54
 The Bristol-Myers Anorexia/Cachexia Recovery Instrument
  (BACRI): a brief assessment of patients' subjective  response
  to treatment for anorexia/cachexia. Cella DF, et al. Qual Life
  Res 1995 Jun;4(3):221-31

 QUEBEC

 The   law   and   ethics  in  relation  to  dentists  treating
  HIV-positive patients: two recent court cases. Graham PE,  et
  al. J Can Dent Assoc 1995 Jun;61(6):487-91

 RADIATION CHIMERA

   IMMUNOLOGY

 Human/mouse  radiation chimera are capable of mounting a human
  primary humoral response. Marcus H, et al. Blood 1995 Jul  1;
  86(1):398-406

 RADIOACTIVE TRACERS

 Clinical  brain  radionuclide imaging studies. Messa C, et al.
  Semin Nucl Med 1995 Apr;25(2):111-43 (250 ref.)

 RANDOMIZED CONTROLLED TRIALS

 Maternal-infant transmission of HIV infection: use of
  zidovudine [news] Klaus BD. Nurse Pract 1995 Apr;20(4):70-2

 RATS, INBRED BN

   IMMUNOLOGY

 The time course and characterization of mercuric
  chloride-induced immunopathology in  the  brown  Norway  rat.
  Qasim FJ, et al. J Autoimmun 1995 Apr;8(2):193-208

 REACTION TIME

 Reaction  time  slowing in HIV-1-infected individuals: role of
  the  preparatory  interval.  Law  WA,  et  al.  J  Clin   Exp
  Neuropsychol 1995 Feb;17(1):122-33

 REAGENT KITS, DIAGNOSTIC

 Assessment  of  suitability  &  ease  of  performance of seven
  commercial assay systems for the detection of  antibodies  to
  HIV-1.  Sreedharan  A,  et  al.  Indian  J  Med Res 1995 May;
  101:179-82

 RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL

   IMMUNOLOGY

 Diseases involving the T-cell receptor/CD3 complex.
  Arnaiz-Villena A, et al. Crit Rev  Oncol  Hematol  1995  Jun;
  19(2):131-47 (170 ref.)

 RECEPTORS, ANTIGEN, T-CELL

   IMMUNOLOGY

 Expression  in  vivo  of  CD45RA,  CD45RB  and  CD44 on T cell
  receptor-transgenic  CD8+  T  cells  following  immunization.
  Pihlgren M, et al. Eur J Immunol 1995 Jun;25(6):1755-9
 On the cellular basis of immunological T cell memory. Bruno L,
  et al. Immunity 1995 Jan;2(1):37-43
 Chimeric  zeta-receptors  direct  human  natural  killer  (NK)
  effector function to permit  killing  of  NK-resistant  tumor
  cells  and  HIV-infected  T  lymphocytes.  Tran  AC, et al. J
  Immunol 1995 Jul 15;155(2):1000-9

   METABOLISM

 Functional significance of CD23- on CD23-transfected Th2 clone.
  Nambu M, et al. Immunol Lett 1995 Jan;44(2-3):163-7

 RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA

   ANALYSIS

 Peripheral T cell receptor  repertoire  among  CD4+  and  CD8+
  subsets  during acute infectious mononucleosis. Slobod KS, et
  al. Viral Immunol 1994;7(3):151-3

   GENETICS

 Malignant and normal T cells show random use of T-cell receptor
  alpha chain variable regions in patients with cutaneous T-cell
  lymphoma. Longley J, et  al.  J  Invest  Dermatol  1995  Jul;
  105(1):62-4
 The  T-cell  receptor  V  beta  repertoire  in naive and human
  immunodeficiency virus-1 (HIV-1) infected chimpanzees.
  Boldt-Houle DM, et al. J Med Primatol 1994 Oct;23(8):432-41

 RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA

   IMMUNOLOGY

 TCR gamma delta cells: mysterious cells of the immune  system.
  Sciammas R, et al. Immunol Res 1994;13(4):268-79 (36 ref.)

 RECEPTORS, CELL SURFACE

   IMMUNOLOGY

 Expression  in  vivo  of  CD45RA,  CD45RB  and  CD44 on T cell
  receptor-transgenic  CD8+  T  cells  following  immunization.
  Pihlgren M, et al. Eur J Immunol 1995 Jun;25(6):1755-9

   METABOLISM

 The macrophage mannose receptor  can  mediate  the  uptake  of
  Mycobacterium avium-intracellulare. American Pediatric Society
  104th  annual meeting and Society for Pediatric Research 63rd
  annual meeting; 1994 May 2-5; Seattle.  Kruskal  BA,  et  al.
  Pediatr   AIDS   HIV  Infect  1994  Oct;5(5):319  (unnumbered
  abstract)

 RECEPTORS, FC

   IMMUNOLOGY

 The role of spleen in the pathogeny of aplastic anemia related
  to increased number of CD3+ CD8+ FcR+ cells. Roman S, et  al.
  Rom J Intern Med 1994 Oct-Dec;32(4):275-82

 RECEPTORS, FIBROBLAST GROWTH FACTOR

   METABOLISM

 Basic  fibroblast growth factor and its low affinity receptors
  in the pathogenesis of HIV-associated nephropathy in
  transgenic mice.  American  Pediatric  Society  104th  annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting;  1994  May 2-5; Seattle. Ray PE, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):318 (unnumbered abstract)

 RECEPTORS, IGE

   METABOLISM

 Functional significance of CD23- on CD23-transfected Th2 clone.
  Nambu M, et al. Immunol Lett 1995 Jan;44(2-3):163-7

 RECEPTORS, INTERFERON

   PHYSIOLOGY

 Lack of interferon gamma receptor beta chain and the prevention
  of interferon gamma signaling in  TH1  cells  [see  comments]
  Pernis A, et al. Science 1995 Jul 14;269(5221):245-7

 RECEPTORS, LYMPHOCYTE HOMING

   IMMUNOLOGY

 Expression  in  vivo  of  CD45RA,  CD45RB  and  CD44 on T cell
  receptor-transgenic  CD8+  T  cells  following  immunization.
  Pihlgren M, et al. Eur J Immunol 1995 Jun;25(6):1755-9

 RECEPTORS, THYROID HORMONE

   METABOLISM

 Interactions of thyroid hormone receptor with the human
  immunodeficiency virus type 1 (HIV-1) long terminal repeat and
  the HIV-1 Tat transactivator. Desai-Yajnik V, et al. J  Virol
  1995 Aug;69(8):5103-12

 RECEPTORS, TUMOR NECROSIS FACTOR

   ANALYSIS

 A   soluble   form  of  tumour  necrosis  factor  receptor  in
  cerebrospinal fluid and serum of HTLV-I-associated myelopathy
  and other neurological diseases. Puccioni-Sohler M, et al.  J
  Neurol 1995 Mar;242(4):239-42

 RECOMBINANT FUSION PROTEINS

   BIOSYNTHESIS

 Engineering human monoclonal antibody fragments: a recombinant
  enzyme-linked Fab. Burioni R, et al. Microbiologica 1995 Apr;
  18(2):127-33

 RECOMBINANT PROTEINS

 (Patho)physiologic pathways to drug targeting: artificial viral
  envelopes.  Schreier  H,  et al. J Mol Recognit 1995 Jan-Apr;
  8(1-2):59-62

   CHEMISTRY

 A molecular sensor  system  based  on  genetically  engineered
  alkaline phosphatase. Brennan CA, et al. Proc Natl Acad Sci U
  S A 1995 Jun 20;92(13):5783-7

 RECOMBINATION, GENETIC

 LTR-directed  homologous  recombination  of  full-length HIV-1
  provirus clone in recA(-) bacteria. Yamada  K,  et  al.  Arch
  Virol 1995;140(6):1007-14

 RECTAL NEOPLASMS

   SURGERY

 Cimetidine   and  survival  with  colorectal  cancer  [letter]
  Matsumoto S. Lancet 1995 Jul 8;346(8967):115

 REFUSAL TO TREAT

 Willingness of  dentists  to  treat  an  HIV-infected  patient
  [letter] Porter SR, et al. AIDS 1995 Apr;9(4):402-3

   LEGISLATION & JURISPRUDENCE

 Eleventh  Circuit affirms decision involving nurse who refused
  to care for an HIV-positive  patient.  Armstrong  v.  Flowers
  Hospital, Inc. Hosp Law Newsl 1995 Jul;12(9):8

 REGENERATION

   IMMUNOLOGY

 T  cells  in regenerating feathers of Smyth line chickens with
  vitiligo. Erf GF, et al. Clin Immunol Immunopathol 1995  Aug;
  76(2):120-6

 REHYDRATION SOLUTIONS

   THERAPEUTIC USE

 Effect of resuscitation solutions on the immune status of dogs
  in  hemorrhagic  shock.  Brown  E,  et  al. Am Surg 1995 Aug;
  61(8):669-72; discussion 672-3

 RELAXATION TECHNIQUES

 Effect of qigong  training  on  proportions  of  T  lymphocyte
  subsets in human peripheral blood. Ryu H, et al. Am J Chin Med
  1995;23(1):27-36

 REPETITIVE SEQUENCES, NUCLEIC ACID

 Transactivation  of the human T-cell lymphotropic virus type 1
  Tax1-responsive 21-base-pair repeats requires Holo-TFIID  and
  TFIIA. Duvall JF, et al. J Virol 1995 Aug;69(8):5077-86

 REPRESSOR PROTEINS

   METABOLISM

 Molecular  cloning  of  a  new  interferon-induced factor that
  represses human immunodeficiency virus type 1  long  terminal
  repeat  expression. Tissot C, et al. J Biol Chem 1995 Jun 23;
  270(25):14891-8

 REPRODUCTION TECHNIQUES

 [What role is left to sperm banks in 1995?] Demoulin A, et al.
  Rev Med Liege 1995 Jun;50(6):254-8 (15 ref.)            (Fre)

 RESEARCH

 Top scientists come to defense of AIDS research office  [news]
  Science 1995 Jul 14;269(5221):151

   ECONOMICS

 AIDS research: who should hold the purse strings? [news] Cohen
  J. Science 1995 Jul 21;269(5222):292

 RESEARCH PERSONNEL

 Italy.  Returning  emigres  add  new luster to AIDS research
  [news] Balter M. Science 1995 Jul 7;269(5220):24-5

 RESEARCH SUPPORT

 Future of AIDS research  office  threatened  [news]  Appel  A.
  Nature 1995 Jul 20;376(6537):205-6

 RESPIRATORY HYPERSENSITIVITY

   IMMUNOLOGY

 Importance of interleukin-4 and interleukin-12 in
  allergen-induced  airway changes in mice. Kips JC, et al. Int
  Arch Allergy Immunol 1995 May-Jun;107(1-3):115-8

 RESPIRATORY PROTECTIVE DEVICES

 Protection against  hospital-acquired  tuberculosis,  American
  style:  a report on the 4th Annual Meeting of the Society for
  Hospital Epidemiology of America (SHEA), New  Orleans,  1994.
  Wilcox MH. J Hosp Infect 1995 Mar;29(3):165-8

 RESPIRATORY SYNCYTIAL VIRUSES

   DRUG EFFECTS

 Inhibition   of  herpes  simplex  virus  type  1,  respiratory
  syncytial virus and echovirus type 11 by peroxidase-generated
  hypothiocyanite. Mikola H, et al.  Antiviral  Res  1995  Mar;
  26(2):161-71

 RESPIRATORY TRACT DISEASES

   EPIDEMIOLOGY

 Respiratory  diseases  in Rwanda [editorial] Prakash UB. Chest
  1995 Jul;108(1):5-7

 RESPIRATORY TRACT INFECTIONS

   DIAGNOSIS

 The polymerase chain reaction in the diagnosis and  evaluation
  of pulmonary infections. Schluger NW, et al. Am J Respir Crit
  Care Med 1995 Jul;152(1):11-6 (40 ref.)
 The  role  of  bronchoscopy  in the diagnosis and treatment of
  pulmonary disease in HIV-infected patients. Lewin SR, et  al.
  Aust N Z J Med 1995 Apr;25(2):133-9

   PATHOLOGY

 Surgical  pathology  of pulmonary infections. Travis WD. Semin
  Thorac Cardiovasc Surg 1995 Apr;7(2):62-9 (68 ref.)

   VIROLOGY

 Viral pulmonary  infections  in  thoracic  and  cardiovascular
  surgery.  Avery  RK, et al. Semin Thorac Cardiovasc Surg 1995
  Apr;7(2):88-94 (83 ref.)

 RETINAL DISEASES

   PATHOLOGY

 [Measuring retinal nerve fiber density with laser  polarimetry
  in patients with AIDS in comparison with health probands with
  reference to computer perimetry findings. A pilot study using
  the nerve fiber analyzer] Thierfelder S, et al. Klin Monatsbl
  Augenheilkd 1995 Mar;206(3):165-9 (Eng. Abstr.)         (Ger)

 RETINITIS

 Cytomegalovirus retinitis. Br J Theatre Nurs 1995 May;5(2):29

   COMPLICATIONS

 Going  blind.  Seyfrit M. Am J Hosp Palliat Care 1995 May-Jun;
  12(3):31-5

 RETROTRANSPOSONS

   DRUG EFFECTS

 Development of a yeast retrotransposon-based system useful for
  screening of potentially  active  anti-retroviral  compounds.
  Sanguinetti M, et al. Microbiologica 1995 Apr;18(2):117-25

 RETROVIRIDAE

   DRUG EFFECTS

 Development of a yeast retrotransposon-based system useful for
  screening  of  potentially  active anti-retroviral compounds.
  Sanguinetti M, et al. Microbiologica 1995 Apr;18(2):117-25

 REVERSE TRANSCRIPTASE

 Continuous  RT-PCR  using  AMV-RT  and  Taq  DNA   polymerase:
  characterization  and  comparison  to  uncoupled  procedures.
  Mallet F, et al. Biotechniques 1995 Apr;18(4):678-87

   ANALYSIS

 Detection  of  reverse transcriptase activity by enzyme-linked
  immunosorbent assay in human immunodeficiency virus  type  1.
  Tomita N, et al. Acta Med Okayama 1995 Apr;49(2):69-73

   ANTAGONISTS & INHIBITORS

 The inhibition of human immunodeficiency virus type 1 in vitro
  by  a non-nucleoside reverse transcriptase inhibitor MKC-442,
  alone and  in  combination  with  other  anti-HIV  compounds.
  Brennan TM, et al. Antiviral Res 1995 Mar;26(2):173-87
 Comparative  anti-HIV  evaluation  of  diverse  HIV-1-specific
  reverse   transcriptase  inhibitor-resistant  virus  isolates
  demonstrates the existence of distinct phenotypic  subgroups.
  Buckheit RW Jr, et al. Antiviral Res 1995 Mar;26(2):117-32
 Sensitivity/resistance  profile  of  a simian immunodeficiency
  virus containing the  reverse  transcriptase  gene  of  human
  immunodeficiency virus type 1 (HIV-1) toward the
  HIV-1-specific non-nucleoside reverse transcriptase
  inhibitors.  Balzarini  J,  et al. Biochem Biophys Res Commun
  1995 Jun 26;211(3):850-6
 Differential inhibition of the activities of reverse
  transcriptase and  various  cellular  DNA  polymerases  by  a
  traditional  Kampo  drug,  sho-saiko-to. Ono K, et al. Biomed
  Pharmacother 1990;44(1):13-6
 Inhibitory  effects  of  Egyptian  folk  medicines  on   human
  immunodeficiency virus (HIV) reverse transcriptase. el-Mekkawy
  S, et al. Chem Pharm Bull (Tokyo) 1995 Apr;43(4):641-8
 Mechanism  of  inhibition  of  HIV-1  reverse transcriptase by
  non-nucleoside inhibitors. Esnouf R, et al. Nat  Struct  Biol
  1995 Apr;2(4):303-8
 High  resolution structures of HIV-1 RT from four RT-inhibitor
  complexes. Ren J, et al. Nat Struct Biol 1995 Apr;2(4):293-302
 Drug synergism by nucleoside analog drugs against HIV-RT based
  on multiple inhibitor kinetics (Meeting  abstract).  Periclou
  AP, et al. Proc Annu Meet Am Assoc Cancer Res; 36:A1720 1995

   CHEMISTRY

 Mechanism  of  inhibition  of  HIV-1  reverse transcriptase by
  non-nucleoside inhibitors. Esnouf R, et al. Nat  Struct  Biol
  1995 Apr;2(4):303-8
 High  resolution structures of HIV-1 RT from four RT-inhibitor
  complexes. Ren J, et al. Nat Struct Biol 1995 Apr;2(4):293-302

   METABOLISM

 Phosphorothioate oligonucleotides block reverse  transcription
  by the Rnase H activity associated with the HIV-1 polymerase.
  Hatta  T,  et  al.  Biochem  Biophys  Res Commun 1995 Jun 26;
  211(3):1041-6
 tRNAs as primer of reverse transcriptases. Marquet R,  et  al.
  Biochimie 1995;77(1-2):113-24 (89 ref.)
 Influence of human immunodeficiency virus nucleocapsid protein
  on synthesis and strand transfer by the reverse transcriptase
  in vitro. Rodriguez-Rodriguez L, et al. J Biol Chem 1995 Jun
  23;270(25):15005-11
 Lower  in  vivo  mutation rate of human immunodeficiency virus
  type 1 than that predicted  from  the  fidelity  of  purified
  reverse  transcriptase.  Mansky  LM, et al. J Virol 1995 Aug;
  69(8):5087-94
 Recognition by viral and cellular DNA polymerases of
  nucleosides bearing bases with nonstandard  hydrogen  bonding
  patterns.  Horlacher  J, et al. Proc Natl Acad Sci U S A 1995
  Jul 3;92(14):6329-33
 Structure of HIV-1 reverse transcriptase in a complex with the
  non-nucleoside  inhibitor  alpha-APA  R  95845   at   2.8   A
  resolution. Ding J, et al. Structure 1995 Apr 15;3(4):365-79

 RHABDOMYOLYSIS

   VIROLOGY

 Primary  coinfection  with  human  immunodeficiency  virus and
  cytomegalovirus presenting as acute  rhabdomyolysis  [letter]
  Ragnaud JM, et al. Clin Infect Dis 1995 Apr;20(4):1077-8

 RHODE ISLAND

 Inpatient  hospice  care: a new option for the terminally ill.
  Martin EW. R I Med 1995 Apr;78(4):118-9

 RHODOCOCCUS EQUI

   ISOLATION & PURIFICATION

 Case reports: pericarditis and lymphadenitis due to Rhodococcus
  equi. Lee-Chiong T, et al. Am J Med Sci 1995 Jul;310(1):31-3

 RIBONUCLEASE H, CALF THYMUS

   DRUG EFFECTS

 Phosphorothioate oligonucleotides block reverse  transcription
  by the Rnase H activity associated with the HIV-1 polymerase.
  Hatta  T,  et  al.  Biochem  Biophys  Res Commun 1995 Jun 26;
  211(3):1041-6

 RIBOSOMAL PROTEINS

   GENETICS

 A unique  tumor  antigen  produced  by  a  single  amino  acid
  substitution. Monach PA, et al. Immunity 1995 Jan;2(1):45-59

 RICIN

   ADMINISTRATION & DOSAGE

 (Patho)physiologic pathways to drug targeting: artificial viral
  envelopes.  Schreier  H,  et al. J Mol Recognit 1995 Jan-Apr;
  8(1-2):59-62

 RIFABUTIN

   ADVERSE EFFECTS

 [Uveitis associated with rifabutin  treatment.  Apropos  of  3
  patients] Chevalley GF, et al. Klin Monatsbl Augenheilkd 1995
  May;206(5):388-90 (Eng. Abstr.)                         (Fre)

 RIMANTADINE

   THERAPEUTIC USE

 Prolonged  influenza  A  infection  responsive  to rimantadine
  therapy in a  human  immunodeficiency  virus-infected  child.
  Evans KD, et al. Pediatr Infect Dis J 1995 Apr;14(4):332-4

 RISK-TAKING

 Safe sex? Wright R. Conn Med 1995 May;59(5):295-8 (29 ref.)

 RNA

   METABOLISM

 tRNAs  as  primer of reverse transcriptases. Marquet R, et al.
  Biochimie 1995;77(1-2):113-24 (89 ref.)

 RNA, ANTISENSE

   GENETICS

 Protection of a T-cell line from human immunodeficiency  virus
  replication by the stable expression of a short antisense RNA
  sequence carried by a shuttle RNA molecule. Cagnon L, et al. J
  Acquir   Immune  Defic  Syndr  Hum  Retrovirol  1995  Aug  1;

  9(4):349-58

 RNA-BINDING PROTEINS

   CHEMISTRY

 NMR solution structure of the RNA-binding peptide  from  human
  immunodeficiency  virus  (type  1)  Rev.  Scanlon  MJ, et al.
  Biochemistry 1995 Jul 4;34(26):8242-9

 RNA, CATALYTIC

   METABOLISM

 Ribozyme-mediated RNA degradation in nuclei suspension.
  Heidenreich  O,  et  al.  Nucleic  Acids  Res  1995  Jun  25;
  23(12):2223-8
 Improved accumulation and activity of ribozymes expressed from
  a tRNA-based RNA polymerase III promoter. Thompson JD, et al.
  Nucleic Acids Res 1995 Jun 25;23(12):2259-68

 RNA, MESSENGER

   METABOLISM

 Improved accumulation and activity of ribozymes expressed from
  a tRNA-based RNA polymerase III promoter. Thompson JD, et al.
  Nucleic Acids Res 1995 Jun 25;23(12):2259-68

 RNA POLYMERASE III

   GENETICS

 Improved accumulation and activity of ribozymes expressed from
  a tRNA-based RNA polymerase III promoter. Thompson JD, et al.
  Nucleic Acids Res 1995 Jun 25;23(12):2259-68

 RNA SPLICING

 Inhibition of RNA splicing at the Rous sarcoma  virus  src  3'
  splice  site is mediated by an interaction between a negative
  cis element and a chicken embryo fibroblast  nuclear  factor.
  Amendt BA, et al. J Virol 1995 Aug;69(8):5068-76

 RNA, TRANSFER

   METABOLISM

 tRNAs  as  primer of reverse transcriptases. Marquet R, et al.
  Biochimie 1995;77(1-2):113-24 (89 ref.)

 RNA, TRANSFER, MET

   GENETICS

 Improved accumulation and activity of ribozymes expressed from
  a tRNA-based RNA polymerase III promoter. Thompson JD, et al.
  Nucleic Acids Res 1995 Jun 25;23(12):2259-68

 RNA, VIRAL

   BIOSYNTHESIS

 Foscarnet decreases human immunodeficiency virus RNA. Kaiser L,
  et al. J Infect Dis 1995 Jul;172(1):225-7

   BLOOD

 Drug resistance and heterogeneous long-term virologic responses
  of human immunodeficiency virus type 1-infected  subjects  to
  zidovudine  and  didanosine  combination  therapy.  The  AIDS
  Clinical  Trials Group 143 Virology Team. Shafer RW, et al. J
  Infect Dis 1995 Jul;172(1):70-8
 Quantitative analysis of HIV-1 RNA in plasma preparations. Zhu
  YS, et al. J Virol Methods 1995 Apr;52(3):287-99

   CHEMISTRY

 The bend in  RNA  created  by  the  trans-activation  response
  element bulge of human immunodeficiency virus is straightened
  by  arginine  and by Tat-derived peptide. Zacharias M, et al.
  Proc Natl Acad Sci U S A 1995 Jun 20;92(13):6052-6

   GENETICS

 Human immunodeficiency virus  type  1  TAR  element  revertant
  viruses  define  RNA  structures required for efficient viral
  gene expression and replication. Harrich D, et  al.  J  Virol
  1995 Aug;69(8):4906-13

   METABOLISM

 tRNAs  as  primer of reverse transcriptases. Marquet R, et al.
  Biochimie 1995;77(1-2):113-24 (89 ref.)
 Interaction of nuclear protein p140 with human immunodeficiency
  virus type 1 TAR RNA in  mitogen-activated  primary  human  T
  lymphocytes.   Rothblum   CJ,   et  al.  J  Virol  1995  Aug;
  69(8):5156-63
 Ribozyme-mediated RNA degradation in nuclei suspension.
  Heidenreich  O,  et  al.  Nucleic  Acids  Res  1995  Jun  25;
  23(12):2223-8

   PHARMACOLOGY

 Inhibition of human immunodeficiency virus expression by sense
  transcripts encoding the retroviral leader RNA. Berkhout B, et
  al. Antiviral Res 1995 Mar;26(2):101-15

 RNA VIRUSES

   DRUG EFFECTS

 Fast, complete and persistent eradication of papilloma warts as
  additional activity of an anti-infective against RNA  viruses
  (Meeting  abstract). Wirth-Bronkowska LE, et al. Experientia;
  50:A26 1994
 Polyanion inhibitors of human immunodeficiency virus and other
  viruses. 1. Polymerized anionic surfactants. Leydet A, et al.
  J Med Chem 1995 Jun 23;38(13):2433-40

 ROTAVIRUS INFECTIONS

   EPIDEMIOLOGY

 The epidemiology of rotavirus infections: a global perspective.
  Haffejee  IE.  J  Pediatr  Gastroenterol   Nutr   1995   Apr;
  20(3):275-86 (165 ref.)

 ROXITHROMYCIN

   PHARMACOLOGY

 Roxithromycin:  its  effects  on concanavalin-A induced spleen
  cell proliferation and interleukin production in mice. Adachi
  M, et al. Int Arch Allergy Immunol 1995 May-Jun;107(1-3):427

 RURAL HEALTH

   STANDARDS

 Village-based AIDS prevention in a rural district  in  Uganda.
  Schopper D, et al. Health Policy Plan 1995 Jun;10(2):171-80

 RWANDA

 Respiratory  diseases  in Rwanda [editorial] Prakash UB. Chest
  1995 Jul;108(1):5-7
 Failure of treatment for chancroid in Rwanda is not related to
  human immunodeficiency virus infection: in vitro resistance of
  Haemophilus ducreyi to trimethoprim-sulfamethoxazole. Bogaerts
  J, et al. Clin Infect Dis 1995 Apr;20(4):924-30
 Four years of natural history of HIV-1  infection  in  african
  women:   a  prospective  cohort  study  in  Kigali  (Rwanda),
  1988-1993. Leroy V, et al. J Acquir Immune  Defic  Syndr  Hum
  Retrovirol 1995 Aug 1;9(4):415-21

 SACCHAROMYCES CEREVISIAE

   DRUG EFFECTS

 Development of a yeast retrotransposon-based system useful for
  screening  of  potentially  active anti-retroviral compounds.
  Sanguinetti M, et al. Microbiologica 1995 Apr;18(2):117-25

 SAFETY

 Do safety issues of plasma products constrain self-sufficiency?
  Savidge  GF.  Blood  Coagul  Fibrinolysis  1994  Dec;5  Suppl
  4:S67-70

 SAIDS VACCINES

 Attenuated vaccines for AIDS? [letter]  Ruprecht  RM,  et  al.
  Lancet 1995 Jul 15;346(8968):177-8
 Attenuated  vaccines  for  AIDS  [letter] Victorino RM, et al.
  Lancet 1995 Jul 15;346(8968):179

 SALARIES AND FRINGE BENEFITS

 Government clarifies rules for family and medical leave.  AIDS
  Policy Law 1995 Apr 7;10(6):7-8

 SALIVA

   VIROLOGY

 FDA approves oral HIV test [news] Infect Control Hosp Epidemiol
  1995 Mar;16(3):186
 Relationship of oral disease to the presence of cytomegalovirus
  DNA in the saliva of AIDS patients. Greenberg MS, et al. Oral
  Surg  Oral  Med  Oral  Pathol  Oral  Radiol  Endod  1995 Feb;
  79(2):175-9

 SALMONELLA TYPHIMURIUM

   IMMUNOLOGY

 Humoral immune responses to recombinant tree pollen  allergens
  (Bet  v  I and Bet v II) in mice: construction of a live oral
  allergy vaccine. Vrtala S, et al. Int  Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):290-4 (15 ref.)

 SAN FRANCISCO

 A case management program for chemically dependent clients with
  multiple  needs.  Brindis C, et al. J Case Manag 1995 Spring;
  4(1):22-8

   EPIDEMIOLOGY

 Hepatitis B virus infection in high-risk inner-city
  neighborhoods in San Francisco. Siegel D, et  al.  Hepatology
  1995 Jul;22(1):44-9

 SARCOIDOSIS

   IMMUNOLOGY

 [Activation  of  immune cells in sarcoidosis: immunopathogenic
  and clinical implications] Muller-Quernheim J. Immun  Infekt
  1995 Jun;23(3):80-5 (40 ref.) (Eng. Abstr.)             (Ger)

 SARCOMA, KAPOSI'S

 Kaposi's  sarcoma:  a  reevaluation. Orfanos CE, et al. Recent
  Results Cancer Res 1995;139:275-96 (94 ref.)

   DRUG THERAPY

 Experimental treatments flourish for KS patients [news] Nelson
  NJ. J Natl Cancer Inst 1995 Jul 19;87(14):1052-4
 Treatment of Kaposi's sarcoma and other manifestations of AIDS
  with human chorionic gonadotropin [letter] Harris PJ.  Lancet
  1995 Jul 8;346(8967):118-9
 Treatment  of HIV-associated Kaposi's sarcoma with paclitaxel.
  Saville MW, et al. Lancet 1995 Jul 1;346(8966):26-8
 Treatment review. Treat Rev 1995 Mar/Apr;(no 17):8

   THERAPY

 Management of human immunodeficiency virus-associated
  malignancies. Conant MA.  Recent  Results  Cancer  Res  1995;
  139:423-32 (12 ref.)

   ULTRASONOGRAPHY

 Endoscopic   ultrasound   in  the  diagnosis  and  staging  of
  gastrointestinal Kaposi's sarcoma. Zoller WG, et al. Endoscopy
  1995 Feb;27(2):191-6

   VIROLOGY

 Controversy: is KS really caused by  new  herpesvirus?  [news]
  Cohen J. Science 1995 Jun 30;268(5219):1847-8
 Herpes cancer? Treat Rev 1995 Mar/Apr;(no 17):3

 SARCOMA VIRUSES, AVIAN

   GENETICS

 Inhibition  of  RNA  splicing at the Rous sarcoma virus src 3'
  splice site is mediated by an interaction between a  negative
  cis  element  and a chicken embryo fibroblast nuclear factor.
  Amendt BA, et al. J Virol 1995 Aug;69(8):5068-76

 SAUDI ARABIA

   EPIDEMIOLOGY

 Occupation risk of  needlestick  injuries  among  health  care
  personnel  in  Saudi  Arabia. Shanks NJ, et al. J Hosp Infect
  1995 Mar;29(3):221-6

 SCABIES

   COMPLICATIONS

 Intolerable pruritis in an HIV-infected man. Zuger A. AIDS Clin
  Care 1995 Mar;7(3):23, 26 (1 ref.)

 SCHISTOSOMIASIS

 Female genital schistosomiasis. New challenges from  a  gender
  perspective.  Feldmeier  H,  et  al. Trop Geogr Med 1995;47(2
  Suppl):S2-15 (105 ref.)

 SCHOOL HEALTH SERVICES

 Impact of a school-based AIDS prevention program on  risk  and
  protective  behavior for newly sexually active students. Levy
  SR, et al. J Sch Health 1995 Apr;65(4):145-51
 Coordination, comprehensiveness  and  access  to  reproductive
  health  services  in school-based clinics. American Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research 63rd annual meeting; 1994 May 2-5; Seattle. Klein JD,
  et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):316  (unnumbered
  abstract)

 SCOTLAND

   EPIDEMIOLOGY

 Spread of maternal HIV infection in Scotland from 1990 to 1992.
  Tappin DM, et al. Scott Med J 1995 Feb;40(1):12-4

 SEASONS

 Peripheral  blood  T lymphocytes in seasonal bronchial asthma.
  Monteseirin J, et al. Allergy 1995 Feb;50(2):152-6

 SELF DISCLOSURE

 Women's self-disclosure of HIV infection: rates, reasons,  and
  reactions. Simoni JM, et al. J Consult Clin Psychol 1995 Jun;
  63(3):474-8

 SENEGAL

   EPIDEMIOLOGY

 Social organisation and SIV sero-epidemiology of a patas monkey
  population  in  Senegal. Galat-Luong A, et al. Folia Primatol
  (Basel) 1994;63(4):226-8

 SEQUENCE DELETION

 vpr deletion mutant of simian immunodeficiency  virus  induces
  AIDS  in  rhesus  monkeys.  Hoch  J, et al. J Virol 1995 Aug;
  69(8):4807-13

 SEQUENCE HOMOLOGY, NUCLEIC ACID

 A conserved  motif  in  the  promoters  of  several  cytokines
  expressed  by  human Th2-type lymphocytes. Staynov DZ, et al.
  Int Arch Allergy Immunol 1995 May-Jun;107(1-3):217-9 (14 ref.)

 SERINE PROTEINASE INHIBITORS

   PHARMACOLOGY

 Secretory leukocyte protease inhibitor: a human saliva protein
  exhibiting anti-human immunodeficiency virus  1  activity  in
  vitro. McNeely TB, et al. J Clin Invest 1995 Jul;96(1):456-64

 SERTOLI CELLS

   IMMUNOLOGY

 Inflammatory mediators increase surface expression of integrin
  ligands, adhesion to lymphocytes, and secretion of interleukin
  6  in  mouse Sertoli cells. Riccioli A, et al. Proc Natl Acad
  Sci U S A 1995 Jun 20;92(13):5808-12

 SEVERE COMBINED IMMUNODEFICIENCY

   VETERINARY

 Reduced provirus burden and enhanced humoral immune function in
  AZT-treated SCID-feline mice inoculated with feline
  immunodeficiency  virus.  Johnson  CM,  et  al.  Vet  Immunol
  Immunopathol 1995 May;46(1-2):169-80

 SEX BEHAVIOR

 Validating population surveys for the measurement  of  HIV/STD
  prevention  indicators.  Konings  E,  et  al.  AIDS 1995 Apr;
  9(4):375-82
 Love, sex, and power. Considering  women's  realities  in  HIV
  prevention.  Amaro  H.  Am  Psychol 1995 Jun;50(6):437-47 (80
  ref.)
 Safe sex? Wright R. Conn Med 1995 May;59(5):295-8 (29 ref.)
 Parents' attitudes and beliefs about HIV/AIDS prevention  with
  condom  availability  in  New  York City public high schools.
  Guttmacher S, et al. J Sch Health 1995 Mar;65(3):101-6
 Impact of a school-based AIDS prevention program on  risk  and
  protective  behavior for newly sexually active students. Levy
  SR, et al. J Sch Health 1995 Apr;65(4):145-51
 The impact of sexual mixing patterns on the  spread  of  AIDS.
  Kault DA. Math Biosci 1995 Jul-Aug;128(1-2):211-41
 Age  at  sexual  debut  predicts  sexually transmitted disease
  knowledge among adolescent males. American Pediatric  Society
  104th  annual meeting and Society for Pediatric Research 63rd
  annual meeting; 1994 May 2-5; Seattle. Genuardi  FJ,  et  al.
  Pediatr   AIDS   HIV  Infect  1994  Oct;5(5):317  (unnumbered
  abstract)
 Communication between adolescents  and  doctors  about  sexual
  behavior and risk prevention. American Pediatric Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting;  1994  May 2-5; Seattle. Schuster MA, et al. Pediatr
  AIDS HIV Infect 1994 Oct;5(5):317 (unnumbered abstract)

   STATISTICS & NUMERICAL DATA

 Crack, crack house sex, and HIV risk. Inciardi  JA.  Arch  Sex
  Behav 1995 Jun;24(3):249-69

 SEX EDUCATION

 AIDS and the business traveller. Pratt RJ. Occup Health (Lond)
  1995 Jun;47(6):194-8

   METHODS

 We  can  protect  ourselves:  a  rhyming puppet show about HIV
  prevention. Zaccone-Tzannetakis PR. J Sch  Health  1995  Apr;
  65(4):152-4

 SEXUAL PARTNERS

 Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with
  hemophilia   and   sex  partners  of  HIV  seropositive  men.
  Multicenter Hemophilia Cohort Study. O'Brien TR, et al. Am  J
  Hematol 1995 Jul;49(3):201-6
 Estimating the sexual mixing patterns in the general population
  from those in people acquiring gonorrhoea infection:
  theoretical  foundation  and empirical findings. Renton A, et
  al. J Epidemiol Community Health 1995 Apr;49(2):205-13

 SEXUALLY TRANSMITTED DISEASES

 Age at sexual  debut  predicts  sexually  transmitted  disease
  knowledge  among adolescent males. American Pediatric Society
  104th annual meeting and Society for Pediatric Research  63rd
  annual  meeting;  1994  May 2-5; Seattle. Genuardi FJ, et al.
  Pediatr  AIDS  HIV  Infect  1994   Oct;5(5):317   (unnumbered
  abstract)

   DRUG THERAPY

 1993   Sexually  transmitted  diseases  treatment  guidelines.
  Atlanta, Georgia, 19-21 January 1993. Clin  Infect  Dis  1995
  Apr;20 Suppl 1:S1-109

   PREVENTION & CONTROL

 Validating  population  surveys for the measurement of HIV/STD
  prevention indicators. Konings  E,  et  al.  AIDS  1995  Apr;
  9(4):375-82
 Physician attitudes towards delivering STD/HIV-related
  preventive services to teens. American Pediatric Society 104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting;  1994  May 2-5; Seattle. Igra V, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):316 (unnumbered abstract)

 SHOCK, HEMORRHAGIC

   IMMUNOLOGY

 Effect of resuscitation solutions on the immune status of dogs
  in hemorrhagic shock. Brown E,  et  al.  Am  Surg  1995  Aug;
  61(8):669-72; discussion 672-3

   THERAPY

 Effect of resuscitation solutions on the immune status of dogs
  in  hemorrhagic  shock.  Brown  E,  et  al. Am Surg 1995 Aug;
  61(8):669-72; discussion 672-3

 SHOCK, SEPTIC

   COMPLICATIONS

 Transient severe myocardial ischemia during septic shock in  a
  young  woman with AIDS. Raggi P, et al. J Natl Med Assoc 1995
  Jun;87(6):441-2

 SICK ROLE

 Women's self-disclosure of HIV infection: rates, reasons,  and
  reactions. Simoni JM, et al. J Consult Clin Psychol 1995 Jun;
  63(3):474-8
 [Coping  with  HIV  infection  and  motivation  for therapy in
  multi-drug dependent patients] Grube M. Nervenarzt 1995  May;
  66(5):361-6 (Eng. Abstr.)                               (Ger)

 SIGMOID

   IMMUNOLOGY

 Immunohistochemical  changes in sigmoid colon after allogeneic
  and autologous bone marrow transplantation. Forbes GM, et al.
  J Clin Pathol 1995 Apr;48(4):308-13

 SIGNAL PROCESSING, COMPUTER-ASSISTED

   INSTRUMENTATION

 [Measuring retinal nerve fiber density with laser  polarimetry
  in patients with AIDS in comparison with health probands with
  reference to computer perimetry findings. A pilot study using
  the nerve fiber analyzer] Thierfelder S, et al. Klin Monatsbl
  Augenheilkd 1995 Mar;206(3):165-9 (Eng. Abstr.)         (Ger)

 SIGNAL TRANSDUCTION

 Lack of interferon gamma receptor beta chain and the prevention
  of  interferon  gamma  signaling  in TH1 cells [see comments]
  Pernis A, et al. Science 1995 Jul 14;269(5221):245-7

   DRUG EFFECTS

 Transforming growth factor  beta  1  costimulated  growth  and
  regulatory function of staphylococcal enterotoxin B-responsive
  CD8+  T  cells.  Rich  S,  et  al.  J  Immunol  1995  Jul 15;
  155(2):609-18

   IMMUNOLOGY

 In the absence of a CD40  signal,  B  cells  are  tolerogenic.
  Buhlmann JE, et al. Immunity 1995 Jun;2(6):645-53
 Developmental  commitment  to the Th2 lineage by extinction of
  IL-12  signaling.  Szabo  SJ,  et  al.  Immunity  1995   Jun;
  2(6):665-75
 Differential  requirement of CD28 costimulation for activation
  of murine CD8+ intestinal intraepithelial lymphocyte  subsets
  and lymph node cells. Gelfanov V, et al. J Immunol 1995 Jul 1;
  155(1):76-82

   PHYSIOLOGY

 Modulation of intracellular signal transduction pathways by the
  hepatitis  B  virus  transactivator  pX.  Natoli  G, et al. J
  Hepatol 1995;22(1 Suppl):14-20 (49 ref.)

 SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME

   DRUG THERAPY

 Zidovudine treatment prolongs survival and decreases virus load
  in the central nervous system  of  rhesus  macaques  infected
  perinatally with simian immunodeficiency virus. Rausch DM, et
  al. J Infect Dis 1995 Jul;172(1):59-69

   EPIDEMIOLOGY

 Social organisation and SIV sero-epidemiology of a patas monkey
  population  in  Senegal. Galat-Luong A, et al. Folia Primatol
  (Basel) 1994;63(4):226-8

   TRANSMISSION

 Oral infection of neonatal rhesus monkeys with cell-free simian
  immunodeficiency  virus.  American  Pediatric  Society  104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Baba TW, et al. Pediatr  AIDS
  HIV Infect 1994 Oct;5(5):323 (unnumbered abstract)

   VIROLOGY

 vpr deletion mutant of simian immunodeficiency virus induces
  AIDS  in  rhesus  monkeys.  Hoch  J, et al. J Virol 1995 Aug;
  69(8):4807-13

 SIMPLEXVIRUS

   GENETICS

 Transactivation of human T-cell leukemia virus type 1 by herpes
  simplex virus type 1. Israel S, et al. Virus Genes 1995  Feb;
  9(3):269-76

 SINGAPORE

 An  economic  analysis  of  AIDS--towards  a proposed model of
  costing: a Singapore experience. Lim JY, et al.  Asia  Pac  J
  Public Health 1994;7(3):143-50

 SINUSITIS

   COMPLICATIONS

 Sinusitis  in  HIV-infected  children. The NICHD IVIG Clinical
  Trial Study Group. American Pediatric  Society  104th  annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting;  1994  May  2-5; Seattle. Mofenson L, et al. Pediatr
  AIDS HIV Infect 1994 Oct;5(5):322 (unnumbered abstract)

   ETIOLOGY

 The management of sinusitis in patients infected with the human
  immunodeficiency virus (HIV). Tami TA. Ear Nose Throat J 1995
  May;74(5):360-3 (28 ref.)

 SIV

 Oral infection of neonatal rhesus monkeys with cell-free simian
  immunodeficiency  virus.  American  Pediatric  Society  104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Baba TW, et al. Pediatr  AIDS
  HIV Infect 1994 Oct;5(5):323 (unnumbered abstract)

   GENETICS

 vpr  deletion  mutant of simian immunodeficiency virus induces
  AIDS in rhesus monkeys. Hoch J, et  al.  J  Virol  1995  Aug;
  69(8):4807-13
 Effects of mutations in constant regions 3 and 4 of envelope of
  simian  immunodeficiency  virus. Morrison HG, et al. Virology
  1995 Jul 10;210(2):448-55

   ISOLATION & PURIFICATION

 Zidovudine treatment prolongs survival and decreases virus load
  in the central nervous system  of  rhesus  macaques  infected
  perinatally with simian immunodeficiency virus. Rausch DM, et
  al. J Infect Dis 1995 Jul;172(1):59-69

   METABOLISM

 A  conserved domain and membrane targeting of Nef from HIV and
  SIV are required for association with a cellular serine kinase
  activity.  Sawai  ET,  et  al.  J  Biol  Chem  1995  Jun  23;
  270(25):15307-14

   PATHOGENICITY

 Repair  and  evolution  of  nef  in  vivo   modulates   simian
  immunodeficiency virus virulence. Whatmore AM, et al. J Virol
  1995 Aug;69(8):5117-23

   PHYSIOLOGY

 Suppression  of  simian  immunodeficiency virus replication by
  human immunodeficiency virus type 1  trans-dominant  negative
  rev mutants. Endres CL, et al. J Virol 1995 Aug;69(8):5164-6
 Mutational  analysis of the conserved cysteine residues in the
  simian immunodeficiency virus matrix protein. Gonzalez SA, et
  al. Virology 1995 Jul 10;210(2):501-7

 SKIN

   CYTOLOGY

 Maturation and migration of cutaneous dendritic cells. Steinman
  R, et al. J Invest Dermatol 1995 Jul;105(1  Suppl):2S-7S  (89
  ref.)

   PATHOLOGY

 Skin-associated  lymphoid  tissue  in  human  immunodeficiency
  virus-1,  human  papillomavirus,  and  herpes  simplex  virus
  infections. Memar OM, et al. J Invest Dermatol 1995 Jul;105(1
  Suppl):99S-104S (56 ref.)
 Skin  necrosis indicating antiphospholipid syndrome in patient
  with AIDS. Soweid AM, et al. South Med J 1995 Jul;88(7):786-8

   VIROLOGY

 The skin as  target,  vector,  and  effector  organ  in  human
  immunodeficiency  virus  disease. Blauvelt A, et al. J Invest
  Dermatol 1995 Jul;105(1 Suppl):122S-126S (62 ref.)
 Human immunodeficiency virus and the skin: selected
  controversies. Duvic M.  J  Invest  Dermatol  1995  Jul;105(1
  Suppl):117S-121S (102 ref.)

 SKIN NEOPLASMS

 New  perspectives  in  experimental  and clinical research for
  cutaneous T cell lymphomas. Burg G,  et  al.  Recent  Results
  Cancer Res 1995;139:225-37 (48 ref.)
 Kaposi's  sarcoma:  a  reevaluation. Orfanos CE, et al. Recent
  Results Cancer Res 1995;139:275-96 (94 ref.)

   DRUG THERAPY

 Experimental treatments flourish for KS patients [news] Nelson
  NJ. J Natl Cancer Inst 1995 Jul 19;87(14):1052-4
 Treatment of Kaposi's sarcoma and other manifestations of AIDS
  with human chorionic gonadotropin [letter] Harris PJ.  Lancet
  1995 Jul 8;346(8967):118-9

   PATHOLOGY

 Histologic patterns of basal cell carcinoma based upon patient
  immunostatus.   Oram  Y,  et  al.  Dermatol  Surg  1995  Jul;
  21(7):611-4

   THERAPY

 Management of human immunodeficiency virus-associated
  malignancies. Conant MA.  Recent  Results  Cancer  Res  1995;
  139:423-32 (12 ref.)
 Perspectives  of  cytokine treatment in malignant skin tumors.
  Garbe C. Recent Results Cancer Res 1995;139:349-69 (119 ref.)

 SKIN TRANSPLANTATION

   IMMUNOLOGY

 Transplantation of skin from human immunodeficiency virus type
  1-transgenic mice to normal congenic mice  results  in  graft
  rejection.   Dumois  JA,  et  al.  J  Infect  Dis  1995  Jul;
  172(1):232-4

 SLEEP DISORDERS

   ETIOLOGY

 Lentiviral infection, immune response peptides and sleep. Darko
  DF, et al. Adv Neuroimmunol 1995;5(1):57-77 (76 ref.)

 SOCIAL BEHAVIOR

 Social organisation and SIV sero-epidemiology of a patas monkey
  population in Senegal. Galat-Luong A, et al.  Folia  Primatol
  (Basel) 1994;63(4):226-8
 The  impact  of  sexual mixing patterns on the spread of AIDS.
  Kault DA. Math Biosci 1995 Jul-Aug;128(1-2):211-41

 SOCIAL SUPPORT

 Unseen and unheard [news] Plant F. Nurs Times 1995 Jun  14-20;
  91(24):17

 SOCIAL WELFARE

   ECONOMICS

 Seeking a moral center [editorial] Kalinoski J. J Assoc Nurses
  AIDS Care 1995 Mar-Apr;6(2):9-10

 SOCIETIES, DENTAL

 President's  address to the General Dental Council [editorial]
  Seward M. Br Dent J 1995 Jun 10;178(11):395-7

 SOCIOLOGY, MEDICAL

 Technology, medicine & health, Part 6. Exploding the myths  of
  medicine.   Davidson   SN.  Healthc  Forum  J  1995  Jul-Aug;
  38(4):54-7, 59, 61-2

 SOUTH AFRICA

 Isoniazid prophylactic therapy for tuberculosis in
  HIV-seropositive patients--a least-cost analysis. Masobe P, et
  al. S Afr Med J 1995 Feb;85(2):75-81

   EPIDEMIOLOGY

 Human immunodeficiency virus seroprevalence in an occupational
  cohort in a South African community. Kravitz JD, et al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1601-4

 SPAIN

 Twice-weekly maintenance therapy with
  sulfadiazine-pyrimethamine  to  prevent recurrent toxoplasmic
  encephalitis in patients  with  AIDS.  Spanish  Toxoplasmosis
  Study Group [see comments] Podzamczer D, et al. Ann Intern Med
  1995 Aug 1;123(3):175-80
 Leishmania-human  immunodeficiency  virus  coinfection  in the
  Mediterranean basin:  isoenzymatic  characterization  of  100
  isolates  of  the Leishmania infantum complex. Pratlong F, et
  al. J Infect Dis 1995 Jul;172(1):323-6
 [Application of DRGs at a regional hospital] Suarez-Varela MM,
  et al. Rev Sanid Hig Publica (Madr) 1994 Sep-Dec;
  68(5-6):579-87 (Eng. Abstr.)                            (Spa)

   EPIDEMIOLOGY

 Sociodemographic predictors and temporal trends of
  extrapulmonary tuberculosis as an  AIDS-defining  disease  in
  Spain. Castilla J, et al. AIDS 1995 Apr;9(4):383-8
 Sequence  analysis  of  HIV-1  vif  gene  in Spanish isolates.
  Olivares I, et al. Virus Genes 1995 Feb;9(3):283-8

 SPECIALTIES, MEDICAL

   EDUCATION

 Training in  infectious  disease:  planning  for  the  future.
  Klempner MS, et al. Infect Agents Dis 1995 Jun;4(2):110-4

 SPECIMEN HANDLING

   METHODS

 FDA approves oral HIV test [news] Infect Control Hosp Epidemiol
  1995 Mar;16(3):186

 SPECTRUM ANALYSIS

   METHODS

 Measuring  interactions of MHC class I molecules using surface
  plasmon resonance. Khilko SN, et al. J Immunol  Methods  1995
  Jun 14;183(1):77-94
 Surface  plasmon  resonance  based  kinetic  studies  of  zinc
  finger-DNA  interactions.  Yang  WP, et al. J Immunol Methods
  1995 Jun 14;183(1):175-82

 SPERMATOCIDAL AGENTS

   PHARMACOLOGY

 The inhibitor of calcium activated neutral  proteinase  is  an
  anti-meiotic  agent.  The  spermicidal and anti-viral action.
  Logothetou-Rella H. Histol Histopathol 1995 Apr;10(2):271-82

 SPERMATOZOA

   PHYSIOLOGY

 The possible roles  of  sperm  and  sperm  antibodies  in  the
  pathogenesis  and  treatment of AIDS. Eldor J. Med Hypotheses
  1995 Mar;44(3):155-8

   TRANSPLANTATION

 The possible roles  of  sperm  and  sperm  antibodies  in  the
  pathogenesis  and  treatment of AIDS. Eldor J. Med Hypotheses
  1995 Mar;44(3):155-8

 SPINAL CORD DISEASES

   ETIOLOGY

 Unifying hypothesis for  the  pathogenesis  of  HIV-associated
  dementia complex, vacuolar myelopathy, and sensory neuropathy.
  Tyor  WR,  et  al. J Acquir Immune Defic Syndr Hum Retrovirol
  1995 Aug 1;9(4):379-88 (135 ref.)

 SPINAL PUNCTURE

 Lumbar puncture for evaluation of latent syphilis in
  hospitalized patients. High prevalence of cerebrospinal fluid
  abnormalities unrelated to syphilis. Carey LA,  et  al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1657-62

 SPLEEN

   METABOLISM

 Docosahexaenoic  acid-induced  alteration  of  Thy-1  and  CD8
  expression  on  murine splenocytes. Jenski LJ, et al. Biochim
  Biophys Acta 1995 May 24;1236(1):39-50

   PHYSIOPATHOLOGY

 The role of spleen in the pathogeny of aplastic anemia related
  to increased number of CD3+ CD8+ FcR+ cells. Roman S, et  al.
  Rom J Intern Med 1994 Oct-Dec;32(4):275-82

   VIROLOGY

 Infection  frequency of dendritic cells and CD4+ T lymphocytes
  in spleens of human immunodeficiency virus-positive patients.
  McIlroy D, et al. J Virol 1995 Aug;69(8):4737-45

 SPLENECTOMY

 Effect of splenectomy on  T  lymphocyte  subsets  in  patients
  infected  with the human immunodeficiency virus. Zurlo JJ, et
  al. Clin Infect Dis 1995 Apr;20(4):768-71

 SPLENOMEGALY

   ULTRASONOGRAPHY

 [Abdominal echography in patients with human  immunodeficiency
  virus (HIV) infection. Diagnostic usefulness in the evaluation
  of  associated medico-surgical pathology] Erdozain JC, et al.
  An Med Interna 1995 Mar;12(3):115-21 (Eng. Abstr.)      (Spa)

 SPONDYLITIS

   DIAGNOSIS

 Role of CT and MR imaging in  the  management  of  tuberculous
  spondylitis. Sharif HS, et al. Radiol Clin North Am 1995 Jul;
  33(4):787-804 (80 ref.)

 SPUMAVIRUS

   PHYSIOLOGY

 Activation  of  HIV  transcription  by  human  foamy  virus in
  transgenic mice. Marino  S,  et  al.  Lab  Invest  1995  Jul;
  73(1):103-10

 SPUTUM

   MICROBIOLOGY

 Use of the polymerase chain reaction technique on
  induced-sputum  samples  for  the  diagnosis  of Pneumocystis
  carinii pneumonia in HIV-infected patients.  A  clinical  and
  cost-analysis  study. Chouaid C, et al. Am J Clin Pathol 1995
  Jul;104(1):72-5
 Recovery of Pseudomonas aeruginosa  in  respiratory  specimens
  from  HIV  positive patients being evaluated for Pneumocystis
  carinii  pneumonia.  Doyle  RL,  et  al.  Thorax  1995   May;
  50(5):548-50

 STAPHYLOCOCCAL INFECTIONS

   ETIOLOGY

 Cancrum  oris in an HIV-positive patient. Barrios TJ, et al. J
  Oral Maxillofac Surg 1995 Jul;53(7):851-5

 STAPHYLOCOCCUS

   IMMUNOLOGY

 Induction of responsiveness in superantigen-induced anergic  T
  cells. Role of ligand density and costimulatory signals. Heeg
  K, et al. J Immunol 1995 Jul 1;155(1):83-92

 STAPHYLOCOCCUS AUREUS

   IMMUNOLOGY

 Staphylococcal  enterotoxin  B affects in vitro IgE synthesis,
  interferon-gamma, interleukin-4 and interleukin-5  production
  in  atopic  eczema. Neuber K, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):179-82

 STLV

   GENETICS

 [Detection  of  STLV-1  integration  in  DNA  extracted   from
  formalin-fixed and paraffin-embedded material from M.
  arctoides lymphoma by the polymerase chain reaction] Chikobava
  MG, et al. Biull Eksp Biol Med 1995 Mar;119(3):314-6    (Rus)

   ISOLATION & PURIFICATION

 [Large-cell  anaplastic  malignant  CD30/Ki-1-positive  T-type
  lymphoma,  associated  with  STLV-1  virus  (baboon malignant
  lymphoma model] Iakovleva LA, et al. Gematol Transfuziol 1995
  Jan-Feb;40(1):10-6 (Eng. Abstr.)                        (Rus)

 STOMACH

   PATHOLOGY

 Gastric wall necrosis in an HIV-positive patient. Pai D, et al.
  Indian J Gastroenterol 1995 Apr;14(2):76

   VIROLOGY

 HIV-1 in cervico-vaginal secretions of infected mothers and in
  the gastric aspirates of their  infants.  American  Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research  63rd annual meeting; 1994 May 2-5; Seattle. Nielsen
  K,  et  al.  Pediatr  AIDS  HIV  Infect   1994   Oct;5(5):322
  (unnumbered abstract)

 STOMACH DISEASES

   PATHOLOGY

 Gastric wall necrosis in an HIV-positive patient. Pai D, et al.
  Indian J Gastroenterol 1995 Apr;14(2):76

 STOMATITIS, APHTHOUS

   DRUG THERAPY

 Thalidomide-resistant HIV-associated aphthae successfully
  treated  with  granulocyte colony-stimulating factor. Manders
  SM, et al. J Am Acad Dermatol 1995 Aug;33(2 Pt 2):380-2

 STREPTOCOCCAL INFECTIONS

   COMPLICATIONS

 Group C streptococcal bacteremia in patients infected with the
  human immunodeficiency virus [letter] Chalasani P, et al. Clin
  Infect Dis 1995 Apr;20(4):1075

   EPIDEMIOLOGY

 Invasive group B streptococcal disease in children beyond early
  infancy. Hussain SM, et al. Pediatr Infect Dis  J  1995  Apr;
  14(4):278-81

 STREPTOCOCCUS AGALACTIAE

   ISOLATION & PURIFICATION

 Invasive group B streptococcal disease in children beyond early
  infancy.  Hussain  SM,  et al. Pediatr Infect Dis J 1995 Apr;
  14(4):278-81

 STREPTOCOCCUS PNEUMONIAE

   IMMUNOLOGY

 Antibody  response  to  23-valent  pneumococcal   vaccine   in
  HIV-infected children. American Pediatric Society 104th annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting; 1994 May 2-5; Seattle. Peters VB, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):323 (unnumbered abstract)

 STRESS

   GENETICS

 A   molecular  mechanism  for  stress-induced  alterations  in
  susceptibility to disease. Licinio J, et al. Lancet 1995  Jul
  8;346(8967):104-6

 STRESS, PSYCHOLOGICAL

   IMMUNOLOGY

 Psychological   stress  and  immunological  responsiveness  in
  normally cycling, follicular-stage women. Caggiula AR, et al.
  J Neuroimmunol 1995 Jun;59(1-2):103-11

   PSYCHOLOGY

 Informal caregivers of persons with AIDS. Clipp EC, et  al.  J
  Palliat Care 1995 Summer;11(2):10-8

 STUDENTS

 College  health  responds  to  HIV:  hard  lessons  and a rich
  heritage. Keeling RP. J Am Coll Health 1995 May;43(6):271-2

 SUBSTANCE ABUSE

 Crack, crack house sex, and HIV risk. Inciardi  JA.  Arch  Sex
  Behav 1995 Jun;24(3):249-69
 Dentists'  responses to drug misusers. Dawkes M, et al. Health
  Trends 1995;27(1):12-4

   NURSING

 The negative attitudes of some  general  nurses  towards  drug
  misusers. Carroll J. Nurs Stand 1995 May 17-23;9(34):36-8

   REHABILITATION

 Assessment of a multistage therapeutic community for
  drug-involved  offenders.  Martin  SS,  et al. J Psychoactive
  Drugs 1995 Jan-Mar;27(1):109-16

 SUBSTANCE ABUSE, INTRAVENOUS

 Serum neopterin level predicts HIV-related mortality  but  not
  progression to AIDS or development of neurological disease in
  gay  men  and  parenteral  drug users. Sacktor N, et al. Arch
  Neurol 1995 Jul;52(7):676-9
 Seroprevalence of human T  cell  lymphotropic  virus  type  II
  infection, with or without human immunodeficiency virus type 1
  coinfection,  among  US intravenous drug users. Briggs NC, et
  al. J Infect Dis 1995 Jul;172(1):51-8

   COMPLICATIONS

 Assessing the risks for perinatal infection. AIDS  Alert  1995
  Apr;10(4):56
 Forthcoming   study  says  3  of  4  new  HIV  infections  are
  drug-related. AIDS Policy Law 1995 Mar 24;10(5):1-2

   EPIDEMIOLOGY

 Practice of drug abuse among inmates of a drug  rehabilitation
  centre  in  Hong  Kong. Lo YC, et al. Public Health 1995 May;
  109(3):201-5

   MICROBIOLOGY

 Cluster of oral atypical Candida albicans isolates in a  group
  of  human immunodeficiency virus-positive drug users. Boerlin
  P, et al. J Clin Microbiol 1995 May;33(5):1129-35

   MORTALITY

 Mortality  among  HIV-infected  intravenous  drug  addicts  in
  Stockholm in relation to methadone treatment. Fugelstad A, et
  al. Addiction 1995 May;90(5):711-6

   PSYCHOLOGY

 Tuberculosis knowledge among  New  York  City  injection  drug
  users. Wolfe H, et al. Am J Public Health 1995 Jul;85(7):985-8
 [Coping  with  HIV  infection  and  motivation  for therapy in
  multi-drug dependent patients] Grube M. Nervenarzt 1995  May;
  66(5):361-6 (Eng. Abstr.)                               (Ger)

   REHABILITATION

 Adherence  to  zidovudine  (AZT)  among HIV-infected methadone
  patients: a pilot study of supervised therapy and  dispensing
  compared  to  usual care. Wall TL, et al. Drug Alcohol Depend
  1995 Mar;37(3):261-9

 SUBSTANCE ABUSE TREATMENT CENTERS

 Practice of drug abuse among inmates of a drug  rehabilitation
  centre  in  Hong  Kong. Lo YC, et al. Public Health 1995 May;
  109(3):201-5

 SUBSTANCE DEPENDENCE

   COMPLICATIONS

 Working on the edge: palliative care for substance users  with
  AIDS. Robb V. J Palliat Care 1995 Summer;11(2):50-3
 Methadone  treatment  and  risk of HIV infection in drug users
  without legal access to clean injection equipment. Wietlisbach
  V, et al. Soz Praventivmed 1995;40(3):183-90

   DRUG THERAPY

 Methadone treatment and risk of HIV infection  in  drug  users
  without legal access to clean injection equipment. Wietlisbach
  V, et al. Soz Praventivmed 1995;40(3):183-90

   NURSING

 The  negative  attitudes  of  some general nurses towards drug
  misusers. Carroll J. Nurs Stand 1995 May 17-23;9(34):36-8

   PSYCHOLOGY

 [Coping with HIV  infection  and  motivation  for  therapy  in
  multi-drug  dependent patients] Grube M. Nervenarzt 1995 May;
  66(5):361-6 (Eng. Abstr.)                               (Ger)

   THERAPY

 A case management program for chemically dependent clients with
  multiple needs. Brindis C, et al. J Case Manag  1995  Spring;
  4(1):22-8

 SUDDEN INFANT DEATH

 Sudden  infant  death  syndrome  (SIDS):  immunoglobulins  and
  hypoxia.  Reid GM, et al. Med Hypotheses 1995 Mar;44(3):202-6
  (46 ref.)

 SULFADIAZINE

   ADMINISTRATION & DOSAGE

 Twice-weekly maintenance therapy with
  sulfadiazine-pyrimethamine to prevent  recurrent  toxoplasmic
  encephalitis  in  patients  with  AIDS. Spanish Toxoplasmosis
  Study Group [see comments] Podzamczer D, et al. Ann Intern Med
  1995 Aug 1;123(3):175-80

   ADVERSE EFFECTS

 Reversible acute  renal  failure  due  to  sulfonamide-induced
  lithiasis in an AIDS patient. Farina LA, et al. Arch Esp Urol
  1995 May;48(4):418-9 (12 ref.)

   THERAPEUTIC USE

 Toxoplasmosis in AIDS: keeping the lid on [editorial; comment]
  Kovacs JA. Ann Intern Med 1995 Aug 1;123(3):230-1

 SULFASALAZINE

   THERAPEUTIC USE

 Sulfasalazine:  arthritis  drug  increases CD4 count? Smith D.
  AIDS Treat News 1995 Mar 3;(no 218):6-7

 SULFONAMIDES

   ADVERSE EFFECTS

 Activation  of  drug-specific  CD4+  and  CD8+  T   cells   in
  individuals allergic to sulfonamides, phenytoin, and
  carbamazepine.  Mauri-Hellweg D, et al. J Immunol 1995 Jul 1;
  155(1):462-72

 SUNLIGHT

   ADVERSE EFFECTS

 Sunlight induced progression of AIDS. Vincek V. Med Hypotheses
  1995 Feb;44(2):119-23 (27 ref.)

 SUPERANTIGENS

   IMMUNOLOGY

 The role of superantigens in the immunobiology of retroviruses.
  Huber BT, et al. Ciba Found Symp 1994;187:132-40;  discussion
  140-3 (43 ref.)
 Staphylococcal  enterotoxin  B affects in vitro IgE synthesis,
  interferon-gamma, interleukin-4 and interleukin-5  production
  in  atopic  eczema. Neuber K, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):179-82
 Induction of responsiveness in superantigen-induced anergic  T
  cells. Role of ligand density and costimulatory signals. Heeg
  K, et al. J Immunol 1995 Jul 1;155(1):83-92

 SURFACE-ACTIVE AGENTS

   PHARMACOLOGY

 Polyanion inhibitors of human immunodeficiency virus and other
  viruses. 1. Polymerized anionic surfactants. Leydet A, et al.
  J Med Chem 1995 Jun 23;38(13):2433-40

 SURGERY, LAPAROSCOPIC

 Role of laparoscopic surgery in the management of acute abdomen
  in   the   HIV-positive  patients.  Bouillot  JL,  et  al.  J
  Laparoendosc Surg 1995 Apr;5(2):101-4

 SURGERY, PLASTIC

 The human immunodeficiency virus and facial  plastic  surgery.
  Maas  CS,  et  al. Ear Nose Throat J 1995 May;74(5):364-8 (34
  ref.)

 SWEDEN

   EPIDEMIOLOGY

 Mortality  among  HIV-infected  intravenous  drug  addicts  in
  Stockholm in relation to methadone treatment. Fugelstad A, et
  al. Addiction 1995 May;90(5):711-6

 SWITZERLAND

 Methadone treatment and risk of HIV infection  in  drug  users
  without legal access to clean injection equipment. Wietlisbach
  V, et al. Soz Praventivmed 1995;40(3):183-90

 SYNOVIAL MEMBRANE

   METABOLISM

 High level of interleukin-10 production by the activated T cell
  population within the rheumatoid synovial membrane. Cohen SB,
  et al. Arthritis Rheum 1995 Jul;38(7):946-52

   PATHOLOGY

 High level of interleukin-10 production by the activated T cell
  population within the rheumatoid synovial membrane. Cohen SB,
  et al. Arthritis Rheum 1995 Jul;38(7):946-52

 SYPHILIS

 Congenital syphilis in infants of adolescent mothers. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Risser  WL,  et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):316
  (unnumbered abstract)

   COMPLICATIONS

 HIV-1, HIV-2, HTLV-I/II  and  Treponema  pallidum  infections:
  incidence,  prevalence,  and HIV-2-associated mortality in an
  occupational cohort in Guinea-Bissau. Norrgren H,  et  al.  J
  Acquir Immune Defic Syndr Hum Retrovirol 1995 Aug 1;9(4):422-8

   DRUG THERAPY

 Syphilis  and  neurosyphilis in a human immunodeficiency virus
  type-1 seropositive population: evidence for frequent
  serologic relapse after therapy. Malone JL, et al. Am  J  Med
  1995 Jul;99(1):55-63
 Treatment  of  syphilis,  1993. Rolfs RT. Clin Infect Dis 1995
  Apr;20 Suppl 1:S23-38 (180 ref.)

 SYPHILIS, CONGENITAL

 Congenital syphilis in infants of adolescent mothers. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Risser WL, et al. Pediatr AIDS HIV Infect  1994  Oct;5(5):316
  (unnumbered abstract)

 SYPHILIS, LATENT

   CEREBROSPINAL FLUID

 Lumbar puncture for evaluation of latent syphilis in
  hospitalized patients. High prevalence of cerebrospinal fluid
  abnormalities  unrelated  to  syphilis. Carey LA, et al. Arch
  Intern Med 1995 Aug 7-21;155(15):1657-62

 SYRINGES

 Isolation of HIV-1 from experimentally contaminated  multidose
  local anaesthetic vials [letter] Byrne JJ. Med J Aust 1995 Jul
  3;163(1):53, 56
 Isolation  of HIV-1 from experimentally contaminated multidose
  local anaesthetic vials [letter] Davis AR. Med J Aust 1995 Jul
  3;163(1):56

 TANZANIA

 Diagnosis and screening of HIV/AIDS using clinical criteria in
  Tanzanian adults. Miller WC, et al.  J  Acquir  Immune  Defic
  Syndr Hum Retrovirol 1995 Aug 1;9(4):408-14
 Enteric  viruses  associated  with  HIV infection in Tanzanian
  children with chronic diarrhea. Cegielski JP, et al.  Pediatr
  AIDS HIV Infect 1994 Oct;5(5):296-9

   EPIDEMIOLOGY

 Toxoplasma  gondii  antibodies  in  pregnant  women  and their
  newborns in Dar es Salaam, Tanzania. Doehring E, et al. Am  J
  Trop Med Hyg 1995 Jun;52(6):546-8
 DNA fingerprinting and phenotyping of Mycobacterium
  tuberculosis   isolates  from  human  immunodeficiency  virus
  (HIV)-seropositive and HIV-seronegative patients in Tanzania.
  Yang ZH, et al. J Clin Microbiol 1995 May;33(5):1064-9

 TASTE

   DRUG EFFECTS

 Changes in taste associated with intravenous administration of
  pentamidine  (revised)  [corrected  and  republished  article
  originally  printed  in  J  Assoc  Nurses  AIDS   Care   1995
  Jan-Feb;6(1):43-8]  Glover J, et al. J Assoc Nurses AIDS Care
  1995 Mar-Apr;6(2):41-6

 TATA BOX

   GENETICS

 Evidence for functional  interaction  between  the  HIV-1  Tat
  transactivator  and  the  TATA  box  binding protein in vivo.
  Veschambre P, et al. J Mol Biol 1995 Jul 7;250(2):169-80

 TAXES

 Viatical settlement tax reform:  Republicans  support  relief,
  Democrats  divided. James JS, et al. AIDS Treat News 1995 Mar
  3;(no 218):7-8

 TEACHING

 Jobless benefits denied to teacher who failed to seek alternate
  work. AIDS Policy Law 1995 Apr 7;10(6):9

 TERMINAL CARE

   ORGANIZATION & ADMINISTRATION

 Inpatient hospice care: a new option for the  terminally  ill.
  Martin EW. R I Med 1995 Apr;78(4):118-9

 TESTIS

   PHYSIOPATHOLOGY

 Testicular dysfunction in human immunodeficiency virus-infected
  men.  Poretsky L, et al. Metabolism 1995 Jul;44(7):946-53 (52
  ref.)

 TETRACHLORODIBENZODIOXIN

   TOXICITY

 Dioxin activates HIV-1 gene expression by an oxidative  stress
  pathway requiring a functional cytochrome P450 CYP1A1 enzyme.
  Yao Y, et al. Environ Health Perspect 1995 Apr;103(4):366-71

 TEXAS

 Texas hair salon settles suit while another faces EEOC action.
  Equal Employment Opportunity Commission. AIDS Policy Law 1995
  Mar 24;10(5):2
 Assessing the information needs of non-institutionally
  affiliated  AIDS service organizations in Texas. Huber JT, et
  al. Bull Med Libr Assoc 1995 Apr;83(2):240-3

 TH1 CELLS

   DRUG EFFECTS

 Pharmacologic modulation  of  Th1  and  Th2  cell  subsets  by
  nedocromil sodium. Farrar JR, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):414-5 (13 ref.)

   IMMUNOLOGY

 The  molecular mechanism of FasL-mediated cytotoxicity by CD4+
  Th1 clones. el-Khatib  M,  et  al.  Cell  Immunol  1995  Jul;
  163(2):237-44
 Th1  and  Th2  cells in autoimmunity. Druet P, et al. Clin Exp
  Immunol 1995 Jul;101 Suppl 1:9-12 (35 ref.)
 A unique  tumor  antigen  produced  by  a  single  amino  acid
  substitution. Monach PA, et al. Immunity 1995 Jan;2(1):45-59
 Peptide-mediated  immunoregulation.  Hetzel C, et al. Int Arch
  Allergy Immunol 1995 May-Jun;107(1-3):275-7 (32 ref.)
 Vaccination with recombinant vaccinia viruses expressing ICP27
  induces protective  immunity  against  herpes  simplex  virus
  through  CD4+  Th1+  T cells. Manickan E, et al. J Virol 1995
  Aug;69(8):4711-6
 How the TH2 response is marshaled  [news;  comment]  Cohen  J.
  Science 1995 Jul 14;269(5221):161
 Lack of interferon gamma receptor beta chain and the prevention
  of  interferon  gamma  signaling  in TH1 cells [see comments]
  Pernis A, et al. Science 1995 Jul 14;269(5221):245-7

   METABOLISM

 Inhibition of Th1 responses prevents inflammatory bowel disease
  in scid mice reconstituted with CD45RBhi CD4+ T cells. Powrie
  F, et al. Immunity 1994 Oct;1(7):553-62
 Generation and in vivo persistence of polarized  Th1  and  Th2
  memory cells. Swain SL. Immunity 1994 Oct;1(7):543-52

   PHYSIOLOGY

 Th1 and Th2 T-helper cells exert opposite regulatory effects on
  procoagulant  activity  and tissue factor production by human
  monocytes. Del Prete G, et al. Blood 1995 Jul 1;86(1):250-7
 The molecular mechanism of FasL-mediated cytotoxicity by  CD4+
  Th1  clones.  el-Khatib  M,  et  al.  Cell  Immunol 1995 Jul;
  163(2):237-44
 Murine  Th1  and  Th2  cell  clones  differentially   regulate
  macrophage  nitric oxide production. Taub DD, et al. J Leukoc
  Biol 1995 Jul;58(1):80-9

 TH2 CELLS

   DRUG EFFECTS

 Roxithromycin: its effects on  concanavalin-A  induced  spleen
  cell proliferation and interleukin production in mice. Adachi
  M, et al. Int Arch Allergy Immunol 1995 May-Jun;107(1-3):427
 Pharmacologic  modulation  of  Th1  and  Th2  cell  subsets by
  nedocromil sodium. Farrar JR, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):414-5 (13 ref.)

   IMMUNOLOGY

 Interleukin-4 is required for the induction of lung Th2 mucosal
  immunity. Coyle AJ, et al. Am J Respir Cell Mol Biol 1995 Jul;
  13(1):54-9
 Th1 and Th2 cells in autoimmunity. Druet P, et  al.  Clin  Exp
  Immunol 1995 Jul;101 Suppl 1:9-12 (35 ref.)
 Developmental  commitment  to the Th2 lineage by extinction of
  IL-12  signaling.  Szabo  SJ,  et  al.  Immunity  1995   Jun;
  2(6):665-75
 Functional significance of CD23- on CD23-transfected Th2 clone.
  Nambu M, et al. Immunol Lett 1995 Jan;44(2-3):163-7
 Peptide-mediated  immunoregulation.  Hetzel C, et al. Int Arch
  Allergy Immunol 1995 May-Jun;107(1-3):275-7 (32 ref.)
 Importance of interleukin-4 and interleukin-12 in
  allergen-induced airway changes in mice. Kips JC, et al.  Int
  Arch Allergy Immunol 1995 May-Jun;107(1-3):115-8
 Staphylococcal  enterotoxin  B affects in vitro IgE synthesis,
  interferon-gamma, interleukin-4 and interleukin-5  production
  in  atopic  eczema. Neuber K, et al. Int Arch Allergy Immunol
  1995 May-Jun;107(1-3):179-82
 Endogenous IL-12 is  required  for  control  of  Th2  cytokine
  responses  capable  of exacerbating leishmaniasis in normally
  resistant mice. Heinzel FP, et al. J  Immunol  1995  Jul  15;
  155(2):730-9
 How  the  TH2  response  is marshaled [news; comment] Cohen J.
  Science 1995 Jul 14;269(5221):161
 Lack of interferon gamma receptor beta chain and the prevention
  of interferon gamma signaling in  TH1  cells  [see  comments]
  Pernis A, et al. Science 1995 Jul 14;269(5221):245-7

   METABOLISM

 Generation  and  in  vivo persistence of polarized Th1 and Th2
  memory cells. Swain SL. Immunity 1994 Oct;1(7):543-52
 A conserved  motif  in  the  promoters  of  several  cytokines
  expressed  by  human Th2-type lymphocytes. Staynov DZ, et al.
  Int Arch Allergy Immunol 1995 May-Jun;107(1-3):217-9 (14 ref.)

   PHYSIOLOGY

 Th1 and Th2 T-helper cells exert opposite regulatory effects on
  procoagulant activity and tissue factor production  by  human
  monocytes. Del Prete G, et al. Blood 1995 Jul 1;86(1):250-7
 Murine   Th1  and  Th2  cell  clones  differentially  regulate
  macrophage nitric oxide production. Taub DD, et al. J  Leukoc
  Biol 1995 Jul;58(1):80-9

 THAILAND

   EPIDEMIOLOGY

 Histopathologic spectrum of AIDS-associated lesions in Maharaj
  Nakorn  Chiang  Mai  Hospital.  Bhoopat L, et al. Asian Pac J
  Allergy Immunol 1994 Dec;12(2):95-104
 Phenotypic and genotypic characteristics of human
  immunodeficiency virus type 1  from  patients  with  AIDS  in
  northern   Thailand.   Yu  XF,  et  al.  J  Virol  1995  Aug;
  69(8):4649-55

 THALIDOMIDE

   THERAPEUTIC USE

 Thalidomide-resistant HIV-associated aphthae successfully
  treated with granulocyte colony-stimulating  factor.  Manders
  SM, et al. J Am Acad Dermatol 1995 Aug;33(2 Pt 2):380-2
 Treatment review. Treat Rev 1995 Mar/Apr;(no 17):8

 THERAPEUTIC COMMUNITY

 Assessment of a multistage therapeutic community for
  drug-involved  offenders.  Martin  SS,  et al. J Psychoactive
  Drugs 1995 Jan-Mar;27(1):109-16

 THIAZOLES

   CHEMICAL SYNTHESIS

 Synthesis and biological investigations of some new
  thiazolylbenzimidazoles and
  benzimidazolylthiazolo[3,2-a]pyridines. Rida SM, et al.  Arch
  Pharm (Weinheim) 1995 Apr;328(4):325-8

 THIOCYANATES

   PHARMACOLOGY

 Inhibition   of  herpes  simplex  virus  type  1,  respiratory
  syncytial virus and echovirus type 11 by peroxidase-generated
  hypothiocyanite. Mikola H, et al.  Antiviral  Res  1995  Mar;
  26(2):161-71

 THIONUCLEOTIDES

   PHARMACOLOGY

 Phosphorothioate  oligonucleotides block reverse transcription
  by the Rnase H activity associated with the HIV-1 polymerase.
  Hatta T, et al. Biochem  Biophys  Res  Commun  1995  Jun  26;
  211(3):1041-6

 THORACIC SURGERY

 Viral  pulmonary  infections  in  thoracic  and cardiovascular
  surgery. Avery RK, et al. Semin Thorac Cardiovasc  Surg  1995
  Apr;7(2):88-94 (83 ref.)

 THROMBOCYTOPENIA

   ETIOLOGY

 Human  immunodeficiency virus-related immune thrombocytopenia.
  Bierling P, et al. Semin Thromb Hemost  1995;21(1):68-75  (41
  ref.)

 THROMBOPLASTIN

   BIOSYNTHESIS

 Th1 and Th2 T-helper cells exert opposite regulatory effects on
  procoagulant  activity  and tissue factor production by human
  monocytes. Del Prete G, et al. Blood 1995 Jul 1;86(1):250-7

 THYMINE

   ANALOGS & DERIVATIVES

 Mechanism of inhibition of HIV-1 reverse transcriptase by
  non-nucleoside inhibitors. Esnouf R, et al. Nat  Struct  Biol
  1995 Apr;2(4):303-8

 THYMINE NUCLEOTIDES

   PHARMACOLOGY

 Drug synergism by nucleoside analog drugs against HIV-RT based
  on  multiple  inhibitor kinetics (Meeting abstract). Periclou
  AP, et al. Proc Annu Meet Am Assoc Cancer Res; 36:A1720 1995

 THYMUS GLAND

   CYTOLOGY

 Human neonatal thymic organ  culture:  an  ex  vivo  model  of
  thymocyte  ontogeny and HIV-1 infection. Rosenzweig M, et al.
  Pathobiology 1994;62(5-6):245-51

   DRUG EFFECTS

 Interference with thymocyte differentiation by an inhibitor of
  S-adenosylhomocysteine hydrolase.  Benveniste  P,  et  al.  J
  Immunol 1995 Jul 15;155(2):536-44

   GROWTH & DEVELOPMENT

 CD40  ligand  expression is developmentally regulated in human
  thymocytes. Fuleihan R, et al. Clin Immunol Immunopathol 1995
  Jul;76(1 Pt 1):52-8

   IMMUNOLOGY

 A novel cell surface antigen, immature thymocyte antigen-1, is
  involved in the differentiation of murine thymocytes. Kishi H,
  et al. J Immunol 1995 Jul 15;155(2):568-77

   VIROLOGY

 HIV-1-induced thymocyte depletion is associated with  indirect
  cytopathogenicity  and infection of progenitor cells in vivo.
  Su L, et al. Immunity 1995 Jan;2(1):25-36

 THYROGLOBULIN

   IMMUNOLOGY

 Depletion of CD4+ and CD8+ cells eliminates immunologic memory
  of  thyroiditogenicity  in  murine  experimental   autoimmune
  thyroiditis. Fuller BE, et al. Autoimmunity 1994;19(3):161-8

 THYROIDITIS, AUTOIMMUNE

   THERAPY

 Depletion of CD4+ and CD8+ cells eliminates immunologic memory
  of   thyroiditogenicity  in  murine  experimental  autoimmune
  thyroiditis. Fuller BE, et al. Autoimmunity 1994;19(3):161-8

 THYROTROPIN

   PHARMACOLOGY

 Growth-promoting actions of parathyroid hormone,
  adrenocorticotrophic hormone, and thyroid-stimulating hormone:
  in vitro studies in normal and pygmy T-lymphoblast cell lines.
  Geffner ME, et al. Pediatr Res 1995 Apr;37(4 Pt 1):507-11

 TISSUE TRANSPLANTATION

 [Analysis  of  the  possibility  of  transmitting  the   human
  immunodeficiency  virus when using cartilage grafts] Bujia J,
  et al. Acta  Otorrinolaringol  Esp  1995  Mar-Apr;46(2):75-81
  (Eng. Abstr.)                                           (Spa)

 TOMOGRAPHY, EMISSION-COMPUTED

 Clinical  brain  radionuclide imaging studies. Messa C, et al.
  Semin Nucl Med 1995 Apr;25(2):111-43 (250 ref.)

 TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON

 Clinical brain radionuclide imaging studies. Messa C,  et  al.
  Semin Nucl Med 1995 Apr;25(2):111-43 (250 ref.)

 TOMOGRAPHY, X-RAY COMPUTED

 Role  of  CT  and  MR imaging in the management of tuberculous
  spondylitis. Sharif HS, et al. Radiol Clin North Am 1995 Jul;
  33(4):787-804 (80 ref.)
 MR imaging and CT of central nervous system tuberculosis in the
  patient with AIDS. Villoria MF, et al. Radiol Clin  North  Am
  1995 Jul;33(4):805-20 (93 ref.)

 TONGUE DISEASES

   ETIOLOGY

 Oral hairy leukoplakia in a child with AIDS. Laskaris G, et al.
  Oral  Surg  Oral  Med Oral Pathol Oral Radiol Endod 1995 May;
  79(5):570-1 (8 ref.)

 TONGUE NEOPLASMS

   DRUG THERAPY

 Treatment of HIV-related hairy  leukoplakia  with  podophyllum
  resin  25% solution. Gowdey G, et al. Oral Surg Oral Med Oral
  Pathol Oral Radiol Endod 1995 Jan;79(1):64-7

 TONSILLECTOMY

   ADVERSE EFFECTS

 Bleeding  after  tonsillectomy  in  severe  von   Willebrand's
  disease.   Alusi  GH,  et  al.  J  Laryngol  Otol  1995  May;
  109(5):437-9

 TOXOPLASMA

   IMMUNOLOGY

 Toxoplasma gondii  antibodies  in  pregnant  women  and  their
  newborns  in Dar es Salaam, Tanzania. Doehring E, et al. Am J
  Trop Med Hyg 1995 Jun;52(6):546-8

 TOXOPLASMOSIS

   DIAGNOSIS

 [34-year-old male with HIV infection hospitalized for fever and
  respiratory failure (clinical conference)] Miro Meda JM,  et
  al. Rev Clin Esp 1995 May;195(5):340-50                 (Spa)

   EPIDEMIOLOGY

 Toxoplasma  gondii  antibodies  in  pregnant  women  and their
  newborns in Dar es Salaam, Tanzania. Doehring E, et al. Am  J
  Trop Med Hyg 1995 Jun;52(6):546-8

 TOXOPLASMOSIS, CEREBRAL

   DRUG THERAPY

 Toxoplasmosis in AIDS: keeping the lid on [editorial; comment]
  Kovacs JA. Ann Intern Med 1995 Aug 1;123(3):230-1

   PREVENTION & CONTROL

 Twice-weekly maintenance therapy with
  sulfadiazine-pyrimethamine  to  prevent recurrent toxoplasmic
  encephalitis in patients  with  AIDS.  Spanish  Toxoplasmosis
  Study Group [see comments] Podzamczer D, et al. Ann Intern Med
  1995 Aug 1;123(3):175-80
 Breakthrough  cerebral toxoplasmosis in patients with AIDS who
  are being treated with clarithromycin [letter] Raffi F, et al.
  Clin Infect Dis 1995 Apr;20(4):1076-7

 TOXOPLASMOSIS, OCULAR

   DRUG THERAPY

 [Treatment of toxoplasmosis retinochoroiditis with  atovaquone
  in  an  AIDS  patient]  Schimkat  M,  et  al.  Klin  Monatsbl
  Augenheilkd 1995 Mar;206(3):173-7 (Eng. Abstr.)         (Ger)

 TRACHEITIS

   PATHOLOGY

 [Herpes  simplex  virus  type  II  infection  as  an exophytic
  endobronchial tumor] Armbruster C, et al. Wien Klin Wochenschr
  1995;107(11):344-6 (Eng. Abstr.)                        (Ger)

 TRANS-ACTIVATION (GENETICS)

 Modulation of intracellular signal transduction pathways by the
  hepatitis B virus transactivator  pX.  Natoli  G,  et  al.  J
  Hepatol 1995;22(1 Suppl):14-20 (49 ref.)
 Transactivation  of the human T-cell lymphotropic virus type 1
  Tax1-responsive 21-base-pair repeats requires Holo-TFIID  and
  TFIIA. Duvall JF, et al. J Virol 1995 Aug;69(8):5077-86
 Activation  of  HIV  transcription  by  human  foamy  virus in
  transgenic mice. Marino  S,  et  al.  Lab  Invest  1995  Jul;
  73(1):103-10
 The  bend  in  RNA  created  by  the trans-activation response
  element bulge of human immunodeficiency virus is straightened
  by arginine and by Tat-derived peptide. Zacharias M,  et  al.
  Proc Natl Acad Sci U S A 1995 Jun 20;92(13):6052-6
 Transactivation of human T-cell leukemia virus type 1 by herpes
  simplex  virus type 1. Israel S, et al. Virus Genes 1995 Feb;
  9(3):269-76

   GENETICS

 Evidence for functional  interaction  between  the  HIV-1  Tat
  transactivator  and  the  TATA  box  binding protein in vivo.
  Veschambre P, et al. J Mol Biol 1995 Jul 7;250(2):169-80
 Modulation of HIV-LTR activity by ras oncogenes. Lembo  D,  et
  al. Microbiologica 1995 Apr;18(2):111-6

 TRANS-ACTIVATORS

   METABOLISM

 Identification of transcriptional activation domain of TREB5, a
  CREB/ATF  family  protein  that  binds  to  HTLV-1  enhancer.
  Matsuzaki Y, et al. J Biochem (Tokyo) 1995 Feb;117(2):303-8
 Constitutively activated Jak-STAT pathway in T cells
  transformed with HTLV-I. Migone TS, et al. Science 1995 Jul 7;
  269(5220):79-81

 TRANSCRIPTION FACTORS

   METABOLISM

 Molecular  cloning  of  a  new  interferon-induced factor that
  represses human immunodeficiency virus type 1  long  terminal
  repeat  expression. Tissot C, et al. J Biol Chem 1995 Jun 23;
  270(25):14891-8
 Evidence for functional  interaction  between  the  HIV-1  Tat
  transactivator  and  the  TATA  box  binding protein in vivo.
  Veschambre P, et al. J Mol Biol 1995 Jul 7;250(2):169-80
 Transactivation of the human T-cell lymphotropic virus type  1
  Tax1-responsive  21-base-pair repeats requires Holo-TFIID and
  TFIIA. Duvall JF, et al. J Virol 1995 Aug;69(8):5077-86

 TRANSCRIPTION, GENETIC

 Human herpesvirus 6A ts suppresses both transformation by H-ras
  and transcription by the  H-ras  and  human  immunodeficiency
  virus  type  1 promoters. Araujo JC, et al. J Virol 1995 Aug;
  69(8):4933-40

   DRUG EFFECTS

 Phosphorothioate oligonucleotides block reverse  transcription
  by the Rnase H activity associated with the HIV-1 polymerase.
  Hatta  T,  et  al.  Biochem  Biophys  Res Commun 1995 Jun 26;
  211(3):1041-6

 TRANSFORMING GROWTH FACTOR BETA

   BIOSYNTHESIS

 Increased central nervous system production  of  extracellular
  matrix   components   and  development  of  hydrocephalus  in
  transgenic mice overexpressing transforming growth factor-beta
  1. Wyss-Coray T, et al. Am J Pathol 1995 Jul;147(1):53-67

   PHARMACOLOGY

 Transforming growth factor  beta  1  costimulated  growth  and
  regulatory function of staphylococcal enterotoxin B-responsive
  CD8+  T  cells.  Rich  S,  et  al.  J  Immunol  1995  Jul 15;
  155(2):609-18

 TRANSIENTS AND MIGRANTS

   STATISTICS & NUMERICAL DATA

 Human immunodeficiency virus seroprevalence in an occupational
  cohort in a South African community. Kravitz JD, et al.  Arch
  Intern Med 1995 Aug 7-21;155(15):1601-4

 TRANSLOCATION (GENETICS)

 Persistence of immunoglobulin heavy chain/c-myc
  recombination-positive lymphocyte clones in the blood of human
  immunodeficiency virus-infected homosexual men. Muller JR, et
  al. Proc Natl Acad Sci U S A 1995 Jul 3;92(14):6577-81

 TRANSPLANTATION, HETEROLOGOUS

 Xenotransplantation workshop ponders science, safety of animal
  tissue   grafts  [news]  Stephenson  J.  JAMA  1995  Jul  26;
  274(4):285, 287-8
 Baboon/man transplant backed for HIV victim [news] Lehrman  S.
  Nature 1995 Jul 20;376(6537):204
 FDA  panel  OKs  baboon  marrow  transplant  [news] Pennisi E.
  Science 1995 Jul 21;269(5222):293-4

   ADVERSE EFFECTS

 Trans-species transplants raise virus fears [news] Lehrman  S.
  Nature 1995 Jul 6;376(6535):8

 TRAVEL

 AIDS and the business traveller. Pratt RJ. Occup Health (Lond)
  1995 Jun;47(6):194-8
 Fever as the presenting complaint of travellers returning from
  the tropics. Doherty JF, et al. QJM 1995 Apr;88(4):277-81

 TREATMENT REFUSAL

 HIV and tuberculosis: noncompliance revisited. Anastasio CJ. J
  Assoc Nurses AIDS Care 1995 Mar-Apr;6(2):11-23

   PSYCHOLOGY

 Adherence  to  zidovudine  (AZT)  among HIV-infected methadone
  patients: a pilot study of supervised therapy and  dispensing
  compared  to  usual care. Wall TL, et al. Drug Alcohol Depend
  1995 Mar;37(3):261-9

 TREPONEMA PALLIDUM

 HIV-1, HIV-2, HTLV-I/II  and  Treponema  pallidum  infections:
  incidence,  prevalence,  and HIV-2-associated mortality in an
  occupational cohort in Guinea-Bissau. Norrgren H,  et  al.  J
  Acquir Immune Defic Syndr Hum Retrovirol 1995 Aug 1;9(4):422-8

 TRETINOIN

   ADMINISTRATION & DOSAGE

 Vitamin A deficiency results in a priming environment conducive
  for  Th1  cell development. Cantorna MT, et al. Eur J Immunol
  1995 Jun;25(6):1673-9

 TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION

   ADVERSE EFFECTS

 Trimethoprim-sulphamethoxazole rechallenge  in  20  previously
  allergic  HIV-infected  patients  after  homeopathic [letter]
  Bissuel F, et al. AIDS 1995 Apr;9(4):407-8

   THERAPEUTIC USE

 Failure of treatment for chancroid in Rwanda is not related to
  human immunodeficiency virus infection: in vitro resistance of
  Haemophilus ducreyi to trimethoprim-sulfamethoxazole. Bogaerts
  J, et al. Clin Infect Dis 1995 Apr;20(4):924-30
 Rapid oral  desensitization  to  trimethoprim-sulfamethoxazole
  (TMP-SMZ):   use  in  prophylaxis  for  Pneumocystis  carinii
  pneumonia in patients with AIDS who were previously intolerant
  to TMP-SMZ. Gluckstein D, et al. Clin Infect  Dis  1995  Apr;
  20(4):849-53

 TRINIDAD AND TOBAGO

   EPIDEMIOLOGY

 HIV-1  prevalence  and risk factors among sexually transmitted
  disease clinic attenders in Trinidad. Cleghorn FR, et al. AIDS
  1995 Apr;9(4):389-94

 TROPICAL CLIMATE

 Fever as the presenting complaint of travellers returning from
  the tropics. Doherty JF, et al. QJM 1995 Apr;88(4):277-81

 TROPISM

   PHYSIOLOGY

 A determinant of feline  immunodeficiency  virus  involved  in
  Crandell feline kidney cell tropism. Siebelink KH, et al. Vet
  Immunol Immunopathol 1995 May;46(1-2):61-9

 TRUTH DISCLOSURE

 The  prevalence  of  patient  disclosure  of  HIV infection to
  doctors [letter] Marks G, et al. Am J Public Health 1995 Jul;
  85(7):1018-9

 TUBERCULIN

   IMMUNOLOGY

 Selection of skin test antigens to evaluate PPD anergy. Wright
  PW, et al. J Fam Pract 1995 Jul;41(1):59-64

 TUBERCULIN TEST

 Selection of skin test antigens to evaluate PPD anergy. Wright
  PW, et al. J Fam Pract 1995 Jul;41(1):59-64
 Risk factors  for  tuberculosis  in  HIV-infected  persons.  A
  prospective  cohort  study.  The  Gruppo  Italiano  di Studio
  Tubercolosi e AIDS (GISTA). Antonucci G, et al. JAMA 1995 Jul
  12;274(2):143-8

   UTILIZATION

 Some HIV clinics changing protocols on anergy. AIDS Alert 1995
  Apr;10(4):suppl 1-2 (2 ref.)
 Anergy tests draw strong reaction from experts. AIDS Alert 1995
  Apr;10(4):47-9 (2 ref.)

 TUBERCULOSIS

 Childhood tuberculosis and infection with the human
  immunodeficiency virus [see comments] Chintu C, et  al.  J  R
  Coll Physicians Lond 1995 Mar-Apr;29(2):92-5 (38 ref.)
 Disseminated  Mycobacterium  bovis  (BCG)  in a child with HIV
  infection. American Pediatric Society 104th annual meeting and
  Society for Pediatric Research 63rd annual meeting; 1994  May
  2-5; Seattle. Ellaurie M, et al. Pediatr AIDS HIV Infect 1994
  Oct;5(5):321 (unnumbered abstract)

   BLOOD

 Testing for HIV infection among individuals with tuberculosis:
  a Joint Statement of the WHO Global Tuberculosis Programme and
  the  Global  Programme on AIDS [news] Bull World Health Organ
  1995;73(3):400, 406-7                              (Eng, Fre)

   COMPLICATIONS

 Sociodemographic predictors and temporal trends of
  extrapulmonary tuberculosis as an  AIDS-defining  disease  in
  Spain. Castilla J, et al. AIDS 1995 Apr;9(4):383-8
 Abdominal  tuberculosis  in  patients  infected with the human
  immunodeficiency virus. Fee MJ, et al. Clin Infect  Dis  1995
  Apr;20(4):938-44
 Tuberculous  pancreatic  abscess  as  an initial AIDS-defining
  disorder in a patient infected with the human immunodeficiency
  virus: case report and review. Jaber B, et al. Clin Infect Dis
  1995 Apr;20(4):890-4 (15 ref.)
 DNA fingerprinting and phenotyping of Mycobacterium
  tuberculosis  isolates  from  human  immunodeficiency   virus
  (HIV)-seropositive and HIV-seronegative patients in Tanzania.
  Yang ZH, et al. J Clin Microbiol 1995 May;33(5):1064-9
 Need for action against tuberculosis [news] World Health Forum
  1995;16(2):218-9

   DIAGNOSIS

 Anergy tests draw strong reaction from experts. AIDS Alert 1995
  Apr;10(4):47-9 (2 ref.)
 Some HIV clinics changing protocols on anergy. AIDS Alert 1995
  Apr;10(4):suppl 1-2 (2 ref.)
 A clinical view of tuberculosis. Hopewell PC. Radiol Clin North
  Am 1995 Jul;33(4):641-53 (68 ref.)
 MR imaging and CT of central nervous system tuberculosis in the
  patient  with  AIDS. Villoria MF, et al. Radiol Clin North Am
  1995 Jul;33(4):805-20 (93 ref.)

   EPIDEMIOLOGY

 Sociodemographic predictors and temporal trends of
  extrapulmonary tuberculosis as an  AIDS-defining  disease  in
  Spain. Castilla J, et al. AIDS 1995 Apr;9(4):383-8
 Tuberculosis  rising  in areas with high HIV rates. AIDS Alert
  1995 Apr;10(4):58-9
 Risk factors  for  tuberculosis  in  HIV-infected  persons.  A
  prospective  cohort  study.  The  Gruppo  Italiano  di Studio
  Tubercolosi e AIDS (GISTA). Antonucci G, et al. JAMA 1995 Jul
  12;274(2):143-8
 Tuberculosis (TBC) in HIV-exposed or infected  U.S.  children.
  American  Pediatric  Society 104th annual meeting and Society
  for Pediatric Research 63rd annual  meeting;  1994  May  2-5;
  Seattle.  Gutman  L, et al. Pediatr AIDS HIV Infect 1994 Oct;
  5(5):323 (unnumbered abstract)
 [Problems of HIV infection and tuberculosis (TB)  in  Asia--an
  epidemetric  model analysis of the impact of HIV infection on
  TB control] Mori T. Nippon Kyobu Shikkan Gakkai  Zasshi  1994
  Dec;32 Suppl:216-22 (Eng. Abstr.)                       (Jpn)

   HISTORY

 Tuberculosis.  Captain  of  all  these men of death. Rubin SA.
  Radiol Clin North Am 1995 Jul;33(4):619-39 (22 ref.)

   IMMUNOLOGY

 Tuberculosis, HIV, hormones and children [editorial;  comment]
  Wilkinson  RJ,  et al. J R Coll Physicians Lond 1995 Mar-Apr;
  29(2):86-8

   MICROBIOLOGY

 A case of disseminated Mycobacterium bovis infection in an AIDS
  patient. Albrecht H, et al. Eur J Clin Microbiol  Infect  Dis
  1995 Mar;14(3):226-9

   NURSING

 HIV and tuberculosis: noncompliance revisited. Anastasio CJ. J
  Assoc Nurses AIDS Care 1995 Mar-Apr;6(2):11-23

   PREVENTION & CONTROL

 Tuberculosis  knowledge  among  New  York  City injection drug
  users. Wolfe H, et al. Am J Public Health 1995 Jul;85(7):985-8
 Chemoprophylaxis in tuberculosis and HIV infection [editorial]
  Walley J, et al. BMJ 1995 Jun 24;310(6995):1621-2
 Bacterial  vaccine  vectors  and  bacillus   Calmette-Guerin.
  Cirillo  JD, et al. Clin Infect Dis 1995 Apr;20(4):1001-9 (75
  ref.)
 Protection against  hospital-acquired  tuberculosis,  American
  style:  a report on the 4th Annual Meeting of the Society for
  Hospital Epidemiology of America (SHEA), New  Orleans,  1994.
  Wilcox MH. J Hosp Infect 1995 Mar;29(3):165-8
 Proposals  for  the  feasible  management  of  tuberculosis in
  HIV-seropositive South Africans [editorial] Lee T, et  al.  S
  Afr Med J 1995 Feb;85(2):68-71
 Isoniazid prophylactic therapy for tuberculosis in
  HIV-seropositive patients--a least-cost analysis. Masobe P, et
  al. S Afr Med J 1995 Feb;85(2):75-81

   TRANSMISSION

 Tuberculosis  and  migration.  The  Mitchell Lecture 1994 [see
  comments] Davies PD. J R Coll Physicians Lond  1995  Mar-Apr;
  29(2):113-8 (38 ref.)

 TUBERCULOSIS, LYMPH NODE

 Isolated   peripheral  tuberculous  lymphadenitis  in  adults:
  current clinical and diagnostic issues. Artenstein AW, et al.
  Clin Infect Dis 1995 Apr;20(4):876-82 (46 ref.)

 TUBERCULOSIS, MENINGEAL

   DIAGNOSIS

 The diagnosis of tuberculous meningitis. Monteyne  P,  et  al.
  Acta Neurol Belg 1995;95(2):80-7 (33 ref.)

 TUBERCULOSIS, MULTIDRUG-RESISTANT

   DRUG THERAPY

 The changing face of tuberculosis. Huebner RE, et al. Annu Rev
  Med 1995;46:47-55 (24 ref.)

   PREVENTION & CONTROL

 Evaluation  of  infection  control  measures in preventing the
  nosocomial transmission of multidrug-resistant  Mycobacterium
  tuberculosis  in  a New York City hospital. Stroud LA, et al.
  Infect Control Hosp Epidemiol 1995 Mar;16(3):141-7

   TRANSMISSION

 Transmission of multidrug-resistant tuberculosis  in  a  large
  urban  setting. Friedman CR, et al. Am J Respir Crit Care Med
  1995 Jul;152(1):355-9

 TUBERCULOSIS, OSTEOARTICULAR

   COMPLICATIONS

 Tuberculosis of the  foot  as  the  initial  manifestation  of
  acquired  immune  deficiency syndrome: a report of two cases.
  Lonner JH, et al. Foot Ankle Int 1995 Mar;16(3):167-71

 TUBERCULOSIS, PULMONARY

 Dentistry and tuberculosis in the 1900s. Riben PD, et al. J Can
  Dent Assoc 1995 Jun;61(6):492, 495-8 (40 ref.)

   DIAGNOSIS

 Selection of skin test antigens to evaluate PPD anergy. Wright
  PW, et al. J Fam Pract 1995 Jul;41(1):59-64
 Bronchoalveolar lavage in pulmonary tuberculosis:  a  decision
  analysis approach. Mohan A, et al. QJM 1995 Apr;88(4):269-76
 Tuberculosis  and  AIDS. Goodman PC. Radiol Clin North Am 1995
  Jul;33(4):707-17 (76 ref.)

   DRUG THERAPY

 The changing face of tuberculosis. Huebner RE, et al. Annu Rev
  Med 1995;46:47-55 (24 ref.)

   EPIDEMIOLOGY

 [Could tuberculosis again be an endemic  disease  in  Hungary?
  (Model study 1968-1993)] Abraham E, et al. Orv Hetil 1995 Jun
  18;136(25):1329-32 (Eng. Abstr.)                        (Hun)

   PREVENTION & CONTROL

 Isoniazid  preventive  therapy  in  areas  of  high  isoniazid
  resistance. Sterling TR, et al. Arch Intern Med 1995 Aug 7-21;
  155(15):1622-8

   TRANSMISSION

 Transmission  of  multidrug-resistant  tuberculosis in a large
  urban setting. Friedman CR, et al. Am J Respir Crit Care  Med
  1995 Jul;152(1):355-9

 TUBERCULOSIS, SPINAL

   DIAGNOSIS

 Role  of  CT  and  MR imaging in the management of tuberculous
  spondylitis. Sharif HS, et al. Radiol Clin North Am 1995 Jul;
  33(4):787-804 (80 ref.)

 TUMOR NECROSIS FACTOR

   ANALYSIS

 The relationship between  serum  or  plasma  levels  of  tumor
  necrosis  factor  alpha and neuropsychological functioning in
  early human immunodeficiency virus infection. Swanson  B,  et
  al. Appl Nurs Res 1995 May;8(2):88-91

   BIOSYNTHESIS

 Cytokine  and  immunoglobulin  subclass  responses  of rats to
  infection  with  Eimeria  nieschulzi.  Smith   NC,   et   al.
  Parasitology 1995 Jul;111 ( Pt 1):51-7
 The  HIV  membrane gp 120 protein is toxic to human brain cell
  cultures through the induction of  interleukin-6  (IL-6)  and
  tumor  necrosis  factor-alpha(TNF-alpha).  American Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research 63rd annual meeting; 1994 May 2-5; Seattle. Yeung M,
  et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):314  (unnumbered
  abstract)
 Tumor   necrosis  factor-alpha  responses  are  depressed  and
  interleukin-6 responses unaltered in feline  immunodeficiency
  virus  infected  cats.  Ma J, et al. Vet Immunol Immunopathol
  1995 May;46(1-2):35-50

   METABOLISM

 Higher cytotoxic activity and increased levels of  IL-1  beta,
  IL-6,  and  TNF-alpha  in patients undergoing cardiopulmonary
  bypass. Marti F, et al. Am J Hematol 1995 Jul;49(3):237-9

   PHARMACOLOGY

 [Effect  of  low  dose  rhTNF-alpha  on  immune  function   of
  lymphocytes in burned rats] Su B, et al. Chung Hua Cheng Hsing
  Shao Shang Wai Ko Tsa Chih 1995 Jan;11(1):36-9 (Eng. Abstr.)
                                                          (Chi)

   PHYSIOLOGY

 Lentiviral infection, immune response peptides and sleep. Darko
  DF, et al. Adv Neuroimmunol 1995;5(1):57-77 (76 ref.)

   SECRETION

 Sunlight induced progression of AIDS. Vincek V. Med Hypotheses
  1995 Feb;44(2):119-23 (27 ref.)

 TUMOR VIRUS INFECTIONS

   COMPLICATIONS

 Epstein-Barr virus associated lymphoproliferative disorder with
  fatal involvement of the gastrointestinal tract in an infant.
  Pan LX, et al. J Clin Pathol 1995 Apr;48(4):390-2
 An association between HIV infection, Epstein-Barr virus (EBV)
  immune  status,  cardiomyopathy, and lymphocytic interstitial
  pneumonia (LIP).  American  Pediatric  Society  104th  annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting;  1994  May 2-5; Seattle. Valentine M, et al. Pediatr
  AIDS HIV Infect 1994 Oct;5(5):320 (unnumbered abstract)

   PATHOLOGY

 Skin-associated  lymphoid  tissue  in  human  immunodeficiency
  virus-1,  human  papillomavirus,  and  herpes  simplex  virus
  infections. Memar OM, et al. J Invest Dermatol 1995 Jul;105(1
  Suppl):99S-104S (56 ref.)
 [Herpes simplex  virus  type  II  infection  as  an  exophytic
  endobronchial tumor] Armbruster C, et al. Wien Klin Wochenschr
  1995;107(11):344-6 (Eng. Abstr.)                        (Ger)

   VIROLOGY

 Hepatosinusoidal leukaemia/lymphoma consisting of Epstein-Barr
  virus-containing  natural  killer cell leukaemia/lymphoma and
  T-cell lymphoma; mimicking malignant histiocytosis. Ohshima K,
  et al. Hematol Oncol 1995 Mar-Apr;13(2):83-97

 UGANDA

 Validating population surveys for the measurement  of  HIV/STD
  prevention  indicators.  Konings  E,  et  al.  AIDS 1995 Apr;
  9(4):375-82

   EPIDEMIOLOGY

 Village-based AIDS prevention in a rural district  in  Uganda.
  Schopper D, et al. Health Policy Plan 1995 Jun;10(2):171-80
 Conjunctival  malignant  disease  with  AIDS  in  USA [letter]
  Goedert JJ, et al. Lancet 1995 Jul 22;346(8969):257-8

 UKRAINE

 [Effective knowledge propaganda  is  the  chief  strategy  for
  preventing HIV infection among adolescents] Usenko AD, et al.
  Vrach Delo 1994 Sep-Dec;(9-12):192-6                    (Rus)

   EPIDEMIOLOGY

 [The  epidemiological  characteristics  of  HIV  infection  in
  Ukraine]  Kobyshcha  IuV,  et  al.  Vrach  Delo 1994 Sep-Dec;
  (9-12):3-7 (Eng. Abstr.)                                (Rus)

 ULTRAVIOLET RAYS

   ADVERSE EFFECTS

 Sunlight induced progression of AIDS. Vincek V. Med Hypotheses
  1995 Feb;44(2):119-23 (27 ref.)

 UMBILICAL VEINS

   VIROLOGY

 Productive  in  vitro  infection  of  human   umbilical   vein
  endothelial  cells  and three colon carcinoma cell lines with
  HIV-1.  Corbeil  J,  et  al.  Immunol  Cell  Biol  1995  Apr;
  73(2):140-5

 UNITED STATES

 Finding suggests AZT therapy may help prevent occupational HIV
  infection. AIDS Alert 1995 Apr;10(4):45-7 (3 ref.)
 Universal  precautions  are  not  universally   practiced   by
  anesthesiologists [letter] Berry AJ, et al. Anesth Analg 1995
  Jul;81(1):205
 Prevention of AIDS transmission through screening of the blood
  supply.  Galel SA, et al. Annu Rev Immunol 1995;13:201-27 (84
  ref.)
 The ratio of AIDS to non-AIDS Medicaid medical costs from 1992
  to 2000. Kotzan JA, et al. Clin Ther 1995 Mar-Apr;17(2):320-9
 Prevention of maternal HIV transmission. Practical guidelines.
  Rouzioux C. Drugs 1995;49 Suppl 1:17-24; discussion 38-40 (27
  ref.)
 Charter implications of compelling dentists to reveal their HIV
  status. Mauth T. Health Law Can 1995;15(4):97-106
 Eleventh Circuit affirms decision involving nurse who  refused
  to  care  for  an  HIV-positive patient. Armstrong v. Flowers
  Hospital, Inc. Hosp Law Newsl 1995 Jul;12(9):8
 FDA approves oral HIV test [news] Infect Control Hosp Epidemiol
  1995 Mar;16(3):186
 Evaluation of infection control  measures  in  preventing  the
  nosocomial  transmission of multidrug-resistant Mycobacterium
  tuberculosis in a New York City hospital. Stroud LA,  et  al.
  Infect Control Hosp Epidemiol 1995 Mar;16(3):141-7
 Patterns  in  Maryland  Medicaid enrollment among persons with
  AIDS. Bartnyska LM, et al. Inquiry 1995 Summer;32(2):184-95
 Service delivery to persons with HIV and AIDS. Saunders E,  et
  al. Iowa Med 1995 Jun;85(6):250-1
 Prenatal  care  of HIV-infected women: analysis of a large New
  York State cohort. Turner BJ, et al. J  Acquir  Immune  Defic
  Syndr Hum Retrovirol 1995 Aug 1;9(4):371-8
 College  health  responds  to  HIV:  hard  lessons  and a rich
  heritage. Keeling RP. J Am Coll Health 1995 May;43(6):271-2
 Seeking a moral center [editorial] Kalinoski J. J Assoc Nurses
  AIDS Care 1995 Mar-Apr;6(2):9-10
 Community-based HIV case management: challenges and
  opportunities. Sowell RL.  J  Assoc  Nurses  AIDS  Care  1995
  Mar-Apr;6(2):33-40
 Infection  control for our patients and ourselves. Stern A, et
  al. J Emerg Med Serv JEMS 1995 Jun;20(6):92-3, 95
 Protection against  hospital-acquired  tuberculosis,  American
  style:  a report on the 4th Annual Meeting of the Society for
  Hospital Epidemiology of America (SHEA), New  Orleans,  1994.
  Wilcox MH. J Hosp Infect 1995 Mar;29(3):165-8
 In  vitro  T cell function, delayed-type hypersensitivity skin
  testing, and CD4+ T  cell  subset  phenotyping  independently
  predict   survival  time  in  patients  infected  with  human
  immunodeficiency virus. Dolan MJ, et al. J  Infect  Dis  1995
  Jul;172(1):79-87
 An  assessment of Ryan White Title IIIb HIV early intervention
  programs in Region VI of  the  United  States  Public  Health
  Service.  Rawlings  MK,  et  al.  J  Natl Med Assoc 1995 Jun;
  87(6):436-40
 Legal obligations to human immunodeficiency virus--seropositive
  patients and health care providers. Smith MH. J Prof Nurs 1995
  May-Jun;11(3):183-91
 Reducing the impact of opportunistic  infections  in  patients
  with  HIV infection. New guidelines [editorial] Kaplan JE, et
  al. JAMA 1995 Jul 26;274(4):347-8
 CDC recommends wider prenatal HIV screening [news] McCarthy M.
  Lancet 1995 Jul 15;346(8968):172
 IOM criticises US blood product safety procedures [news]  Rowe
  PM. Lancet 1995 Jul 22;346(8969):243
 Ascertaining  exposure  categories of HIV-infected individuals
  with previously unrecorded risk data [see comments] Stevenson
  EM, et al. Med J Aust 1995 Jul 17;163(2):66-9
 Future of AIDS research  office  threatened  [news]  Appel  A.
  Nature 1995 Jul 20;376(6537):205-6
 Baboon/man  transplant backed for HIV victim [news] Lehrman S.
  Nature 1995 Jul 20;376(6537):204
 What  administrators  need  to  know  about  the   rights   of
  HIV-infected  employees.  Riley  JB  Jr,  et al. Nephrol News
  Issues 1995 Mar;9(3):18-24
 Human immunodeficiency virus transmission in household
  settings--United States. Pediatr AIDS HIV  Infect  1994  Oct;
  5(5):325-8
 A pediatrician's view. Building strong adolescents [editorial]
  Altemeier WA 3rd. Pediatr Ann 1995 Apr;24(4):181-2
 Inpatient  hospice  care: a new option for the terminally ill.
  Martin EW. R I Med 1995 Apr;78(4):118-9
 Top scientists come to defense of AIDS research office  [news]
  Science 1995 Jul 14;269(5221):151
 Italy.  Returning  emigres  add  new luster to AIDS research
  [news] Balter M. Science 1995 Jul 7;269(5220):24-5
 AIDS research: who should hold the purse strings? [news] Cohen
  J. Science 1995 Jul 21;269(5222):292
 FDA panel OKs  baboon  marrow  transplant  [news]  Pennisi  E.
  Science 1995 Jul 21;269(5222):293-4

   EPIDEMIOLOGY

 Rates  of  p24  antigenemia  and viral isolation in comparable
  white  and  black  HIV-infected  subjects.  Military  Medical
  Consortium for Applied Retroviral Research. Brown AE, et  al.
  AIDS 1995 Apr;9(4):325-8
 Does  zidovudine  cause non-Hodgkin's lymphoma? [letter] Cote
  TR, et al. AIDS 1995 Apr;9(4):404-5
 The changing face of tuberculosis. Huebner RE, et al. Annu Rev
  Med 1995;46:47-55 (24 ref.)
 Patients with human immunodeficiency virus  infection  in  the
  hemodialysis   unit.   How  vulnerable  are  the  caregivers?
  [editorial; comment] Gilbert DN, et al. Arch Intern Med  1995
  Aug 7-21;155(15):1575-6
 A  conversation  with Kristine Gebbie: the first national AIDS
  policy coordinator [interview by Susan Gaskins] Gebbie  K.  J
  Assoc Nurses AIDS Care 1995 Mar-Apr;6(2):47-9
 HIV  and  AIDS. An EMS perspective. Murphy PM 3rd. J Emerg Med
  Serv JEMS 1995 Jun;20(6):62-70, 73, 76; quiz 74-5
 Seroprevalence of human T  cell  lymphotropic  virus  type  II
  infection, with or without human immunodeficiency virus type 1
  coinfection,  among  US intravenous drug users. Briggs NC, et
  al. J Infect Dis 1995 Jul;172(1):51-8
 Conjunctival malignant  disease  with  AIDS  in  USA  [letter]
  Goedert JJ, et al. Lancet 1995 Jul 22;346(8969):257-8
 Multifocal  lower  genital  tract  neoplasia in women with HIV
  disease. Abercrombie PD, et al. Nurse Pract 1995 May;20(5):68,
  74, 76
 Relationship  between  use  of  condoms  and  other  forms  of
  contraception  among  human  immunodeficiency  virus-infected
  women. Supplement to HIV and AIDS Surveillance Project Group.
  Diaz T, et al. Obstet Gynecol 1995 Aug;86(2):277-82
 Tuberculosis (TBC) in HIV-exposed or infected  U.S.  children.
  American  Pediatric  Society 104th annual meeting and Society
  for Pediatric Research 63rd annual  meeting;  1994  May  2-5;
  Seattle.  Gutman  L, et al. Pediatr AIDS HIV Infect 1994 Oct;
  5(5):323 (unnumbered abstract)

 UNITED STATES FOOD AND DRUG ADMINISTRATION

 FDA panel OKs  baboon  marrow  transplant  [news]  Pennisi  E.
  Science 1995 Jul 21;269(5222):293-4

 UNIVERSAL PRECAUTIONS

 Universal   precautions   are  not  universally  practiced  by
  anesthesiologists [letter] Berry AJ, et al. Anesth Analg 1995
  Jul;81(1):205

 UP-REGULATION (PHYSIOLOGY)

   DRUG EFFECTS

 Implication of cyclosporine in up-regulation of Bcl-2
  expression and maintenance of CD8 lymphocytosis in
  cytomegalovirus-infected allograft recipients. Labalette M, et
  al. Transplantation 1995 Jun 27;59(12):1714-23

 URACIL

   ANALOGS & DERIVATIVES

 The inhibition of human immunodeficiency virus type 1 in vitro
  by a non-nucleoside reverse transcriptase inhibitor  MKC-442,
  alone  and  in  combination  with  other  anti-HIV compounds.
  Brennan TM, et al. Antiviral Res 1995 Mar;26(2):173-87

 URBAN HEALTH

 Hepatitis B virus infection in high-risk inner-city
  neighborhoods in San Francisco. Siegel D, et  al.  Hepatology
  1995 Jul;22(1):44-9

 URBAN POPULATION

 Tuberculosis  knowledge  among  New  York  City injection drug
  users. Wolfe H, et al. Am J Public Health 1995 Jul;85(7):985-8

 UREA

   ANALOGS & DERIVATIVES

 Synthesis and anti-HIV activity of new  urea  and  nitrosourea
  derivatives of diamino acids. Dulude H, et al. Bioorg Med Chem
  1995 Feb;3(2):151-60
 Flexibility  and  function  in  HIV-1  protease [see comments]
  Nicholson LK, et al. Nat Struct Biol 1995 Apr;2(4):274-80

 URETERAL DISEASES

   VIROLOGY

 Cytomegalovirus ureteritis as a cause of renal  failure  in  a
  child infected with the human immunodeficiency virus. Mueller
  BU, et al. Clin Infect Dis 1995 Apr;20(4):1040-3

 URTICARIA

   PHYSIOPATHOLOGY

 Mast  cells and T lymphocytes in chronic urticaria. Barlow RJ,
  et al. Clin Exp Allergy 1995 Apr;25(4):317-22

 UVEITIS

   ETIOLOGY

 The  relationship  between  HTLV-I-infected  cell  lines   and
  uveitis. Fukushima A, et al. Graefes Arch Clin Exp Ophthalmol
  1995 Apr;233(4):231-5

 UVEITIS, ANTERIOR

   CHEMICALLY INDUCED

 [Uveitis  associated  with  rifabutin  treatment. Apropos of 3
  patients] Chevalley GF, et al. Klin Monatsbl Augenheilkd 1995
  May;206(5):388-90 (Eng. Abstr.)                         (Fre)

 VACCINATION

   VETERINARY

 Recombinant FeLV vaccine: long-term protection and  effect  on
  course and outcome of FIV infection. Hofmann-Lehmann R, et al.
  Vet Immunol Immunopathol 1995 May;46(1-2):127-37
 Vaccination  against feline immunodeficiency virus using fixed
  infected cells. Verschoor EJ, et al. Vet Immunol Immunopathol
  1995 May;46(1-2):139-49

 VACCINES, SYNTHETIC

 Poxvirus-based vaccine candidates for cancer, AIDS, and  other
  infectious diseases. Perkus ME, et al. J Leukoc Biol 1995 Jul;
  58(1):1-13 (154 ref.)

   ADVERSE EFFECTS

 The safety and use of canarypox vectored vaccines. Plotkin SA,
  et al. Dev Biol Stand 1995;84:165-70

   GENETICS

 The safety and use of canarypox vectored vaccines. Plotkin SA,
  et al. Dev Biol Stand 1995;84:165-70

   IMMUNOLOGY

 Vaccination with recombinant vaccinia viruses expressing ICP27
  induces  protective  immunity  against  herpes  simplex virus
  through CD4+ Th1+ T cells. Manickan E, et al.  J  Virol  1995
  Aug;69(8):4711-6
 Antibody  response  to booster doses of hepatitis B vaccine in
  HIV-infected children. American Pediatric Society 104th annual
  meeting  and  Society  for  Pediatric  Research  63rd  annual
  meeting; 1994 May 2-5; Seattle. Choudhury SA, et al.  Pediatr
  AIDS HIV Infect 1994 Oct;5(5):321 (unnumbered abstract)

   ISOLATION & PURIFICATION

 Adenovirus as vector for HIV: efficacy and safety issues. Natuk
  RJ, et al. Dev Biol Stand 1995;84:153-6

   THERAPEUTIC USE

 Human T cell lymphotropic virus: necessity for and feasibility
  of  a  vaccine.  de  The  G,  et  al.  Ciba Found Symp 1994;
  187:47-55; discussion 55-60 (19 ref.)
 Humoral immune responses to recombinant tree pollen  allergens
  (Bet  v  I and Bet v II) in mice: construction of a live oral
  allergy vaccine. Vrtala S, et al. Int  Arch  Allergy  Immunol
  1995 May-Jun;107(1-3):290-4 (15 ref.)

 VACCINIA VIRUS

   IMMUNOLOGY

 Vaccination with recombinant vaccinia viruses expressing ICP27
  induces  protective  immunity  against  herpes  simplex virus
  through CD4+ Th1+ T cells. Manickan E, et al.  J  Virol  1995
  Aug;69(8):4711-6

 VAGINA

   VIROLOGY

 HIV-1 in cervico-vaginal secretions of infected mothers and in
  the  gastric  aspirates  of their infants. American Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research 63rd annual meeting; 1994 May 2-5; Seattle.  Nielsen
  K,   et   al.  Pediatr  AIDS  HIV  Infect  1994  Oct;5(5):322
  (unnumbered abstract)

 VALINE

   ANALOGS & DERIVATIVES

 Comparative analysis of the X-ray structures of HIV-1 and HIV-2
  proteases in complex with CGP 53820, a novel  pseudosymmetric
  inhibitor.  Priestle  JP,  et  al.  Structure  1995  Apr  15;
  3(4):381-9

 VARIATION (GENETICS)

 Causes  of  HIV diversity [letter] Bonhoeffer S, et al. Nature
  1995 Jul 13;376(6536):125

 VASCULITIS

   PATHOLOGY

 [Granulomatous angiitis of the central nervous system
  complicated by the  syndrome  of  inappropriate  antidiuretic
  hormone]  Shiozi Y, et al. No To Shinkei 1995 Jun;47(6):595-9
  (Eng. Abstr.)                                           (Jpn)

 VASCULITIS, HYPERSENSITIVITY

   CHEMICALLY INDUCED

 The time course and characterization of mercuric
  chloride-induced immunopathology in  the  brown  Norway  rat.
  Qasim FJ, et al. J Autoimmun 1995 Apr;8(2):193-208

 VICTORIA

   EPIDEMIOLOGY

 Ascertaining  exposure  categories of HIV-infected individuals
  with previously unrecorded risk data [see comments] Stevenson
  EM, et al. Med J Aust 1995 Jul 17;163(2):66-9

 VIRAL CORE PROTEINS

   METABOLISM

 Influence of human immunodeficiency virus nucleocapsid protein
  on synthesis and strand transfer by the reverse transcriptase
  in vitro. Rodriguez-Rodriguez L, et al. J Biol Chem 1995 Jun
  23;270(25):15005-11

 VIRAL ENVELOPE PROTEINS

 (Patho)physiologic pathways to drug targeting: artificial viral
  envelopes. Schreier H, et al. J Mol  Recognit  1995  Jan-Apr;
  8(1-2):59-62

   GENETICS

 Two  different  mutations  in  the  envelope protein of feline
  immunodeficiency  virus  allow  the  virus  to  escape   from
  neutralization  by  feline serum antibodies. Siebelink KH, et
  al. Vet Immunol Immunopathol 1995 May;46(1-2):51-9

   IMMUNOLOGY

 Serological diagnosis of feline immunodeficiency virus
  infection using recombinant transmembrane glycoprotein.
  Calzolari M,  et  al.  Vet  Immunol  Immunopathol  1995  May;
  46(1-2):83-92

   METABOLISM

 Endocytosis of endogenously synthesized HIV-1 envelope protein.
  Mechanism and role in processing for association with class II
  MHC. Rowell JF, et al. J Immunol 1995 Jul 1;155(1):473-88
 Analysis  of  the  cleavage site of the human immunodeficiency
  virus type 1 glycoprotein: requirement of precursor  cleavage
  for glycoprotein incorporation. Dubay JW, et al. J Virol 1995
  Aug;69(8):4675-82
 Effect  of  amino acid substitutions on calmodulin binding and
  cytolytic properties of the LLP-1 peptide  segment  of  human
  immunodeficiency  virus  type 1 transmembrane protein. Tencza
  SB, et al. J Virol 1995 Aug;69(8):5199-202

   PHYSIOLOGY

 A single mutation within the V3 envelope neutralization domain
  of feline immunodeficiency virus determines its  tropism  for
  CRFK cells. Verschoor EJ, et al. J Virol 1995 Aug;69(8):4752-7

 VIRAL MATRIX PROTEINS

   BIOSYNTHESIS

 High  expression  of latent membrane protein 1 of Epstein-Barr
  virus and  BCL-2  oncoprotein  in  acquired  immunodeficiency
  syndrome-related primary brain lymphomas. Camilleri-Broet S,
  et al. Blood 1995 Jul 15;86(2):432-5

   GENETICS

 Mutational  analysis of the conserved cysteine residues in the
  simian immunodeficiency virus matrix protein. Gonzalez SA, et
  al. Virology 1995 Jul 10;210(2):501-7

   METABOLISM

 Unidirectional budding of HIV-1 at the  site  of  cell-to-cell
  contact  is  associated with co-polarization of intercellular
  adhesion molecules and HIV-1 viral matrix protein. Fais S, et
  al. AIDS 1995 Apr;9(4):329-35

 VIRAL PROTEINS

   IMMUNOLOGY

 Neutralization of feline immunodeficiency virus by  polyclonal
  feline  antibody:  simultaneous  involvement of hypervariable
  regions 4 and 5 of the surface glycoprotein. Siebelink KH, et
  al. J Virol 1995 Aug;69(8):5124-7

   METABOLISM

 The trans-inhibitory Rep78 protein of  adeno-associated  virus
  binds  to  TAR region DNA of the human immunodeficiency virus
  type 1 long terminal repeat. Batchu RB, et al. FEBS Lett 1995
  Jul 3;367(3):267-71
 Arginine-rich  regions  succeeding  the  nuclear  localization
  region of the herpes simplex virus type 1 regulatory  protein
  ICP27 are required for efficient nuclear localization and late
  gene  expression.  Hibbard  MK,  et  al.  J  Virol  1995 Aug;
  69(8):4656-67

 VIRAL VACCINES

 Poxvirus-based vaccine candidates for cancer, AIDS, and  other
  infectious diseases. Perkus ME, et al. J Leukoc Biol 1995 Jul;
  58(1):1-13 (154 ref.)
 Vaccination  against feline immunodeficiency virus using fixed
  infected cells. Verschoor EJ, et al. Vet Immunol Immunopathol
  1995 May;46(1-2):139-49

   IMMUNOLOGY

 Vaccination with recombinant vaccinia viruses expressing ICP27
  induces protective  immunity  against  herpes  simplex  virus
  through  CD4+  Th1+  T cells. Manickan E, et al. J Virol 1995
  Aug;69(8):4711-6
 Recombinant FeLV vaccine: long-term protection and  effect  on
  course and outcome of FIV infection. Hofmann-Lehmann R, et al.
  Vet Immunol Immunopathol 1995 May;46(1-2):127-37
 FIV  vaccine  studies.  II.  Clinical  findings, hematological
  changes and kinetics of blood lymphocyte subsets.
  Hofmann-Lehmann R, et al. Vet Immunol Immunopathol 1995  May;
  46(1-2):115-25
 FIV vaccine studies. I. Immune response to recombinant FIV env
  gene  products and outcome after challenge infection. Lutz H,
  et al. Vet Immunol Immunopathol 1995 May;46(1-2):103-13

   THERAPEUTIC USE

 Human T cell lymphotropic virus: necessity for and feasibility
  of a vaccine. de  The  G,  et  al.  Ciba  Found  Symp  1994;
  187:47-55; discussion 55-60 (19 ref.)

 VIREMIA

   DRUG THERAPY

 Decreased  human  immunodeficiency virus type 1 plasma viremia
  during antiretroviral therapy reflects downregulation of viral
  replication in lymphoid tissue. Cohen OJ, et  al.  Proc  Natl
  Acad Sci U S A 1995 Jun 20;92(13):6017-21

   EPIDEMIOLOGY

 Prevalence of viremia in human immunodeficiency virus-infected
  patients  with renal disease [see comments] Kimmel PL, et al.
  Arch Intern Med 1995 Aug 7-21;155(15):1578-84

   VETERINARY

 Recombinant FeLV vaccine: long-term protection and  effect  on
  course and outcome of FIV infection. Hofmann-Lehmann R, et al.
  Vet Immunol Immunopathol 1995 May;46(1-2):127-37

 VIRUS ACTIVATION

   IMMUNOLOGY

 Cross-linking  of  CD30  induces HIV expression in chronically
  infected T  cells.  Biswas  P,  et  al.  Immunity  1995  Jun;
  2(6):587-96

 VIRUS DISEASES

   COMPLICATIONS

 Links and interactions between mycoplasmas and viruses: past
  confusions and present realities. Chastel C. Arch Virol 1995;
  140(5):811-26 (101 ref.)
 Enteric  viruses  associated  with  HIV infection in Tanzanian
  children with chronic diarrhea. Cegielski JP, et al.  Pediatr
  AIDS HIV Infect 1994 Oct;5(5):296-9
 Fever as the presenting complaint of travellers returning from
  the tropics. Doherty JF, et al. QJM 1995 Apr;88(4):277-81

   PATHOLOGY

 [Morphologic characteristics of digestive tract mucosa in virus
  infections]  Parkhmenko  IuG, et al. Arkh Patol 1995 Mar-Apr;
  57(2):21-5 (Eng. Abstr.)                                (Rus)

   THERAPY

 Principles for adoptive T cell therapy of human viral diseases.
  Riddell SR, et al. Annu Rev Immunol 1995;13:545-86 (249 ref.)

   TRANSMISSION

 Trans-species transplants raise virus fears [news] Lehrman  S.
  Nature 1995 Jul 6;376(6535):8

 VIRUS INHIBITORS

   PHARMACOLOGY

 Secretory leukocyte protease inhibitor: a human saliva protein
  exhibiting  anti-human  immunodeficiency  virus 1 activity in
  vitro. McNeely TB, et al. J Clin Invest 1995 Jul;96(1):456-64

 VIRUS INTEGRATION

 [Detection  of  STLV-1  integration  in  DNA  extracted   from
  formalin-fixed and paraffin-embedded material from M.
  arctoides lymphoma by the polymerase chain reaction] Chikobava
  MG, et al. Biull Eksp Biol Med 1995 Mar;119(3):314-6    (Rus)

 VIRUS REPLICATION

 HIV  infection  decreases  intracellular  nicotinamide adenine
  dinucleotide [NAD] Murray MF,  et  al.  Biochem  Biophys  Res
  Commun 1995 Jul 6;212(1):126-31
 Protection  of a T-cell line from human immunodeficiency virus
  replication by the stable expression of a short antisense RNA
  sequence carried by a shuttle RNA molecule. Cagnon L, et al. J
  Acquir  Immune  Defic  Syndr  Hum  Retrovirol  1995  Aug   1;
  9(4):349-58
 Human  immunodeficiency  virus  type  1  TAR element revertant
  viruses define RNA structures required  for  efficient  viral
  gene  expression  and  replication. Harrich D, et al. J Virol
  1995 Aug;69(8):4906-13
 Effect of CD8 T cell lines derived from vertically HIV infected
  children on HIV  replication  in  naturally  infected  cells.
  American  Pediatric  Society 104th annual meeting and Society
  for Pediatric Research 63rd annual  meeting;  1994  May  2-5;
  Seattle. Heerema AE, et al. Pediatr AIDS HIV Infect 1994 Oct;
  5(5):314 (unnumbered abstract)
 CD8-mediated suppression of autologous HIV-1 replication in a 5
  week  old  HIV-1  infected infant. American Pediatric Society
  104th annual meeting and Society for Pediatric Research  63rd
  annual  meeting;  1994  May  2-5;  Seattle. Pollack H, et al.
  Pediatr  AIDS  HIV  Infect  1994   Oct;5(5):320   (unnumbered
  abstract)
 Routine  immunizations  of  HIV-infected  individuals  and HIV
  replication. American Pediatric Society 104th annual  meeting
  and  Society for Pediatric Research 63rd annual meeting; 1994
  May 2-5; Seattle. Ramilo O, et al. Pediatr  AIDS  HIV  Infect
  1994 Oct;5(5):321 (unnumbered abstract)

   DRUG EFFECTS

 Antitubulin   drugs  inhibit  HIV-1  replication  by  blocking
  tyrosine phosphorylases.  American  Pediatric  Society  104th
  annual meeting and Society for Pediatric Research 63rd annual
  meeting; 1994 May 2-5; Seattle. Nquyen QV, et al. Pediatr AIDS
  HIV Infect 1994 Oct;5(5):324 (unnumbered abstract)
 Hydroxyurea (HU) increases activation of 2',3'-dideoxycytidine
  (ddC) (Meeting abstract). Agarwal RP, et al. Proc Annu Meet Am
  Assoc Cancer Res; 36:A2410 1995
 Dehydroepiandrosterone inhibits replication of feline
  immunodeficiency virus in chronically infected cells. Bradley
  WG, et al. Vet Immunol Immunopathol 1995 May;46(1-2):159-68

   GENETICS

 Suppression  of  simian  immunodeficiency virus replication by
  human immunodeficiency virus type 1  trans-dominant  negative
  rev mutants. Endres CL, et al. J Virol 1995 Aug;69(8):5164-6
 Mutational  analysis of the conserved cysteine residues in the
  simian immunodeficiency virus matrix protein. Gonzalez SA, et
  al. Virology 1995 Jul 10;210(2):501-7
 Role of the conserved dipeptide Gly75 and Cys76 on  HIV-1  Vpr
  function.   Mahalingam  S,  et  al.  Virology  1995  Jul  10;
  210(2):495-500
 Effects of mutations in constant regions 3 and 4 of envelope of
  simian immunodeficiency virus. Morrison HG, et  al.  Virology
  1995 Jul 10;210(2):448-55

   PHYSIOLOGY

 A  determinant  of  feline  immunodeficiency virus involved in
  Crandell feline kidney cell tropism. Siebelink KH, et al. Vet
  Immunol Immunopathol 1995 May;46(1-2):61-9

 VIRUSES

   DRUG EFFECTS

 Iodine-mediated inactivation of lipid- and  nonlipid-enveloped
  viruses in human antithrombin III concentrate. Highsmith F, et
  al. Blood 1995 Jul 15;86(2):791-6

 VISUAL PERCEPTION

 The  Charles  Bonnet syndrome: a brief review and case report.
  Maricle RA, et al. Psychiatr Serv 1995  Mar;46(3):289-91  (10
  ref.)

 VITAMIN A DEFICIENCY

   IMMUNOLOGY

 Vitamin A deficiency results in a priming environment conducive
  for  Th1  cell development. Cantorna MT, et al. Eur J Immunol
  1995 Jun;25(6):1673-9

 VITAMIN D DEFICIENCY

   IMMUNOLOGY

 Tuberculosis, HIV, hormones and children [editorial;  comment]
  Wilkinson  RJ,  et al. J R Coll Physicians Lond 1995 Mar-Apr;
  29(2):86-8

 VITAMIN E

   BLOOD

 Immunoglobulin E levels in relationship to HIV-1 disease, route
  of infection, and vitamin E status. Miguez-Burbano MJ, et al.
  Allergy 1995 Feb;50(2):157-61

 VITILIGO

   IMMUNOLOGY

 T cells in regenerating feathers of Smyth line  chickens  with
  vitiligo.  Erf GF, et al. Clin Immunol Immunopathol 1995 Aug;
  76(2):120-6

 VOLUNTARY HEALTH AGENCIES

   ORGANIZATION & ADMINISTRATION

 Integrated case management: the AID Atlanta Model. Sowell  RL,
  et al. J Case Manag 1995 Spring;4(1):15-21

 VOLUNTARY WORKERS

 Is   the   unpaid/paid  donation  debate  for  better  or  for
  worse?--advantages of unpaid donations.  Contreras  M.  Blood
  Coagul Fibrinolysis 1994 Dec;5 Suppl 4:S27-8

   EDUCATION

 High-risk  vulnerable  populations  and volunteers: a model of
  education and service collaboration. Hutchison RR, et  al.  J
  Community Health Nurs 1995;12(2):111-9

 VON WILLEBRAND'S DISEASE

   COMPLICATIONS

 Bleeding   after  tonsillectomy  in  severe  von  Willebrand's
  disease.  Alusi  GH,  et  al.  J  Laryngol  Otol  1995   May;
  109(5):437-9

   DIAGNOSIS

 Hemophilia and von Willebrand's disease: 1. Diagnosis,
  comprehensive  care and assessment. Association of Hemophilia
  Clinic Directors of Canada. Can  Med  Assoc  J  1995  Jul  1;
  153(1):19-25 (31 ref.)

   THERAPY

 Hemophilia   and   von  Willebrand's  disease:  1.  Diagnosis,
  comprehensive care and assessment. Association of  Hemophilia
  Clinic  Directors  of  Canada.  Can  Med  Assoc J 1995 Jul 1;
  153(1):19-25 (31 ref.)
 Hemophilia  and  von  Willebrand's  disease:  2.   Management.
  Association of Hemophilia Clinic Directors of Canada. Can Med
  Assoc J 1995 Jul 15;153(2):147-57

 WALKING

 [A  case  of  amnesia  and  walking  disorder  associated with
  subacute progression of HIV encephalopathy] Fujii T,  et  al.
  Nippon Naika Gakkai Zasshi 1995 May 10;84(5):798-9      (Jpn)

 WATER MICROBIOLOGY

 What's in the water? Treat Rev 1995 Mar/Apr;(no 17):4-5

 WEIGHT LOSS

 Plasma  interferon  alpha and the wasting syndrome in patients
  infected  with  the  human  immunodeficiency  virus  [letter]
  Constans J, et al. Clin Infect Dis 1995 Apr;20(4):1069-70
 Winning a losing battle. Winson G. Nurs Times 1995  Jun  7-13;
  91(23):40-3

 WOMEN

 Combined use of condoms with other contraceptive methods among
  inner-city  Baltimore  women.  Santelli  JS, et al. Fam Plann
  Perspect 1995 Mar-Apr;27(2):74-8

   PSYCHOLOGY

 Love, sex, and power. Considering  women's  realities  in  HIV
  prevention.  Amaro  H.  Am  Psychol 1995 Jun;50(6):437-47 (80
  ref.)

 WOMEN'S HEALTH

 HIV conference spotlights women's concerns.  AIDS  Alert  1995
  Apr;10(4):54-7
 Framework  for counseling pregnant women presented. AIDS Alert
  1995 Apr;10(4):57-8
 HIV and AIDS: issues for women in Australia. Lucke JC, et  al.
  Health Care Women Int 1995 May-Jun;16(3):221-8

 WORK CAPACITY EVALUATION

 HIV infection and neuropsychological impairment [letter] Marsh
  NV. N Z Med J 1995 Jun 14;108(1001):235

 WORLD HEALTH

 The epidemiology of rotavirus infections: a global perspective.
  Haffejee   IE.   J   Pediatr  Gastroenterol  Nutr  1995  Apr;
  20(3):275-86 (165 ref.)
 Need for action against tuberculosis [news] World Health Forum
  1995;16(2):218-9

 X CHROMOSOME

 X-linked pure familial spastic paraparesis. Characterization of
  a large kindred with magnetic resonance imaging studies. Cambi
  F, et al. Arch Neurol 1995 Jul;52(7):665-9

 XEROSTOMIA

   VIROLOGY

 Relationship of oral disease to the presence of cytomegalovirus
  DNA in the saliva of AIDS patients. Greenberg MS, et al. Oral
  Surg Oral  Med  Oral  Pathol  Oral  Radiol  Endod  1995  Feb;
  79(2):175-9

 YEASTS

   DRUG EFFECTS

 A  comparison  of  susceptibility to five antifungal agents of
  yeast cultures from burn patients. Still JM Jr, et al.  Burns
  1995 May;21(3):167-70

 ZALCITABINE

   ADMINISTRATION & DOSAGE

 Results of a clinical trial comparing two doses of
  2'3'-dideoxycytidine  (ddC) in the treatment of children with
  symptomatic human immunodeficiency virus (HIV) infection  who
  were  intolerant or had failed zidovudine (ZDV) therapy (ACTG
  138). The Pediatric  AIDS  Clinical  Trials  Group.  American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Spector  SA, et al. Pediatr AIDS HIV Infect 1994 Oct;5(5):323
  (unnumbered abstract)

   ANALOGS & DERIVATIVES

 Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine
  in patients  with  AIDS  or  advanced  AIDS-related  complex.
  Wainberg MA, et al. AIDS 1995 Apr;9(4):351-7

   PHARMACOKINETICS

 Zalcitabine.  Clinical pharmacokinetics and efficacy. Devineni
  D, et al. Clin Pharmacokinet 1995 May;28(5):351-60 (52 ref.)
 Hydroxyurea (HU) increases activation of 2',3'-dideoxycytidine
  (ddC) (Meeting abstract). Agarwal RP, et al. Proc Annu Meet Am
  Assoc Cancer Res; 36:A2410 1995

   PHARMACOLOGY

 Effect of zidovudine and didanosine treatment on heart function
  in  children  infected  with  human  immunodeficiency  virus.
  Domanski MJ, et al. J Pediatr 1995 Jul;127(1):137-46

   THERAPEUTIC USE

 Combination 3TC/AZT therapy shows promise. AIDS Clin Care 1995
  Mar;7(3):22
 Zalcitabine. Clinical pharmacokinetics and efficacy.  Devineni
  D, et al. Clin Pharmacokinet 1995 May;28(5):351-60 (52 ref.)
 Effect of zidovudine and didanosine treatment on heart function
  in  children  infected  with  human  immunodeficiency  virus.
  Domanski MJ, et al. J Pediatr 1995 Jul;127(1):137-46
 3TC and AZT. Treat Rev 1995 Mar/Apr;(no 17):2

 ZAMBIA

   EPIDEMIOLOGY

 Benefits  of  HIV  screening  of blood transfusions in Zambia.
  Foster S, et al. Lancet 1995 Jul 22;346(8969):225-7

 ZIDOVUDINE

   ADMINISTRATION & DOSAGE

 Health beliefs  and  discontinuation  of  zidovudine  therapy.
  Geletko  SM,  et  al.  Am  J  Health  Syst  Pharm 1995 Mar 1;
  52(5):505-7
 Adherence to zidovudine  (AZT)  among  HIV-infected  methadone
  patients:  a pilot study of supervised therapy and dispensing
  compared to usual care. Wall TL, et al. Drug  Alcohol  Depend
  1995 Mar;37(3):261-9
 Perspectives  in  drug therapy of HIV infection. Darbyshire J.
  Drugs 1995;49 Suppl 1:1-3; discussion 38-40
 Early versus delayed treatment of  HIV  infection.  Zidovudine
  should  be  given before symptoms develop. Richman DD, et al.
  Drugs 1995;49 Suppl 1:9-16; discussion 38-40 (37 ref.)
 Prevention of maternal HIV transmission. Practical guidelines.
  Rouzioux C. Drugs 1995;49 Suppl 1:17-24; discussion 38-40 (27
  ref.)
 Time to hit HIV, early and hard [editorial; comment] Ho DD.  N
  Engl J Med 1995 Aug 17;333(7):450-1

   ADVERSE EFFECTS

 Does  zidovudine  cause non-Hodgkin's lymphoma? [letter] Cote
  TR, et al. AIDS 1995 Apr;9(4):404-5
 Metabolic  abnormalities  in  skeletal  muscle   of   patients
  receiving zidovudine therapy observed by 31P in vivo magnetic
  resonance spectroscopy. Sinnwell TM, et al. J Clin Invest 1995
  Jul;96(1):126-31

   ANALOGS & DERIVATIVES

 Drug synergism by nucleoside analog drugs against HIV-RT based
  on  multiple  inhibitor kinetics (Meeting abstract). Periclou
  AP, et al. Proc Annu Meet Am Assoc Cancer Res; 36:A1720 1995

   PHARMACOKINETICS

 Exposure to zidovudine in the fetal baboon. American Pediatric
  Society  104th  annual  meeting  and  Society  for  Pediatric
  Research 63rd annual meeting; 1994 May 2-5; Seattle.  Garland
  M,   et   al.  Pediatr  AIDS  HIV  Infect  1994  Oct;5(5):315
  (unnumbered abstract)

   PHARMACOLOGY

 Effect of zidovudine and didanosine treatment on heart function
  in  children  infected  with  human  immunodeficiency  virus.
  Domanski MJ, et al. J Pediatr 1995 Jul;127(1):137-46

   THERAPEUTIC USE

 Finding suggests AZT therapy may help prevent occupational HIV
  infection. AIDS Alert 1995 Apr;10(4):45-7 (3 ref.)
 Combination 3TC/AZT therapy shows promise. AIDS Clin Care 1995
  Mar;7(3):22
 Zidovudine  is  beneficial  in  human  immunodeficiency  virus
  associated nephropathy. Ifudu O, et al. Am  J  Nephrol  1995;
  15(3):217-21
 Review   of   antiretroviral  therapy  in  the  prevention  of
  HIV-related AIDS dementia complex (ADC). Portegies  P.  Drugs
  1995;49 Suppl 1:25-31; discussion 38-40 (45 ref.)
 The   value  of  the  CD4+  count  of  500  cells/microliters.
  Volberding P. Drugs 1995;49 Suppl 1:4-8; discussion 38-40 (18
  ref.)
 Zidovudine for the prevention of vertical HIV transmission:  a
  decision  analytic approach. Rouse DJ, et al. J Acquir Immune
  Defic Syndr Hum Retrovirol 1995 Aug 1;9(4):401-7
 The predictive value of T cell function in vitro and  pre-AIDS
  zidovudine  use for survival after AIDS diagnosis in a cohort
  of homosexual men in Amsterdam. Bindels PJ, et al.  J  Infect
  Dis 1995 Jul;172(1):97-104
 Zidovudine treatment prolongs survival and decreases virus load
  in  the  central  nervous  system of rhesus macaques infected
  perinatally with simian immunodeficiency virus. Rausch DM, et
  al. J Infect Dis 1995 Jul;172(1):59-69
 Drug resistance and heterogeneous long-term virologic responses
  of human immunodeficiency virus type 1-infected  subjects  to
  zidovudine  and  didanosine  combination  therapy.  The  AIDS
  Clinical  Trials Group 143 Virology Team. Shafer RW, et al. J
  Infect Dis 1995 Jul;172(1):70-8
 Effect of zidovudine and didanosine treatment on heart function
  in  children  infected  with  human  immunodeficiency  virus.
  Domanski MJ, et al. J Pediatr 1995 Jul;127(1):137-46
 A controlled trial of zidovudine in primary human
  immunodeficiency virus infection  [see  comments]  Kinloch-De
  Loes S, et al. N Engl J Med 1995 Aug 17;333(7):408-13
 A comparison of immediate with deferred zidovudine therapy for
  asymptomatic  HIV-infected adults with CD4 cell counts of 500
  or more per cubic millimeter. AIDS Clinical Trials Group [see
  comments] Volberding PA, et al. N Engl J  Med  1995  Aug  17;
  333(7):401-7
 Maternal-infant transmission of HIV infection: use of
  zidovudine [news] Klaus BD. Nurse Pract 1995 Apr;20(4):70-2
 Clinical characteristics of children enrolled into a
  randomized, double-blind trial of antiretroviral therapy (ACTG
  152).  American  Pediatric  Society  104th annual meeting and
  Society for Pediatric Research 63rd annual meeting; 1994  May
  2-5; Seattle. Englund JA, et al. Pediatr AIDS HIV Infect 1994
  Oct;5(5):322 (unnumbered abstract)
 Laboratory   characteristics   of  children  enrolled  into  a
  randomized, double-blind trial of antiretroviral therapy (ACTG
  152). American Pediatric Society  104th  annual  meeting  and
  Society  for Pediatric Research 63rd annual meeting; 1994 May
  2-5; Seattle. Englund JA, et al. Pediatr AIDS HIV Infect 1994
  Oct;5(5):322 (unnumbered abstract)
 Markers prognostic for survival  in  zidovudine  treated,  HIV
  infected  children.  ACTG  Protocol 043 Study Group. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  McKinney  RS.  Pediatr  AIDS  HIV  Infect  1994  Oct;5(5):323
  (unnumbered abstract)
 Results of a clinical trial comparing two doses of
  2'3'-dideoxycytidine (ddC) in the treatment of children  with
  symptomatic  human immunodeficiency virus (HIV) infection who
  were intolerant or had failed zidovudine (ZDV) therapy  (ACTG
  138).  The  Pediatric  AIDS  Clinical  Trials Group. American
  Pediatric  Society  104th  annual  meeting  and  Society  for
  Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
  Spector SA, et al. Pediatr AIDS HIV Infect 1994  Oct;5(5):323
  (unnumbered abstract)
 Decreased  human  immunodeficiency virus type 1 plasma viremia
  during antiretroviral therapy reflects downregulation of viral
  replication in lymphoid tissue. Cohen OJ, et  al.  Proc  Natl
  Acad Sci U S A 1995 Jun 20;92(13):6017-21
 3TC and AZT. Treat Rev 1995 Mar/Apr;(no 17):2
 AZT and children. Treat Rev 1995 Mar/Apr;(no 17):2
 Reduced provirus burden and enhanced humoral immune function in
  AZT-treated SCID-feline mice inoculated with feline
  immunodeficiency  virus.  Johnson  CM,  et  al.  Vet  Immunol
  Immunopathol 1995 May;46(1-2):169-80

 ZIMBABWE

   EPIDEMIOLOGY

 Effect  of  nutritional  and  HIV  status  on  bacteraemia  in
  Zimbabwean  children  who died at home. Wolf BH, et al. Eur J
  Pediatr 1995 Apr;154(4):299-303

 ZINC FINGERS

   PHYSIOLOGY

 Surface  plasmon  resonance  based  kinetic  studies  of  zinc
  finger-DNA interactions. Yang WP, et al.  J  Immunol  Methods
  1995 Jun 14;183(1):175-82